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Abstract 
Translation is a highly regulated and quality-controlled process ensuring the production of 
correct polypeptides. Although translation initiation is a major target of regulation, 
translational control occurs also at the end of translation. Both, translation termination and 
ribosome recycling are tightly connected and create a pool of ribosomal subunits necessary 
for multiple rounds of translation. Arriving mRNAs from the nucleus are controlled in the 
cytoplasm for the presence of correct open reading frames (ORFs). In cases where errors 
are detected, the regarding faulty mRNAs and the truncated proteins are degraded. The 
three cytoplasmic quality control pathways are nonsense mediated decay (NMD), no-stop 
decay (NSD) and no-go decay (NGD). NMD targets mRNAs that contain a premature 
termination codon (PTC), whereas NSD recognizes transcripts that lack a stop codon. NGD 
finally senses ribosomes that stall on regular codons, because of strong secondary 
structures or rare codons. 
In this study, we have characterized the role of the DEAD-box RNA helicase 5 
(Dbp5/DDX19) in translation termination. Moreover, we have identified a novel role of Dbp5 
in the cytoplasmic mRNA quality control. 
Current models anticipate that the translation termination factors eRF1 and eRF3 are 
recruited to terminating ribosomes in a complex. In our studies we used a combination of in 
vivo and in vitro experiments to shown that Dbp5 regulates a stepwise assembly of the 
termination complex. Our experiments indicate that the termination factor Rli1 and eRF3-
GDP associate with the ribosome first. Subsequently, Dbp5-ATP delivers eRF1 to the stop 
codon. Dbp5 dissociates upon ATP-hydrolysis, allowing eRF1 to contact eRF3 and 
terminate translation. Upon GTP hydrolysis by eRF3, eRF1 is placed in the peptidyl 
transferase center to initiate peptidyl-tRNA hydrolysis. eRF3-GDP is displaced from the 
termination complex by Hcr1, which was delivered by eIF3. Rli1 can now bind to eRF1 to 
mediate the release of the peptide. The interaction of Rli1 and eRF1 enables ATP hydrolysis 
by Rli1, which leads to the splitting of the ribosomes into their subunits. Therefore, the 
delivery of eRF1 through Dbp5 prevents a premature dissociation of eRF1 from the 
ribosome through premature contact with eRF3. This is important, because defects in DBP5 
result in the readthrough of the stop codon and elongated polypeptides. Thus, the stepwise 
Dbp5 controlled termination complex assembly is essential for correct translation 
termination.  
Defects in DBP5 do not only affect normal translation. Our data furthermore show a function 
of this helicase in NMD, as an NMD-reporter construct accumulate in RAT8 mutants. 
Importantly, we have shown that Dbp5 not only collaborates with eRF1 and eRF3 in regular 
translation and NMD, but we could also show that it regulates NSD through delivery of the 
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interacts with Dom34 and Hbs1, which is different from regular termination, where Dbp5 
does not contact eRF3. This suggests a different functional mode of Dbp5 in NSD and NGD 
than in regular termination. In fact, Dom34, and Hbs1 show a decreased interaction with 
each other and the ribosome when Dbp5 is not functional, supporting this view. Importantly, 
this binding defect culminates in the accumulation of NSD transcripts.  
Therefore, Dbp5 does not only govern regular translation termination and NMD via 
controlling the eRF1 and eRF3 interaction, but it is also an important factor required for NSD 
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 Introduction 
2.1. Eukaryotic translation termination and ribosome recycling 
A rapidly dividing cell is estimated to synthesize 13,000 proteins per second (von der Haar, 
2008) and contains ~200.000 ribosomes (Warner, 1999). In consideration of the 
tremendous resources cells use for translation, approximately more then the half of the 
energy is used for translation in a logarithmically growing yeast cell, it is important to 
understand this complex process to get insights into the biology of life. In accord with its 
critical role in protein synthesis, the translation apparatus adapts mRNA specific protein 
synthesis on growth conditions and external stimuli. The basic mechanism of translation is 
well conserved and involves the following steps: initiation, elongation, termination and 
ribosome recycling. The multiple players necessary for initiation and elongation are well 
described in several reviews (Dever and Green, 2012; Dever et al., 2016). This work 
focuses on translation termination and ribosome recycling, which were considered as 
distinct mechanisms for a long time. However, Shoemaker et al. (2011) highlight a key 
connection between eukaryotic translation termination and recycling, with which the 
mechanism clearly differs from the independently evolved and heterogeneous processes in 
bacteria. 
 
2.1.1. Translation termination and recycling 
Translation termination takes place as soon as the elongating ribosome reaches a stop 
codon (UAA, UAG or UGA) on the mRNA and involves stop codon recognition at the 
ribosomal A-site, subsequent hydrolysis of the P-site peptidyl-tRNA and finally the release 
of the polypeptide chain (Jackson et al., 2012). Subsequently, the post-termination complex 
is recycled and provides a pool of 40S and 60S subunits for additional rounds of translation 
(Dever and Green, 2012). In eukaryotes two essential release factors are well known to 
mediate translation termination. The eukaryotic release factor 1 (eRF1) and eukaryotic 
release factor 3 (eRF3) encoded by the SUP45 and SUP35, respectively in S. cerevisiae 
are the main players in translation termination (von der Haar and Tuite, 2007). All three 
kinds of stop codons are recognized and bound by eRF1, which subsequently promotes 
hydrolysis of the peptidyl-tRNA in the ribosomal peptidyl transferase center (PTC). The 
interaction between eRF1 and eRF3 is critical for stop codon recognition (Wada and Ito, 
2014) and GTP hydrolysis by eRF3 enhances translation termination efficiency (Salas-
Marco and Bedwell, 2004). Upon GTP hydrolysis eRF3 dissociates from eRF1 and 
Ribonuclease L inhibitor 1 (Rli1) is able to bind to eRF1. Binding of Rli1 (ABCE1 in human), 
an ABC-family ATPase, promotes eRF1 mediated hydrolysis of the peptidyl-tRNA and 
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2.1.2. The eukaryotic release factors eRF1 and eRF3 
In contrast to bacteria, which contain the two release factors RF1 and RF2, eRF1 is the only 
class I release factor in eukaryotes and as such capable of recognizing all three termination 
codons (Jackson et al., 2012). 
The structure of eRF1 mimics a tRNA and is composed of three domains (Song et al., 2000; 
Taylor et al., 2012) (Fig 1). The N-terminal domain with its conserved TASNIKS and YxCxxF 
motifs is required for recognizing all three termination codons (Bertram et al., 2000). The 
central domain or domain M with its methylated GGQ motif promotes hydrolysis of the 
peptidyl-tRNA bond (Heurgué-Hamard et al., 2005) and the C-terminal domain interacts 
with the class II release factor eRF3 (Blanchet et al., 2015; Conard et al., 2012). 
In yeast, a temperature sensitive mutant (sup45-2) of eRF1 was described, which loses the 
ribosome binding ability upon a temperature shift to the non-permissive temperature of 
37°C. The temperature sensitivity of the mutant is caused by an Ile222Ser missense 
mutation, which is located within the β8 motif of the M domain (Song et al., 2000; Stansfield 
et al., 1995). This binding defect results in a translation termination defect as the peptidyl-
tRNA hydrolysis is disturbed (Stansfield et al., 1997). 
 
Figure 1 - Structure and domains of the eukaryotic release factors eRF1 and eRF3. 
The ribbon structure of human eRF1 and eRF3 are shown. For both proteins, their different domains 
and important motifs are displayed. Adopted from Jackson et al. (2012).  
The eRF3 protein consists of an essential C-terminus and a dispensable N-terminus that is 
capable to elicit the prion [PSI+] activity of eRF3 (Jackson et al., 2012). The C-terminal 
region contains the domain 1 or G and the β-barrel domains 2 and 3 (Fig 1). Domain 1 is 
necessary for the binding of GTP and shows structural similarities to the corresponding 
domains in bacterial RF3 and in the eukaryotic elongation factor eEF1A (Kong et al., 2004). 
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the N-terminal domain is required for the interaction with the poly(A)-binding protein Pab1, 
although it is dispensable for termination (Kushnirov et al., 1988; Stansfield et al., 1997; 
Uchida et al., 2002). In mammals, the gene duplication of eRF3 leads to two different 
variants that differ in the length of their N-termini, called eRF3a (GSPT1) and eRF3b 
(GSPT2) (Hoshino et al., 1998). Binding of eRF3 to eRF1 increases its binding affinity to 
GTP (Pisareva et al., 2006). Because, both eRF1 and 80S ribosomes are required for the 
stimulation of the GTPase activity of eRF3 (Frolova et al., 1996), GTP hydrolysis should 
occur at the ribosome after eRF1 binding. 
 
2.1.3. The iron sulfur containing ATP-binding cassette protein Rli1 
Rli1 was originally identified as an inhibitor of the ribonuclease RNase L, which was 
characterized as a protein that is activated by the interferon system in response to viral 
infections in mammalian cells (Bisbal et al., 1995). However, an additional function of Rli1 
in translation termination is described, where its main function was shown to be in splitting 
the ribosome into its subunits at the end of translation (Khoshnevis et al., 2010; Pisarev et 
al., 2010; Shoemaker et al., 2011). 
The yeast Rli1 protein has 68% amino acid identity with human ABCE1 (Dean and Annilo, 
2005). It comprises a cysteine-rich N-terminal domain, which carries two cubic [4FE-4S] 
clusters, followed by two nucleotide binding domains (NBDs) arranged in the typical head-
to-tail orientation (Kispal et al., 2005). These two ATP binding cassettes (ABC) share high 
sequence homology with members of the ABC protein family and are connected by a unique 
hinge domain (Barthelme et al., 2011; Chen et al., 2006) (Fig 2). Rli1 is essential and 
mutations in conserved motifs involved in ATP binding and hydrolysis are lethal (Barthelme 
et al., 2007; Dong et al., 2004; Karcher et al., 2005). The ADP-bound and nucleotide-free 
states are in an open conformation and ATP binding induces a conformational change 
required for closure of the nucleotide binding site (Chen et al., 2003; Karpowich et al., 2001). 
It is assumed that Rli1 converts the chemical energy of ATP hydrolysis into a tweezers-like 
motion of the NBDs that could be transferred to interaction partners as this is characteristic 
for ABC-proteins (Chen et al., 2003; Karcher et al., 2005). Addition of the non-hydrolysable 
ATP analogue AMPPNP arrests Rli1 in a conformation that associates efficiently with the 
40S but not with the 60S ribosomal subunit (Andersen and Leevers, 2007; Dong et al., 
2004; Kispal et al., 2005). 
There is no homolog of Rli1 known in bacteria, but the protein is highly conserved in 
eukaryotes and archaea (Chen et al., 2006; Kispal et al., 2005). However, for the known 
interaction partner of Rli1 in higher eukaryotes, RNase L, no orthologue is present in either 
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Figure 2 - Structural overview and conformation of Pyrococcus abysii ABCE1. 
Top-view of pabABCE1 in a stereo plot of a ribbon representation. The Fe-S domains bound to iron 
(red) and sulfur (yellow) are shown in green. The two nucleotide binding domains NBD1 and NBD2 
are indicated in yellow (NBD2) and red (NBD2). The P-loop/Walker A motif is highlighted by P, while 
the signature motif is indicated by S. Furthermore, the helix-loop-helix insertion of NBD1 (blue) and 
the hinge domain (pale blue) are shown. Adopted from Karcher et al. (2008). 
Yarunin et al. (2005) showed that the majority of Rli1 is bound to 40S subunits, 80S 
ribosomes and polysomes under low-salt conditions. Furthermore, depletion of Rli1 in yeast 
leads to processing and export defects of the large and small ribosomal subunits. In accord, 
depletion of Nar1, required for incorporation of Fe-S clusters into Rli1, affects nuclear 
accumulation of pre-ribosomal subunits. Taken together with the binding of Rli1 to late 20S 
and 7S pre-rRNAs, an additional function in late ribosome biogenesis of Rli1 is probable 
(Kispal et al., 2005; Yarunin et al., 2005).  
A further possible function of Rli1 might be in translation initiation. Dong et al. (2004) showed 
that Rli1 in yeast associates with eukaryotic translation initiation factors in vivo, such as 
eukaryotic initiation factor 5 (eIF5), eukaryotic initiation factor 3 (eIF3) and with subunits of 
the eIF3. Moreover, depletion of Rli1 leads to reduced protein synthesis and polysome run-
off, as well as to fewer polysomes. Additionally, the interaction of the 40S subunit with the 
eukaryotic initiation factor 2 (eIF2) and eukaryotic initiation factor 1 (eIF1) was markedly 
decreased if Rli1 is not functional, indicating a role in the assembly of 43S pre-initiation 
complexes (Dong et al., 2004; Kispal et al., 2005). 
Its main function, however, is in ribosome splitting. Pisarev et al. (2010) showed that Rli1 is 
involved in the dissociation of the ribosome after translation termination, which is also 
termed ribosome recycling. For ribosomal splitting, Rli1 requires also the canonical 
translation termination factors eRF1 and eRF3 (Khoshnevis et al., 2010; Rodnina, 2010; 
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movement, which is generated through ATP-hydrolysis. In addition to its function in regular 
translation termination, Rli1 is also involved in separating the ribosomal subunits of empty 
or stalled ribosomes on mostly defective transcripts in no-go decay (NGD) and no-stop 
decay (NSD). In contrast to regular termination, in which Rli1 interacts with eRF1 and eRF3, 
here it requires the eRF1-eRF3 paralogues Dom34 (pelota in humans) and Hbs1 (Pisareva 
et al., 2011; Shoemaker et al., 2011). 
 
2.1.4. Current model of translation termination and recycling 
Termination occurs when the ribosome reaches the end of the open reading frame (ORF) 
and a stop codon enters the A-site. Upon arrival of the elongating ribosome at the stop 
codon current models assume that the ternary complex eRF1-eRF3-GTP binds to the A-
site of pre-TCs (termination complex). This binding likely results in conformational changes 
in pre-TCs that induces a 2-nt forward shift of their toe-print (Alkalaeva et al., 2006) allowing 
the stop codon to reach the P1 pocket of eRF1 (Blanchet et al., 2015). This mode of 
rearrangements has been supported by crystal structures of pre-TCs (Cheng et al., 2009; 
Song et al., 2000). Binding of the complex to the 80S ribosome stimulates the GTPase 
activity of eRF3 (Frolova et al., 1996). GTP hydrolysis of eRF3 induces further 
conformational changes in eRF1 that enable the GGQ motif of its M domain to enter the 
PTC. This conformation is able to mediate the subsequent peptidyl-tRNA hydrolysis, which 
is abrogated if eRF3 is bound to GMPPNP instead of GTP (Alkalaeva et al., 2006). Effective 
peptidyl-tRNA hydrolysis, is further supported by an interaction of Rli1 with eRF1, which is 
conducted via the NBD2 of Rli1 and the C-terminus of eRF1 (Becker et al., 2012; Preis et 
al., 2014; Shoemaker et al., 2011). Moreover, depletion of Rli1 causes increased 
readthrough activity of stop codons in a dual reporter assay, indicating a connecting role of 
Rli1 in translation termination and recycling. This is further supported by nonsense 
suppression assays in which it was shown that overexpression of RLI1 can compensate the 
readthrough activity of translation termination factor mutants (Khoshnevis et al., 2010). 
Interestingly, Rli1 cannot interact with eRF1 on ribosomal complexes, if eRF3 is sterically 
fixed in its GTP-bound form (e.g. with GMPPNP) (Pisarev et al., 2010). Thus, a model in 
which Rli1 is not able to bind to eRF1 before eRF3 leaves the post-TC complex is likely. In 
addition, even though Rli1 binds effectively to the 40S ribosomal subunit in its ATP-bound 
form, this interaction is not sufficient to enhance the NTPase activity of Rli1. This was only 
observed for the interaction with eRF1 bound to post- and pre-TCs (Pisarev et al., 2010). 
Furthermore, it was shown, that only in the presence of ATP but not ADP or AMPPNP, Rli1 
is able to disassemble eRF1 bound post-TCs (Pisarev et al., 2010). This led to the 
suggestion, that the ATPase activity of Rli1 and its binding to eRF1 are requirements for 
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is a prerequisite for efficient recycling (Pisarev et al., 2010). This model shows similarities 
between the eukaryotic and bacterial ribosome recycling, whereby bacteria use the 
recycling factor RRF/EG-G and its GTP hydrolysis for phosphate release and subunit 
dissociation (Savelsbergh et al., 2009). According to the presented data, the following 
model for translation termination and ribosome recycling mediated by eRF1, eRF3 and Rli1 
was proposed: 
As soon as the ribosome reaches a stop codon, it is assumed that eRF1-eRF3-GTP as a 
ternary complex is recruited to the free A-site of the ribosome (Fig 3). GTP hydrolysis by 
eRF3 causes a conformational change of eRF1 that places the GGQ motif in the PTC. 
Furthermore, dissociation of eRF3 allows Rli1 to take over the binding site of eRF1 and 
stabilize eRF1 in its favorable conformation (Brown et al., 2015). Subsequently, eRF1 acts 
as peptidyl-tRNAse and releases the peptide from the ribosome. 
 
Figure 3 - Model of translation termination and ribosome recycling. 
Upon arrival of the 80S ribosome at the stop codon the A-site is free. Thus, eRF1 (blue) and eRF3 
(brown) together with GTP (green) are recruited in a ternary complex to the ribosomal A-site and 
eRF1 recognizes the stop codon. GTP-hydrolysis of eRF3 leads to the proper positioning of eRF1 in 
the peptidyl-transferase center. Subsequently, ABCE1/Rli1 (green) is able to bind to eRF1 at the 
same binding site of eRF3 and locks eRF1 in its favorable position. That allows eRF1 to hydrolyze 
the peptidyl-tRNA (cyan) and the polypeptide is released. Subsequently, Rli1 mediates the ATPase 
dependent splitting of the ribosomal subunits in association with eRF1. The subunits are directly 
occupied by eIF3j to avoid subunit rejoining. Modified from Dever and Green (2012).  
While the binding of Rli1 to eRF1 and the ribosome induces its ATPase activity, the resulting 
tweezers-like motion of Rli1 separates the ribosomal subunits. In detail, those post-
termination ribosomes are split into free 60S subunits, the deacylated tRNA and mRNA-
bound 40S subunit. Therefore the mechanical driving force of Rli1 that disrupts some 
intersubunit bridges during recycling (Barthelme et al., 2011; Nürenberg and Tampé, 2013; 
Pisarev et al., 2010) and eRF1 and eRF3 are sufficient to mediate translation termination 
shown by a kinetic in vitro analysis (Shoemaker and Green, 2011). However, in vivo several 
additional factors have been identified to be involved in translation termination. Therefore, 
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Several findings point to a connection between initiation, termination and recycling in 
translation. Poly uridylate binding 1 (Pub1) was shown to interact with the N-terminal prion 
domain of eRF3, but it binds independently of eRF1 and eRF3 to the ribosome. Lack of 
Pub1 decreases the efficiency of nonsense readthrough in different nucleotide surroundings 
(Urakov et al., 2017). Furthermore, several mutations in eIF3 reduce the rate of stop codon 
readthrough and these mutants genetically interact with mutant eRFs (Beznosková et al., 
2013). Moreover, deletion of the high copy suppressor of Rpg1 (Hcr1), which is not 
considered as a bona fide eIF3 subunit anymore, increases readthrough and accumulates 
eRF3 in heavy polysomes (Beznosková et al., 2013, 2015). Additionally, Schuller et al. 
(2017) described that ribosomes accumulate at stop codons and in the 3’ UTR in the 
absence of the eukaryotic initiation factor 5 A (eIF5A). Moreover, adding recombinant eIF5A 
in a reconstituted translation system increases the rate of peptidyl-tRNA hydrolysis more 
than 17-fold. Another interesting finding is, that Rli1 can bind Hcr1 (Khoshnevis et al., 2010). 
Furthermore, the dissociation efficiency of Rli1 and the subsequent release of tRNA and 
mRNA from recycled 40S subunits is enhanced by the presence of eukaryotic initiation 
factor 6 (eIF6) and eukaryotic initiation factors 1, 1A and 3 (Jackson et al., 2010; Pisarev et 
al., 2010; Si et al., 1997). Most surprising, however was the discovery, that the mRNA-
export factor Dbp5 is required for translation termination (Bolger et al., 2008; Gross et al., 
2007) (see also chapter 2.3.2). 
Taken together, it seems that not only translation termination and ribosome recycling are 
tightly connected steps in translation, but also initiation, termination and recycling are 
functionally linked. Thus, the identification of the functions of the additional factors required 
for translation in vivo is essential to get the full picture and the regulatory layers that are 
important in nature. 
 
2.2. Cytoplasmic mRNA surveillance systems 
Eukaryotic mRNAs have to pass several different quality control checkpoints to ensure the 
production of correct polypeptides. Nuclear quality control monitors 5’ capping, 3’ 
polyadenylation and splicing and allows nuclear export through recruitment of export factors 
(Doma and Parker, 2007; Soheilypour and Mofrad, 2018; Zander et al., 2016). 
The cytoplasmic quality control of mRNAs is a co-translational process that tests the 
presence of an intact ORF. If a ribosome stalls because of secondary structures (e.g. 
sequence of rare codons or stem loops) or because a truncated mRNAs that lacks a stop 
codon altogether, the mRNA and truncated protein are degraded through NGD or NSD. If 
the mRNA contains a premature stop codon e.g. due to splicing defects, these transcripts 
are eliminated via the nonsense mediated decay (NMD) (Lykke-Andersen and Bennett, 
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If a ribosome never reaches a correct termination codon, it is useful that this error is 
detected at an early time point to avoid accumulation of defective proteins (Pechmann et 
al., 2013). To ensure this, cells tag such faulty proteins for degradation already during 
translation. 
 
2.2.1. Nonsense mediated decay (NMD) 
Nonsense mediated decay factors recognize and typically degrade mRNAs with translation 
termination codons that are classified as premature termination codon (PTC). A major group 
of transcripts containing a PTC originates from unspliced mRNAs, indicating that NMD 
might act as a fail-save mechanism for nuclear splicing (He et al., 1993; He et al., 2003). 
However, in multicellular organisms NMD is not only part of the cellular quality control 
system, but also necessary to dynamically adjust their transcriptomes to varying 
physiological conditions. It is part of the maturation pathway of lymphocytes (Wang et al., 
2002) and plays a crucial role in several developmental stages (Medghalchi, 2001; 
Metzstein and Krasnow, 2006). Although several models of NMD are discussed, in yeast 
the model shown in Fig 4 is currently widely accepted. 
 
Figure 4 - NMD initiation in S. cerevisiae. 
Upf1 binds nonspecifically to every mRNA and remains bound if the ribosome terminates at a PTC 
and not RTC (regular termination codon). Thus, eRF3 and Upf1 interact and thereby recruit Upf2 and 
Upf3. Recruitment of the Upf-complex inhibits further translation and recruit downstream factors that 
promote rapid degradation of the mRNA. Xrn1 act from 5’ to 3’ and the Ski complex and the exosome 
degrade the PTC-containing mRNA from 3’ into 5’ direction. Modified from Beißel et al. (2020). 
The proteins nuclear accommodation of mitochondria 7, (NAM7 but more frequently called 
Upf1), nonsense mediated mRNA decay 2 (NMD2, but more frequently named Upf2) and 




                                                                                                                                                    Introduction 
eukaryotes (Kervestin and Jacobson, 2012; Schweingruber et al., 2013). Upf1 is composed 
of a helicase domain, two RecA-like domains forming the helicase core and two regulatory 
domains called 1B and 1C. The ability of Upf1 to recognize PTC containing mRNAs 
depends on its ATPase and helicase activities (Franks et al., 2010; Kashima et al., 2006; 
Weng et al., 1996). It also has a cysteine histidine rich (CH) domain, which is essential for 
the interaction with the C-terminal domain of Upf2 (Dehecq et al., 2018). Upf2 instead 
connects Upf1 with Upf3 with the aid of one of its MIF4G domains that binds to Upf3 (He 
and Jacobson, 1995; He et al., 1997; Mendell et al., 2000). Upf3 contains both, a nuclear 
localization signals (NLSs) as well as a nuclear export signals (NESs) and shuttles between 
nucleus and cytoplasm (Shirley et al., 1998). Several groups could show that inhibition of 
translation elongation via cycloheximide treatment or translation mutants also affects NMD 
(Peltz et al., 1992; Zhang et al., 1997; Zuk and Jacobson, 1998). Additionally, stop codon 
recognition by eRF1 and eRF3 is a perquisite for activation of NMD. These results, 
corroborate that NMD requires translation termination as a starting point for its initiation 
(Kervestin and Jacobson, 2012).  
Current models suggest that the PTC of nonsense mRNAs is initially recognized by the 
canonical translation termination factors eRF1 and eRF3. How the surveillance machinery 
distinguishes between a PTC and a regular termination codon (RTC) is still a matter of 
debate. Two models are considered as the most likely. The first is the faux-UTR model, 
which is based on the observation that elongated 3’UTRs of mRNAs are sensed by the cell 
(Muhlrad and Parker, 1999). In normal translation termination, the poly(A) binding protein 
Pab1 is in close proximity to eRF3, whereas in premature termination the lack of eRF3 and 
Pab1 interaction allows the binding of Upf1 to eRF3 (Brogna and Wen, 2009). The second 
proposed model is the marking model, that assumes that a PTC does not only differ from a 
regular termination codon (RTC) in its distance to the poly(A) tail but also in the protein 
composition on the 3’ UTR. Downstream sequence elements (DSEs) in yeast are occupied 
by regulatory factors, which are removed by the translating ribosome (Peltz et al., 1993; 
Ruiz-Echevarría et al., 1998). If these regulatory factors are still bound to the mRNA, NMD 
is triggered. Similarly, intron splicing leads in higher eukaryotes to the deposition of exon 
junction complexes (EJCs), that have to be removed by the ribosome to prevent that NMD 
is triggered (Lykke-Andersen and Jensen, 2015). When a stop codon is reached, the Upf 
protein complex is recruited to the termination complex and stabilized to trigger mRNA 
degradation. He et al. (2003) and Muhlrad and Parker (1994) could show that NMD targets 
are degraded by the 5´-3´ decapping pathway and exoribonuclease 1 (Xrn1) catalyzed RNA 
degradation. Furthermore, deadenylation and 3’-5’ decay by the exosome and the Ski 
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2.2.2. Dom34 and Hbs1 
No-stop decay (NSD) and no-go decay NGD are part of the cytoplasmic mRNA co- 
translational quality control surveillance system and degrade mRNAs lacking a stop codon 
and mRNAs with translation inhibiting secondary structures. The yeast protein duplication 
of multilocus region (Dom34) and its co-factor HSP70 subfamily B suppressor (Hbs1) play 
a crucial role in NSD and NGD. As such, both proteins and their human homologs called 
Pelota and HBS1 are broadly conserved in archaea and eukaryotes, albeit with the 
exception that the translational GTPase Hbs1 seems to be functionally replaced by the 
related GTPase aEF1 in archaea (Kobayashi et al., 2010). Hbs1 is a member of the 
translational GTPase family that includes the eukaryotic eEF1A and eRF3 proteins. eEF1A 
delivers tRNAs to the ribosome and eRF3 was suggested to deliver eRF1 to the ribosome 
(Dever and Green, 2012; Jackson et al., 2012). These proteins bind their interaction 
partners (eEF1A + tRNA, eRF3 + eRF1 and Hbs1 + Dom34) in a GTP dependent manner 
at distinct states of the ribosome. Hbs1 has a paralogue, super killer 7 (Ski7), that arose 
from gene duplication in yeast (Marshall et al., 2018).  
 
Figure 5 - Structures of Dom34 and Hbs1. 
Ribbon representation of Saccharomyces cerevisiae Dom34 (left) and Hbs1 bound to GDP (right). 
Modified from Graille and Seraphin (2012). 
As a member of the eEF1A protein family, it is not surprising that both Hbs1 and eRF3 share 
a conserved part consisting of the G domain, domain I and II and a nonconserved N-terminal 
domain (Becker et al., 2011).  
Structural analyses of Pelota (Dom34) from Thermoplasma acidophilum (TaPelota) 
revealed that the protein possesses a tripartite structure that is organized in a cloverleaf-
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domain of Dom34 is similar to that of eRF1, but the two proteins differ in in their N-terminal 
domains (Lee et al., 2007). This indicates that the domains in eRF1, which are important 
for the interaction with eRF3, are structurally conserved in Dom34, and represent the 
binding domain for Hbs1. The binding of Dom34 to Hbs1 enhances the affinity of Hbs1 to 
GTP (Graille et al., 2008). However, as described earlier (chapter 2.1.2), the NTD of eRF1 
is thought to recognize the stop codons in the ribosomal A-site via its conserved NIKS loop, 
while Dom34 lacks this loop. Furthermore, Dom34 misses the conserved GGQ motif 
required for catalysis of peptide release. 
 
2.2.3. No-go-decay (NGD) 
NGD leads to ribosome stalling, that can turn out to be harmful, because it might change 
protein expression or involves changes in protein conformation or function. It occurs due to 
secondary structures like stem-loops (SL), rare codons or positively charged nascent NCs 
polypeptides (Chen et al., 2010; Doma and Parker, 2006; Van Den Elzen et al., 2010; 
Kobayashi et al., 2010; Kuroha et al., 2010; Tsuboi et al., 2012). As soon as the ribosome 
stalls on an mRNA, the endonucleolytic cleavage in close proximity to the stalled ribosome 
results in two mRNA fragments (Van Den Elzen et al., 2010; Passos et al., 2009; Tsuboi et 
al., 2012). The 3’ fragment is rapidly degraded via the 5’-3’ directed Xrn1 exoribonuclease. 
The 5’-end of transcripts, however, requires in addition Dom34-Hbs1 and Rli1 action before 
degradation of the 3’-ends of the endonucleolytically cleaved mRNAs can occur. The 
released 3’ end of the 5’ fragment is subsequently degraded via the exosome (Tsuboi et al., 
2012).  
 
2.2.4. No-stop decay (NSD) 
mRNA maturation, in particular splicing, is of importance for the generation of alternative 
splice variants and responsible for an increased variation of gene products. All processing 
events are highly regulated, but given the complexity of the reactions, errors can occur. For 
instance, polyadenylation usually occurs at the 3’ end of mRNA, but can be incorporated 
within an open reading frame at cryptic sites, resulting in mRNAs that lack a stop codon. 
Such mRNAs are called nonstop mRNAs (Frischmeyer et al., 2002; Van Hoof et al., 2002; 
Ozsolak et al., 2010; Pelechano et al., 2013). Another source of non-stop mRNAs is 
generated through endonucleolytic cleavage during NMD in higher eukaryotes. These 
RNAs parts comprise a proper 5’-end, but lack both a stop codon and poly-(A)-tail (Lykke-
Andersen and Jensen, 2015). NSD was first identified by using artificial model substrates. 
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the homologous of Aft/Crb1 encoding protein transcript as endogenous substrate for NSD 
(Guydosh and Green, 2014). 
In general, if the ribosome translates to the end of a truncated mRNA, the A-site is not 
mRNA bound and leads to the degradation of this aberrant transcript and the ribosome-
associated polypeptide. Biochemical analysis with a reconstituted translation system 
suggested a direct role of Dom34-Hbs1 in recognizing these complexes and in release of 
the mRNA, but found no indication for an influence of these proteins in peptide release 
(Pisareva et al., 2011; Shoemaker et al., 2010). Studies in cells of Drosophila melanogaster 
showed that Rli1 is also necessary for resolving stalled ribosomes on truncated mRNAs 
from the translation machinery (Frischmeyer et al., 2002). Additionally, the fungi specific 
GTPase Ski7, which recruits the Ski complex and subsequently the exosome is essential 
for 3’-5’ mediated degradation (Frischmeyer et al., 2002; van Hoof et al., 2000; Van Hoof et 
al., 2002; Tsuboi et al., 2012).  
 
2.2.5. Ribosome-associated quality control (RQC) 
Considering that Dom34 lacks the GGQ motif required to hydrolyze the ester bond between 
the peptide and tRNA, an additional pathway is required to degrade the nascent peptidyl-
tRNA. The ribosome-associated quality control (RQC) machinery recognizes nascent 
chains (NCs) associated with stalled ribosomes and promotes the ubiquitylation and 
degradation of stalled NCs at the 60S subunit (Bengtson and Joazeiro, 2010; Brandman et 
al., 2012; Shao and Hegde, 2014; Shao et al., 2015). The yeast E3 ubiquitin ligase, called 
RING domain mutant killed by Rft1 deletion (Rkr1, but more frequently called Lnt1), was 
identified to ubiquitinylate the product of nonstop mRNA. Ubiquitylation by Ltn1 (Listerin in 
mammals) makes the NC accessible for degradation by the proteasome (Bengtson and 
Joazeiro, 2010). In parallel, a search for genetic interactions with LTN1 mutants and mRNA 
decay pathway mutants uncovered mutations in ribosome quality control 1 (Rqc1), 
ribosome quality control complex 2 (Rqc2) and the cell division cycle 48 (Cdc48) complex 
(Brandman et al., 2012; Defenouillère et al., 2013). Together with the 60S subunit, these 
factors form the 60S-associated ribosome quality control complex (RQC). Recruitment of 
Cdc48 to the ribosome requires Rqc1, Rqc2, Ltn1 and an ubiquitinylated NC, whereby 
Cdc48 finally delivers the NC to the proteasome for degradation (Brandman et al., 2012; 
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2.2.6. Current model of no-go and no-stop decay 
Shoemaker et al. (2011) could show that Rli1 is capable of stimulating ribosome subunit 
dissociation with either eRF1 or Dom34 in an ATP dependent manner. Furthermore, they 
revealed that ribosome recycling requires energy because it is inhibited by GTPase deficient 
eRF3 and Hbs1 or in the presence of a non-hydrolysable GTP analog, GDPPNP. Together 
with the finding that binding of Dom34 to Hbs1 promotes its GTP binding affinity, a model 
comparable to normal translation termination is probable. In this model, it is suggested that 
Dom34 and Hbs1 bind to the ribosome presumably together with GTP in a ternary complex 
(Becker et al., 2011) (Fig 6). In yeast, the ribosome is marked as stalled by the histone E3 
ubiquitin ligase (Hel2, ZNF598 in mammals). Hel2 ubiquitinates uS10 at K6/8 and plays a 
crucial role in RQC (Garzia et al., 2017; Juszkiewicz and Hegde, 2017; Matsuo et al., 2017; 
Sundaramoorthy et al., 2017). GTP hydrolysis by Hbs1 accommodates Dom34 into the 
active site. Thereby, Dom34 could directly interact with the decoding center contacting 
mRNA, rRNA and uS7. As a consequence the mRNA-tRNA interaction with the ribosome 
is destabilized (Becker et al., 2011). Interestingly, cryoEM structures indicate that the N-
terminal domain of Hbs1 contacts the mRNA entry site (Becker et al., 2011). Following GTP 
hydrolysis by Hbs1, GDP-Hbs1 dissociates from the complex and Rli1 can take over the 
binding site of Dom34. In NGD and NSD Rli1 might act with Dom34, like it does in regular 
termination with eRF1, to lock it in its favorable position for the ATP-dependent splitting of 
the ribosome. However, in contrast to regular termination, peptide release does not occur 
(Shoemaker et al., 2011). The released mRNA is rapidly degraded via the Ski complex and 
the exosome from its 3’ end (Kashima et al., 2014). The Ski (Ski2-Ski3-Ski8) complex in 
yeast is recruited by Ski7 and is required for 3’-5’ degradation (Schmidt et al., 2016). The 
nascent protein is degraded via the ribosome associated quality control pathway. This 
model coopts in general both NGD and NSD, but there are some notable differences. In 
NSD the A-site of the ribosome is empty and after recycling of the ribosomes, the mRNA is 
freely accessible for degradation. In no-go decay the mRNA is occupied by stalled 
ribosomes and an endonucleolytic cleavage event in close proximity to the ribosome is 
necessary to generate two different mRNA substrates (Doma and Parker, 2006). Recent 
work has identified Cue2 as a possible endonuclease involved in NGD (D’Orazio et al., 
2019). The 3’ fragment is rapidly degraded from the 5’ end by Xrn1. After cleavage, Dom34-
Hbs1-Rli1 is required for the degradation of the 5’ fragment, which is then treated like a no-
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Figure 6- Model for no-stop and no-go decay. 
(A) If a ribosome stalls in a poly(A) tail or truncated mRNA, Dom34 together with Hbs1 and GTP is 
recruited on a ternary complex. Subsequently, GTP hydrolysis by Hbs1 leads to the dissociation of 
Hbs1 and binding of Rli1 to Dom34. Ribosome splitting by Dom34 in a Rli1-ATP hydrolysis dependent 
manner leads to the degradation of the truncated protein via the ribosome associated quality control 
(RQC) system. The mRNA is degraded by the exosome, which is recruited by the Ski complex. 
(B) In no-go decay ribosome stalling occurs because of e.g. stem loop structure or a sequence of 
rare codons within an mRNA. That leads to endonucleolytic cleavage of the mRNA by Cue2 in close 
proximity to the ribosome and results in two mRNA fragments. The 5’ mRNA fragment and truncated 
protein are degraded similar to no-stop complexes. The 3’ fragment of the mRNA is degraded via 
Xrn1. Modified from Inada (2017). 
2.3. The DEAD-Box RNA-helicase Dbp5/Rat8 
The DEAD-box protein 5 (Dbp5) is well known for its ATPase dependent remodeling activity 
on RNA-protein complexes and functions in mRNA export (Schmitt et al., 1999; Snay-
Hodge et al., 1998; Tseng et al., 1998; Zhao et al., 2002). Furthermore, Dbp5 is described 
to mediate tRNA export and physically interacts with components of the transcription factor 
complex TFIIH in yeast (Estruch and Cole, 2003; Lari et al., 2019). Additionally, Dbp5 was 
identified to be involved in translation termination and ribosomal maturation (Gross et al., 
2007; Neumann et al., 2016). Dbp5 (encoded by RAT8 (ribonucleic trafficking protein 8) in 
yeast and DDX19 in humans) belongs to the helicase superfamily 2 (SF2) and is conserved 
and essential in all eukaryotes. To fulfill its function, the stimulation by its co-factors GLFG 
lethal (Gle1) and inositol 1,2,3,4,5,6-hexakisphosphate (IP6), is required (Alcázar-Román et 
al., 2006; Gross et al., 2007; Neumann et al., 2016; Weirich et al., 2006). The helicase core 
of Dbp5 is composed of two highly conserved Rec-A-like domains, which are connected by 
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that is capable of ATP hydrolysis in its closed state, while the open state is required for ADP 
release (Tieg and Krebber, 2013).The helicase core of Dbp5 contains 13 characteristic 
sequence motifs and the eponymous sequence Asp-Glu-Ala-Asp (DEAD) in motif 2 
(Fairman-Williams et al., 2010; Linder and Jankowsky, 2011). Additionally, the unique N-
terminal extension of Dbp5 is important for its autoregulation and determines the specificity 
of the enzyme (Collins et al., 2009). In recent work, an Xpo1- dependent nuclear export 
signal has been identified in the N-terminal extension of the protein (Lari et al., 2019). 
 
Figure 7- The domain structure of Dbp5. 
Scheme of the domain structure of Dbp5 (yellow). The catalytic helicase core of Dbp5 consists of 
two RecA-like domains, which contain 13 conserved motifs for ATP and RNA binding (red). 
Furthermore, the regions for its co-factors binding (grey) and the unique N-terminal, extension that 
contains a nuclear export signal (NES, purple), are displayed. Additionally, the amino acid exchanges 
and their position in the helicase core, resulting in temperature sensitivity, for rat8-2 (blue) and rat8-
3 (green) are indicated. Modified from Tieg and Krebber (2013). 
Different temperature-sensitive mutants of DBP5 are known. All of them contain point 
mutations, which lead to single amino acid exchanges in the two RecA-like domains of Dbp5 
(Snay-Hodge et al., 1998). These mutants grow almost like wild type cells at the permissive 
temperature of 25°C, while shifts to 37°C lead to cell death (Snay-Hodge et al., 1998). All 
of these mutants show a rapid poly(A) accumulation and translation termination defects 
upon shift to the non-permissive temperature (Gross et al., 2007; Snay-Hodge et al., 1998). 
The rat8-2 mutant is known to localize together with other export factors in cytoplasmic foci 
after shift to 37°C (Scarcelli et al., 2008). 
 
2.3.1. Functions of Dbp5 
Dbp5 is mainly localized at the nuclear rim and in the cytoplasm, but the protein is also 
found in the nucleus (Hodge et al., 1999; Zhao et al., 2002). Estruch and Cole (2003) 
suggested, that Dbp5 might have a function in transcription initiation in the nucleus, because 
they could show that Dbp5 genetically and physically interacts with components of the 
transcription factor complex TFIIH in yeast. It was also suggested that Dbp5 might shuttle 
with the mRNA into the cytoplasm. However, live cell imaging experiments showed that 
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transport, indicating that Dbp5 is not part of transported mRNP (Zhao et al., 2002). 
Interestingly, Lari et al. (2019) showed that the nuclear shuttling of Dbp5 is not essential for 
mRNA export but rather important for tRNA export. They identified a physical interaction of 
Dbp5 and tRNAs and tRNA export defects were apparent in DBP5 mutants after a 
temperature shift to 37°C. 
 
Figure 8 - The ATPase cycle of Dbp5 during nuclear mRNA export. 
Dbp5 (yellow) appears in an open conformation with separated RecA-like domains in its nucleotide-
free state. (1) Dbp5 first binds ATP (red). (2) Dbp5-ATP subsequently interacts with the mRNP 
(green) and with its co-factors IP6 and Gle1 (grey). Hence, the catalytic center is remodeled into a 
close conformation, which is now competent to hydrolyze ATP. (3). ATP hydrolysis leads to a partial 
opening of the helicase core and simultaneously mRNA release and (4) displacement of the export 
reporter Mex67-Mtr2. (5) Subsequent binding of Dbp5 to Nup159 orchestrates a further opening of 
the helicase core leading to the release of ADP. Modified from Tieg and Krebber (2013). 
At the nuclear pore complex (NPC), Dbp5 interacts with the cytoplasmic fibrils of the NPC 
by an association with the N-terminal domain (NTD) of the nucleoporin Nup159 (encoded 
by RAT7 (ribonucleic acid trafficking protein 7) in yeast and NUP214 in humans) (Hodge et 
al., 1999; Von Moeller et al., 2009; Napetschnig et al., 2009; Schmitt et al., 1999; Snay-
Hodge et al., 1998; Weirich et al., 2004). Therefore, yeast strains lacking the NTD of Nup159 
or DBP5 mutants, which have lost their Nup159 binding ability, exhibit defects in the NPC 
association and show a solely cytoplasmic Dbp5 localization (Hodge et al., 2011; Schmitt 
et al., 1999; Weirich et al., 2004). However, Nup159 is not only needed to tether Dbp5 to 
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release factor (Noble et al., 2011) (Fig 8). The binding site of Nup159 overlaps with the 
binding site of RNA and an Nup159 association with Dbp5 stimulates a conformational 
change in the helicase that culminates in ADP release and recycling of the enzyme. (Von 
Moeller et al., 2009; Montpetit et al., 2011; Napetschnig et al., 2009; Noble et al., 2011).  
For the ATPase activity itself, Dbp5 requires the stimulation by its co-factors Gle1 and IP6 
(Alcázar-Román et al., 2006; Weirich et al., 2006). The binding of Dbp5 and Gle1, is mainly 
mediated via their C-terminal domains and is stabilized by the binding of IP6 (Alcázar-
Román et al., 2010; Dossani et al., 2009; Montpetit et al., 2011; Weirich et al., 2006). 
Temperature sensitive mutants of DBP5 showed a rapid accumulation of mRNAs in the 
nucleus upon shift to their non-permissive temperatures (Snay-Hodge et al., 1998; Tseng 
et al., 1998). Additionally, temperature sensitive mutants of GLE1, NUP159 and strains 
lacking the N-terminal β-propeller domain of Nup159, exhibit mRNA export defects and 
show increased amounts of Mex67 that remains bound to the mRNA (Lund and Guthrie, 
2005; Murphy and Wente, 1996; Del Priore et al., 1996). During transcription and maturation 
mRNAs are packed with proteins into messenger ribonucleoprotein complexes (mRNPs) 
that are exported to the cytoplasm. Correctly processed mRNAs contain a 3’ poly(A) tail 
and a 5’ cap structure and are competent for export and every step is quality controlled by 
e.g. by the guard proteins (Grünwald et al., 2011; Stewart, 2010; Zander and Krebber, 
2017). This group of proteins include the shuttling serine, arginine (SR) containing proteins 
Npl3, Gbp2, Hrb1 and the poly(A) binding proteins Nab2 (Hackmann et al., 2014; Stewart, 
2010; Zander and Krebber, 2017). Upon quality control they recruit the export receptor 
heterodimer Mex67-Mtr2 (TAP-p15 in metazoans), which interacts with all FG-repeat 
containing nucleoporins of the NPC and channels the messenger ribonucleoprotein mRNP 
through the NPC (Sträßer et al., 2000). Dbp5 displaces the mRNP bound export factor 
Mex67-Mtr2 at the NPC that leads to directionality of mRNA export (Lund and Guthrie, 2005; 
Tran et al., 2007). 
An additional function for Dbp5 is described for the nuclear export of pre-ribosomal subunits, 
which is independent of its ATPase activity (Neumann et al., 2016). Yeast temperature 
sensitive DBP5 mutants accumulate both ribosomal subunits in the nucleus and Dbp5 
interacts with the well-described ribosomal transport factor NMD3. Interestingly, GLE1 
mutants and ATPase deficient DBP5 mutants show no defect in ribosomal maturation 
(Neumann et al., 2016), suggesting a different export mechanism for ribosomal subunits 
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2.3.2. Role of Dbp5 in translation termination 
Dbp5 is located at the cytoplasmic side of the NPC, creating a typical rim staining of the 
nuclear envelope (Snay-Hodge et al., 1998). However, a remarkable fraction of Dbp5 is 
also present in the cytoplasm, reflecting its function in translation termination (Gross et al., 
2007). This function was first identified through growth analyses showing that mutants of 
DBP5 were hypersensitive to translational inhibitors (Gross et al., 2007). Subsequently, 
Bolger et al. (2008) revealed that also temperature sensitive mutants of GLE1 are 
hypersensitive to translation inhibitors. Furthermore, it was shown that Dbp5 and Gle1 are 
part of polysomal fractions in sucrose-density gradient analysis, indicating that Dbp5 is part 
of actively translating ribosomes (Gross et al., 2007). In agreement, DBP5 mutants showed 
increased readthrough activities in a dual reporter assay (Gross et al., 2007). 
Additionally, GLE1 mutants lacking the interaction domain for IP6 and cells deleted for IPK 
(inositol phosphate kinase; phosphorylates IP6), exhibit defects in sufficient stop codon 
recognition (Alcázar-Román et al., 2010; Bolger et al., 2008). It is of interest to note that 
temperature sensitive mutants of DBP5 and GLE1 showed an increased readthrough 
activity comparable to that of the SUP35 mutant sup35-1 (Alcázar-Román et al., 2010; 
Bolger et al., 2008). Taking into account, that overexpression of DBP5, but not of the ATP-
deficient mutant dbp5 (e240Q), rescues the increased stop codon readthrough of sup45-2 
mutants, it became clear that the ATPase activity of Dbp5 is necessary for efficient stop-
codon recognition by eRF1 (Gross et al., 2007). Accordingly, a physical interaction between 
Dbp5 and eRF1 was detected and that the binding of eRF1 and eRF3 is decreased in  
rat8-2 mutants (Gross et al., 2007). Moreover, also Gle1 was identified as an interaction 
partner of eRF1 (Bolger et al., 2008). Likewise, it was recently shown that the human protein 
DDX19 stabilizes translation termination complexes and participate in translation 
(Mikhailova et al., 2017). In summary, the ATPase dependent remodeling activity of Dbp5, 
which is stimulated via Gle1 and IP6, is possibly required for the proper positioning of eRF1 
in the ribosomal A-site. (Baierlein et al., 2010). These data could suggest that Dbp5 might 
help eRF1 for its proper positioning at the A-site of the ribosome. Also, it seems to mediate 
the interaction of eRF1 and eRF3. However, it is currently unknown if Dbp5 might also have 
a function with the non-canonical termination factors Dom34 and Hbs1 in NSD and/or NGD. 
To be able to generate a comprehensive in vivo translation termination model including 
novel translation termination factors and their order of action and addressing their function 
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 Material and Methods 
3.1. Materials 
Solutions and media were autoclaved at 121 °C for 20 min and sensitive compounds sterile-
filtered. Glassware was autoclaved, or sterilized at 180 °C for 6 h. 
Table 1 - List of consumable materials 
Materials Source 
Amersham™ Protran® 0.45 µm Nitrocellulose Membranes GE Healthcare 
cOmplete™, EDTA-free Protease Inhibitor  Roche 
Cozy™ Prestained Protein Ladder HighQu 
Cycloheximide Carl Roth 
Difco Skim Milk Becton, Dickinson and Co. 
GFP-Trap®-A Beads ChromoTek GmbH 
Glass Beads Type S 0.4-0,6 mm Carl Roth 
Glutahtione Sepharose 4B Beads GE Healthcare 
GSTrap 4B Gluthathione Sepharose GE Healthcare 
HDGreen™ Plus DNA Stain Intas Science Imaging 
Isopropyl-β-D-thiogalactopyranosid (IPTG) Carl Roth 
MYC-Trap®-A Beads ChromoTek GmbH 
Lambda DNA/EcoR1+HindIII Marker Thermo Fisher Scientific 
Oligonucleotides Sigma-Aldrich 
PageRuler™ Prestained Protein Ladder Thermo Fisher Scientific 
PageRuler™ Unstained Protein Ladder Thermo Fisher Scientific 
Ponceau S Carl Roth 
qPCRBIO SyGreen Mix Lo-ROX Nippon Genetics 
Rotiophorese Gel 30 (37.5:1) Acrylamide Carl Roth 
RiboLOCK RNAse Inhibitor Thermo Fisher Scientific 
TRIzol™ Reagent Thermo Fisher Scientific 
Salomon Sperm-Carrier DNA AppliChem GmbH 
WesternBright™ Quantum™ Western Blotting HRP 
Substrate 
Advansta 
Whatman® Blotting Paper Hahnemühle 
  
Enzymes Source 
DreamTag DNA Polymerase Thermo Fisher Scientific 
FastAP Alkaline Phosphatase Thermo Fisher Scientific 
Gibson Assembly® Master Mix New England Biolabs 
Phusion® High-Fidelity DNA Polymerase  New England Biolabs 
Q5® High-Fidelity DNA Polymerase  New England Biolabs 
Restriction Enzymes New England Biolabs 
Restriction Enzymes Thermo Fisher Scientific 
RNase A AppliChem 
RNase-Free DNase Quiagen 
Zymolase 20T Zymo Research 
  
Kits Source 
Nucleospin® Gel and PCR Clean-up 
MACHERY-NAGEL Nucleospin® Plasmid Nucleospin® RNA 
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Table 2 - List of equipment 
Equipment Source 
ÄKTAprime Plus GE Healthcare 
BioPhotometer Eppendorf 
CFX Connect 96FX2 qPCR Cycler Bio-Rad Laboratories 
Eclipse E400 Tetrad Microscope Nikon 
FastPrep-24® Cell Homogenizer MP Biomedicals 
Fusion-SL-3500.WL Peqlab 
Foxy Jr. ® Fraction Collector, Optical Unit Type 11, 
Absorbance Detector UA-6 Teledyne Isco 
Gene Pulser Xcell™ Electroporation System Bio-Rad Laboratories 
Gradient Master 108 BioComp Instruments 
UV Gel Detection System INTAS 
Heraeus™ Pico™ 21 Thermo Fisher Scientific 
Heraeus™ Fresco™ 21 Thermo Fisher Scientific 
Heraeus™ Multifuge™ X3R with TX750 or F15-8x50cy 
Rotor 
Thermo Fisher Scientific 
Light Microscope Leitz Biomed Typ 020-507-010 Leica Microsystems 
Microfluidizer™ LM10 Unitronics 
Milli-Q® Water Purification System Millipore 
My Cycler 1,065 Bio-Rad Laboratories 
Nano Drop 2000 Spectrophotometer Thermo Fisher Scientific 
Neubauer Improved Hemocytometer Carl Roth 
PerfectBlue Semi-Dry Electro Blotter Sedec M  Peqlab 
Sonifierer Cell Disrupter S-250A Branson Ultrasonics 
Sorvall™ WX80 Ultracentrifuge with TH-641 rotor Thermo Fisher Scientific 
T100™ Thermal Cycler Bio-Rad Laboratories 
  
 
Table 3 - List of software 
Software Source 
Adobe Illustrator CS6/2020 Adobe Systems 
Adobe Photoshop CS6/CC 2019 Adobe Systems 
ApE Plasmid Editor M. Wayne Davis 
Bio-1D Peqlab 
CFX Manager 3,1 Bio-Rad Laboratories 
Snapgene  GSL Biotech 
Office® 2011/2019 Microsoft 
PrimeView 8.0 GE Healthcare 
Prism8 GraphPad 
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Table 4 - List of Escherichia coli media 
LB Conc. 2YT Conc. 
Ampicillin* (if added)  100 µg/ml Ampicillin* (if added)  100 µg/ml 
Kanamycin* (if added) 20 µg/ml Kanamycin* (if added) 20 µg/ml 
Chloramphenicol * (if added) 34 µg/ml Chloramphenicol * (if added) 34 µg/ml 
Agar-Agar (for plates only) 1.5 % (w/v) NaCl 85 mM 
NaCl 85 mM Tryptone 1.6 % (w/v) 
Tryptone 1 % (w/v) Yeast Extract 1 % (w/v) 
Yeast Extract 0.5 % (w/v)   
    
Auto Inducing Medium  Conc. SOC Conc. 
LB Media  Glucose 20 mM 
Ampicillin* (if added)  100 µg/ml KCl 2.5 mM 
Kanamycin* (if added) 20 µg/ml MgCl2 10 mM 
Chloramphenicol * (if added) 34 µg/ml MgSO4 10 mM 
Glucose 0.05 % (v/v) NaCl 10 mM 
Glycerol 0.5 % (v/v) Peptone 2 % (w/v) 
Lactose 0.2 % (v/v) Yeast Extract 0.5 % (w/v) 
K2HPO4 25 mM   
NaH2PO4 25 mM   
Na2SO4 0.5 mM   
NH4Cl 50 mM   
    
(Sambrook 1989 modified) *Sterile antibiotics were added separately 
 
Table 5 – List of Saccharomyces cerevisiae media 
YPD Conc. B-plates Conc. 
Agar-Agar (for plates only) 1.8 % (w/v) Agar-Agar* 3 % (w/v) 
Glucose 2 % (w/v) Ammonium Sulphate 3 mM 
Peptone 2 % (w/v) Glucose* 2 % (w/v) 
Yeast Extract 1 % (w/v) Nitrogen Base 0.17 % (w/v) 
    
Sporulation Medium Conc. Selective Media Conc. 
Glucose** 0.05 % (w/v) Agar-Agar* (for plates only) 1.8 % (w/v) 
Potassium Acetate**  150 mM Ammonium Sulphate 40 mM 
Yeast Extract** 0.25 % (w/v) Glucose* 2 % (v/v) 
Adenine** 40 mg/ml Nitrogen Base 0.17 % (w/v) 
Arginine** 20 mg/ml Yeast Dropout Mix 0.2 % (w/v) 
Histidine** 20 mg/ml   
Leucine** 20 mg/ml FOA Conc. 
Lysine** 20 mg/ml 5-Fluoroorotic Acid (FOA) 0.1 % (w/v) 
Methionine** 20 mg/ml Agar 1.8 % (w/v) 
Phenylalanine** 100 mg/ml Ammonium Sulphate 0.51 % (w/v) 
Threonine** 350 mg/ml Glucose 2 % (w/v) 
Tryptophan** 20 mg/ml Yeast Dropout Mix 0.2 % (w/v) 
Tyrosine** 40 mg/ml Nitrogen Base 0.17 % 
(w/v) 
Uracil** 40 mg/ml   
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Table 6 – List of Saccharomyces cerevisiae strains 
Name Genotype Source Parental 
Strains 
HKY36 his3∆200; leu2∆1; ura3-52; (Winston et 
al., 1995) 
 
HKY128 RAT8::HIS3; ura3-52; leu2∆1; trp1∆63; his3∆200 (Snay-Hodge 
et al., 1998) 
 
HKY314 his3∆1; leu2∆0; ura3∆0; met15∆0 Euroscarf  
HKY456 RAT8::HIS3; leu2∆1; trp1∆63; his3∆200 (Neumann et 
al., 2016) 
128 




HKY492 UPF1::kanMX4; his3∆1; leu2∆0; lys2∆0; ura3∆0 Euroscarf  
HKY1631 
 
DOM34-GFP:HIS3MX6; his3∆1; leu2∆0; ura3∆0; 
met15∆0 
Invitrogen  
HKY1632 HBS1-GFP:HIS3MX6; his3∆1; leu2∆0; ura3∆0; 
met15∆0 
Invitrogen  
HKY1646 RAT7∆N(1-500); ura3-52; leu2∆1; his3∆200; 
trp1∆63 
(Hodge et al., 
1999) 
 
HKY1797 DOM34::kanMX4; ura3∆0; leu2∆0; met15∆0; 
his3∆1 
Euroscarf  
HKY1798 Hbs1::kanMX4; ura3∆0; leu2∆0; met15∆0; his3∆1 Euroscarf  
HKY1693 DOM34-GFP:HIS3MX6; RAT8::HIS3; leu2∆0; 
ura3∆0 
This study 477x 
1631 
HKY1694 HBS1-GFP:HIS3MX6; RAT8::HIS3; leu2∆0; 
ura3∆0 
This study 477x 
1632 
HKY1888 Dom34::kanMX4; RAT8::HIS3; leu2∆0; his3∆1; 
ura3∆0 
This study 477x 
1797 
HKY1890 Hbs1::kanMX4; RAT8::HIS3; leu2∆0; his3∆1; 
ura3∆0 
This study 477x 
1798 
 
Table 7– List of Escherichia coli strains 
Name Gentotype Application 
DH5α F-Φ80lacZΔM15Δ (lacZYA-argF) U169 recA1 end 
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Table 8 – List of Plasmids  
Name Genotype Source 
pHK88 URA3; CEN; AMPR (Sikorski and Hieter, 
1989) 
pHK630 PRAT8RAT8 LEU2; 2µ; AMPR (Snay-Hodge et al., 
1998) 
pHK638 PRAT8 RAT8-3 LEU2; 2µ; AMPR (Snay-Hodge et al., 
1998) 
pHK693 PRAT8 RAT8-2-MYCLEU2; 2µ; AMPR (Snay-Hodge et al., 
1998) 
pHK1282 PTACGST in pGEX-6P-1; AMPR (Beißel et al., 2019) 
pHK1288 PTACGST-DBP5 in pGEX-4T-1; KANR (Beißel et al., 2019) 
pHK1414 PTACGST-RLI1 in pGEX-6P-1; AMPR (Beißel et al., 2019) 
pHK1574 PCBP80CBP80-MYC; URA3; CEN; AMPR This study 
pHK1578 PCBP80CBP80PTC-MYC; URA3; CEN; AMPR This study 
pHK1631 
 
PADHMYC-HBS1; URA3; CEN; AMPR This study 
pHK1640 PADHDOM34; URA3; CEN; AMPR This study 
pHK1647 PADHDOM34-MYC; URA3; CEN; AMPR This study 
pHK1653 PGAL-GFP-GGN12-FLAG-HIS3; URA3; CEN; 
AMPR 
(Tsuboi et al., 2012) 
pHK1654 PGAL-GFP-SL-FLAG-HIS3; URA3; CEN; AMPR (Tsuboi et al., 2012) 
pHK1655 PGAL-GFP-FLAG-HIS3; URA3; CEN; AMPR (Tsuboi et al., 2012) 
pHK1656 PGAL-GFP-FLAG-HIS3; URA3; CEN; AMPR (Tsuboi et al., 2012) 
 
Table 9 – List of Oligonucleotides 
Name Genotype Origin/Purpose 
HK2507 ACTCACTATAGGGCGAATTTGGAGCTGACGATTCTT
CGAGTGTGTC 
CBP80 pHK755 fw  
HK2508 ACTTTTGTTCACCTCTAGAGGAATTAACTTCCTTTGT
TTCTTGAATCC 
CBP80 pHK755 rev 
HK2625 GCCTAAATGACAGAGAATCCCACCTGTTGTAC CBP80 muta. fw 













DOM34-MYC GA rev 
HK2134 ATGCCCGAAGGTTATGTACAGG GFP qPCR fw 
HK2135 CATTCTTTTGTTTGTCTGCCATG GFP qPCR rec 
HK3089 AGTTACGCTAGGGATAACAGGG 21S qPCR fw 
HK3090 AGTTACGCTAGGGATAACAGGG 21S qPCR rev 
HK2696 AGTTACGCTAGGGATAACAGGG CBP80 qPCR fw 
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3.2. Methods 
3.2.1. Cell Culture 
3.2.1.1. Escherichia coli cell culture 
Cultivation of E. coli was performed compliant to standard protocols (Sambrook et al., 
1989). DH5α bacteria cells were standardly cultivated in LB media (see Table 4) containing 
the corresponding antibiotics for specific resistance genes encoded in the plasmid-DNA 
(100 µg/ml Ampicillin, 20 µg/ml Kanamycin or 34 µg/ml Chloramphenicol).  
After transformation (see 3.2.2.5.), liquid media was inoculated with a single colony from an 
agar plate and cultivated with gently rotating at 37 °C over night. To determine the cell yield, 
the optical density of the cells was measured at 600 nm by using a photometer. For 
expression and/or protein purification Rosetta 2 bacterial cells were inoculated and 
cultivated in 10 ml LB media over night. The LB medium was supplemented with the 
corresponding antibiotics for specific resistance genes encoded in the plasmid-DNA. 
Subsequently, 2 ml of the saturated cell suspension was used to inoculate 2 l auto inducing 
medium (AIM see Table 4) and incubated at 16 °C for 3 days. 
 
3.2.1.2. Cultivation of Saccharomyces cerevisiae cells 
Yeast cells without plasmid-DNA were grown in YPD medium (see Table 5). The selective 
medium was chosen regarding the plasmid- or genome-encoded selection marker gene. 
The used yeast drop out mix contained all other amino acids needed and ingredients 
required for cell growth (Sherman and Hicks, 1991). For long time storage, the yeast strains 
were kept in 50 % glycerol at -80 °C. These stocks were streaked out on YPD plates and 
grown for 1 day. Subsequently, cells were re-streaked on YPD plates again and incubated 
for 1 day at 25 °C. Yeast strains were either transformed (see 3.2.3.2.) or kept on YPD 
plates at 4 °C. Positive transformants that grew on selective media were stored at 4 °C. 
Cells were freshly inoculated in liquid media, according to experimental purposes. In regular 
intervals, the yeast strains were re-streaked onto fresh agar plates or streaked out from 
frozen stocks. For experiments, cell material from the agar plate was used to inoculate  
200 ml of YPD or selective media and grown overnight at 25 °C. The next day, the cell 
number was determined by counting them with a hemocytometer and diluted in at last  
400 ml media to 0.5-1.0x 107 cells/ml. As soon as the cells reached the log-phase  
(2-3x107 cells/ml), they were either shifted for the indicated time period to the non-
permissive temperature and/or immediately harvested by centrifugation at 4100x g and  
4 °C for 5 min. The cell pellet was resuspended in 5 ml distilled water, transferred in a  
15 ml falcon tube and centrifuged again under the same conditions and either immediately 
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encoded a galactose- inducible promotor, cells were grown to log-phase in 2 % (v/v) sucrose 
as carbon source. For galactose induction of mRNA expression, 2 % (v/v) galactose was 
added and cells were harvested after the indicated time periods.  
 
3.2.2. Construction of plasmid DNAs 
3.2.2.1. Polymerase chain reaction (PCR) 
In general, all polymerase chain reactions (PCRs), were performed by amplification of 
particular DNA-fragments from plasmid-DNA or genomic DNA with appropriate primer pairs. 
For analytic PCRs, DNA was amplified using the Dream Taq polymerase (Thermo Fisher 
Scientific). For DNA, which was later used for cloning purposes, proof-reading polymerases 
(New England Biolabs) were preferred. The reaction conditions varied for each enzyme 
based on the manufacture’s protocols. Subsequently, the sizes of the produced PCR 
products were quality controlled by agarose gel electrophoresis.  
 
Table 10 – PCR reaction composition 
Polymerase: Dream Taq Phusion Q5 
dNTPs 200 µM each 200 µM each 200 µM each 
Primers 0.2 µM each 0.5 µM each 0.5 µM each 
Polymerase 0.025 U/µl 0.02 U/µl 0.02 U/µl 
Template DNA 0.5 µg genomic DNA or 20 ng plasmid 
 
Table 11 – PCR program 
Polymerase: Dream Taq Phusion Q5 
Initial Denaturation 95 °C - 3 min 98 °C - 30 s 98 °C - 30 s 
Denaturation 95 °C – 30 s 98 °C – 10 s 98 °C – 10 s 
Annealing 30 s 30 s 30 s 
According to melting temperature of primers 
Extension 72 °C – 1 min/kb 72 °C – 30 s/kb 72 °C – 30 s/kb 
Final Extension 72 °C – 10 min 72 °C – 10 min 72 °C – 10 min 
 
3.2.2.2. Restriction digestion and DNA separation 
Restriction digestion was conducted to analyze plasmid-DNA or to produce linearized DNA-
fragments from plasmids. Restriction enzymes and their appropriate buffers were chosen 
as proposed from the manufacture. For the digestion, 2-5 µg of plasmid-DNA were mixed 
with buffer and enzyme in a total volume of 20 µl and incubated over night at 37 °C. To 
avoid rapid re-ligation of linearized plasmids that were linearized only by a single restriction 
enzyme, the 5’ and 3’ phosphate groups of the DNA were dephosphorylated. 
Dephosphorylation was carried out by adding 1 U of Fast AP alkaline phosphatase (Thermo 
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step, the enzymes were deactivated by heating for 15 min at 65 °C. The DNA was visualized 
by agarose gel electrophoresis. 
 
3.2.2.3. Agarose gel electrophoresis and DNA extraction 
DNA was analyzed and separated by agarose gel electrophoresis. To prepare a 1 % gel,  
1 g agarose was added to 100 ml TAE buffer (40 nM Tris-acetate, 1 mM EDTA) and heated 
in a microwave until the mixture was homogenized and the agarose melted. After letting the 
solution cool down under constant stirring, either 4 µl of ethidium bromide (10 mg/ml) or  
10 µl HD Green Plus DNA Stain (Intas Science Imaging) was added. Afterwards, the 
agarose solution was poured into a gel chamber and a comb was added to form sample 
pockets. After this, the polymerized gel was placed in an electrophoresis chamber flooded 
with 1x TAE buffer. The DNA samples were mixed with a 6x DNA loading dye and loaded 
into the gel in parallel with a DNA size standard (Thermo Fisher Scientific). Subsequently a 
voltage of 120 V was applied and after 30 - 90 min the DNA bands were visualized with an 
UV transilluminator. If necessary, the desired DNA fragments were purified with the 
Nucleospin Gel and PCR clean-up kit (MACHEREY-NAGEL). Finally, the DNA was eluted 
in the provided elution buffer (5 nM Tris/HCl, pH 8.5) and measured with the NanoDrop 
spectrophotometer (Thermo Fisher Scientific). 
 
3.2.2.4. Gibson Assembly 
For the Gibson assembly (GA), inserts with 30-40 bp overhangs were created by using 
primers, which have beside their annealing sequence to the insert, an overhang that 
correspond to the plasmid backbone. For the GA reaction, 100 ng linearized vector fragment 
and a two-fold molar excess of insert were mixed in a total volume of 10 µl. This solution 
was then mixed with 10 µl of 2x GA-master mix (New England Biolabs) and incubated at  
50 °C for 1 h. The 5’ exonuclease shortens the 5’ ends of the vector and thereby generates 
3’ overhangs. Due to the generated overlaps in the insert sequence, the insert can anneal. 
Finally, the Phusion DNA-polymerase extends the 3’ ends and the gaps are filled by the 
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3.2.2.5. Transformation of Escherichia coli  
For all cloning purposes, the DH5α Escherichia coli strain was used. For protein purification 
and in vitro assays, the Rossetta 2 strain was used. 
 
3.2.2.6. Heat shock transformation 
To get chemically ultra-competent cells, the protocol provided by Inou et al. (1990) was 
followed. For transformation 100 µl cell suspension were placed on ice and mixed with 200-
300 ng plasmid or 10 µl GA reaction mix and incubated on ice for 30 min. Subsequently, 
the cells were exposed to a heat shock at 42 °C for 2 min and after that immediately placed 
on ice. 1 ml SOC medium was added. After 45-60 min incubation at 37 °C, the cells were 
precipitated at 3500 x g for 1 min and resuspended in 100 µl of the residual liquid. The 
suspension was plated on LB plates containing the corresponding antibiotic(s) and 
incubated at 37 °C overnight. 
 
3.2.2.7. Electroporation 
For electroporation, the DNA suspension had to be free of ions that would otherwise elicit 
a bypass for the current. Therefore, the DNA suspension was dialyzed on a nitrocellulose 
membrane in a deionized water containing petri-dish prior to transformation. Electro 
competent cells were prepared according to Dower et al. (1988) and 50 µl of them were 
mixed with 10 µl of the dialyzed DNA sample. Then this mixture was pipetted between the 
electrodes of an electroporation cuvette (1 mm gap), which was cooled on ice. The cuvette 
was placed in the electroporator (Bio-Rad Laboratories), which generates a pulse 
(exponential decay, 155 V, 50 µF, 150 Ω) for penetration of the DNA through the cell wall. 
After electroporation, 1 ml SOC was immediately added. After 45-60 min in the incubator at 
37 °C, the cells were centrifuged at 3500x g for 1 min and resuspended in 100 µl residual 
liquid. The suspension was plated on LB plates containing the corresponding antibiotic(s) 
and incubated at 37 °C overnight. 
 
3.2.2.8. Plasmid Extraction from E. coli cultures 
To determine the genotype of the generated plasmid-DNA construct after Gibson assembly 
(see 3.2.2.4.), plasmid-DNA was extracted from 10 ml bacteria cultures by using the 
NucleoSpin Plasmid purification kit (MACHEREY-NAGEL), following the manufacturer’s 
instructions. For plasmid-DNA amplification, 100 to 200 ml bacteria cultures were prepared 
and plasmid-DNAs were isolated with the NucleoBond Xtra midi kit (MACHEREY-NAGEL) 
as described in the manufacturer’s protocol. In both cases, the E. coli were grown in LB 
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the isolated plasmid-DNA was determined with the NanoDrop spectrophotometer (Thermo 
Fisher Scientific). 
 
3.2.2.9. E. coli colony PCR 
For determine successfully generate Gibson assembly products, several E. coli colonies 
were picked from the transformed antibiotic containing LB-plate. The whole cell lysate was 
then transferred into an PCR tube and in addition streaked onto a fresh LB-plate containing 
the same antibiotic. The PCR tube was filled with 10 µl Dream Taq reaction mix and a PCR 
run was performed as described in (see 3.2.2.1.). Positive clones, regarding to positive 
results in the colony-PCR, inoculated from the LB-plate in 10 ml liquid LB medium containing 
the corresponding antibiotic and incubated overnight. Plasmids were isolated as described 
in chapter 3.2.2.8.. 
 
3.2.2.10. Sequencing of plasmid-DNA 
Altered DNA constructs were sequenced to screen for the gene of interest and sent to LGC 
Genomics for Sanger sequencing. 
 
3.2.3. Manipulation of Saccharomyces cerevisiae 
3.2.3.1. Crossing of yeast strains 
Crossing of yeast strains was performed as described by Sherman (1991) and Sherman 
and Hicks (1991). In general, all yeast strains in this study are haploid strains. For the 
generation of diploid strains, two haploid strains with the mating types MATa or MATα were 
mixed on YPD-plates and incubated at 25° C for 1 day. Afterwards, the strains were plated 
onto selective agar plates containing the selective markers of both haploid strains and 
selected for diploids. To induce sporulation, the diploid cells were transferred into 2 ml 
sporulation medium (see Table 5) and incubated in a rotator under agitation at 25 °C for  
5 days. The presence of tetrads (asci with 4 spores), was verified using a light microscope 
and the tetrads were prepared for dissection. For that, a cell culture (100 µl) was centrifuged 
at 16200x g for 1 min and washed once with 1 ml distilled water and diluted in 100 µl distilled 
H2O. For digestion of the cell wall, the cell suspension was incubated with 1 µg/µl zymolase 
(Zymo Research) at room temperature for 10 min. Afterwards, the cells were washed with 
100 µl P-solution to stop digestion and subsequently diluted in 1 ml water, from which  
100 µl were pipetted on one third of a YPD plate. The tetrads were picked and separated 
from the plate with the tetrad microscope attached to a micromanipulator (Nikon). After  
2-3 days growth at 25°C, the tetrads were plated onto different selective agar plates to 
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and/or genes. Candidates were further analyzed for mating types, by re-plating the spores 
onto plates that contained lawns of MATa or MATα reference strains. After 1 day of growth 
they were transferred to selective B-plates (Sprague, 1991). The references strains were 
isoleucine and valine auxotroph, which was complemented by the tested tetrads. Thus, only 
cells that had a different mating type were able to form diploids and grew on B-plates. All 
knockout strains contained either a KanMX4 cassette or HIS3 marker. To select for 
KanMX4, 100 µl geneticin (40 µg/µl) was mixed with the medium for a YPD plate. For 
selection for HIS3, selective media plates lacking histidine were used. The same procedure 
was used to select for GFP tagged proteins that are fused to a HIS3MX6 cassette. 
 
3.2.3.2. Yeast cell transformation 
Yeast cells were treated with lithium acetate and heat shocked to introduce plasmid-DNA  
into the cells following the protocol of Gietz et al. (1992). Cells were grown in liquid media 
at 25 °C to a density of approx. 1-2x107 cells/ml and harvested by centrifugation at 4100x g 
for 5 min. The cell pellet was washed once with distilled water and once with TE lithium 
acetate buffer (10 mM Tris, 1 mM EDTA, 100 mM lithium acetate, pH 7.5). After every 
washing step, the cells were collected by centrifugation at 3500x g for 2 min. Finally, the 
cell pellet was resuspended in 100 µl of lithium acetate buffer. For transformation, 50 µl of 
this cell suspension (~0.5x108 cells) were mixed with 1 µg plasmid-DNA and 50 µg (5 µL) 
Salmon sperm-carrier DNA (AppliChem GmbH) and 300 µl PEG-TE lithium acetate buffer 
(10 mM Tris, pH 7.5, 1 mM EDTA, 100 mM lithium acetate, 40 % (v/v) poly ethylene glycol 
4000). Prior to use, the carrier DNA was boiled at 95 °C for 5 min and rapidly cooled on ice 
to generate single DNA strands. Subsequently, the cell suspension was incubated under 
agitation at 25 °C for 30-60 min and then heat-shocked to 42 °C for 15 min. Afterwards, 
cells were centrifuged at 16200x g for 1 min and washed with 1 ml distilled water. After a 
second centrifugation step, the cell pellet was resuspended in 100 µl residual water and 
plated onto a selective agar plate. Finally, the plate was incubated at 25 °C for 2-3 days 
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3.2.4. Cell biology methods 
3.2.4.1. Growth analysis of yeast strains 
To determine potential growth defects of certain gene knock-outs, or tagging of certain gene 
products, temperature sensitive strains, strains containing a tagged version of a protein or 
different combinations of these were analyzed. Cell suspension were prepared in 10-fold 
serial dilutions. For this, yeast cells from agar plates were solved in water and the cell 
density was determined by cell counting with a hemocytometer. The cells were diluted  
10-fold from 1x107 to 1x103 and pipetted in 15 µl rows onto a plate. The cells were grown 
at 16 °C, 25 °C, 30 °C, 35 °C or 37 °C for 2-5 days and images were taken by scanning. In 
this study, only dilution series, that showed a growth defect or rescue effect of growth 
defects by overexpression of a gene, are shown. Additionally, to increase the growth defect 
of strains combined with NSD and NGD reporters, the medium was supplemented with 1 
mM diamide as described earlier (Jamar et al., 2017). 
 
3.2.4.2. Loss of URA3 gene selection 
To lose URA3 gene containing plasmid-DNA, FOA plates (see Table 5) were used. On FOA 
plates, cells expressing URA3 produce the toxic compound 5-fluorouracil, which is lethal to 
the cells. Selection of cells that loss URA3 containing plasmid-DNA was performed before 
(non-essential protein) or after (essential protein) transformation of the strain with a 
substituting plasmid-DNA that contained a different marker gene such as LEU2. 
 
3.2.5. Protein biochemical methods 
3.2.5.1. Preparation of yeast whole cell lysates 
For experimental approaches, yeast cells were grown in 400-600 ml cultures to log-phase 
(2-3x107 cells/ml) and harvested by centrifugation at 4 °C and 4100 g for 5 minutes. The 
cell precipitates were washed with distilled water, transferred into a 2 ml screw top tube or 
15 ml falcon tube and centrifuged again. For cell lysis, the same amount of glass beads 
type S 0.4-0,6 mm (Carl Roth) and assay specific lysis buffer supplemented with 
cOmplete™ EDTA-free protease inhibitor cocktail (5 µl per 100 ml cell lysate) were added 
to the cell pellets. Afterwards, the cells were disrupted by using the FastPrep-24®  
(MP Biomedicals) machine with the settings of 5.0 m/s for 30 seconds, at least 2 times. The 
lysate was purified from cell debris by centrifugation at 4 °C and 16200x g for 10 minutes 
and the supernatant was used directly for the experimental approach. To avoid protein 
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3.2.5.2. Co-Immunoprecipitation (Co-IP) analysis 
For the analysis of protein interactions in vivo, co- immunoprecipitation (co-IP) experiments 
were conducted. In general, a protein fused to a protein tag is immunoprecipitated by the 
corresponding antibody bound to beads. Pulling down of the tagged protein leads to the co-
precipitation of all proteins bound directly or indirectly to the tagged protein. The co-
precipitated proteins were separated via SDS Page and analyzed on western blot. In this 
study, co-immunoprecipitation experiments were performed with cells expressing either 
GFP- or myc-tagged proteins, as described earlier (Gross et al., 2007). For immobilization 
of the tagged proteins, GFP-Trap®-A beads and MYC- Trap®-A beads (ChromoTek), which 
covalently bind the antibodies, were used. The GFP- or MYC- beads were homogenized by 
vigorous shaking and 10 µl of this suspension (slurry) was washed 5 times with 1 ml 
PBSKMT buffer (1x (10x PBS, pH 7.5), 2 mM KCl 2.5 mM MgCl2 and 0.5 % (v/v) Trition -X-
100) and always collected by centrifugation each time at 500x g for 2 minutes. After the last 
washing step, the beads were resuspended with the lysate and incubated at 8 °C for 2 h to 
precipitate the tagged protein. The beads were washed at least 3 times with 1 ml lysate 
buffer and centrifuged at 500x g for 2 minutes. In the last step, the supernatant was removed 
completely and exchanged by 30 µl 2x sample buffer (125 mM Tris/HCl, pH 6.8, 25 % (v/v) 
glycerol, 2 % (w/v) sodium dodecyl sulfate (SDS), 5 % (v/v) β-mercaptoethanol and a tip of 
bromophenol blue). Control aliquots were collected from the lysate fractions before Co-IP. 
 
3.2.5.3. Expression of recombinant proteins 
For the expression and purification of recombinant proteins, E. coli Rosetta 2 (DE3) cells 
were transformed with the required plasmid-DNA. Rosetta 2 cells contain a genome 
encoded T7-polymerase expression system, which can easily be used as an E. coli 
expression system for recombinant protein expression. Furthermore, Rosetta 2 (DE3) 
harbor a plasmid that expresses tRNAs for infrequently used codons in E. coli and 
additionally encodes for a chloramphenicol resistance. Moreover, the low incubation 
temperature of 16 °C increase the folding capacity of eukaryotic proteins. The expression 
of glutathione s-transferase (GST)- tagged recombinant yeast proteins its affinity purification 
were performed regarding the standard protocols (Harper and Speicher, 2011). For the 
expression of GST-Dbp5, a preculture of 10 ml LB medium was mixed with 100 µg/ml of 
ampicillin and 34 µg/ml of chloramphenicol and inoculated with Rosetta 2 cells containing 
GST-DBP5 expressing plasmid-DNA. The pre-culture was incubated at 37 °C overnight and 
2 ml of pre-culture was used to inoculate 2 L of auto inducing medium the next day (AIM). 
AIM contains glucose, glycerol and lactose as carbon source. The main culture was 
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glycerol were used as carbon source, whereas lactose induced the expression of the 
recombinant protein. Furthermore, the low temperature induced chaperone expression, 
which support a better folding capacity of the protein. After 3 days of growth, the cells were 
harvested by centrifugation at 4100x g and 4 °C for 10 minutes and washed once with 
distilled water. After an additional identical centrifugation step the pellet was resuspended 
in binding buffer (10 mM PBS (10 mM Na2HPO4, 140 mM NaCl, 2,7 mM KCl, 1.8 mM 
KH2PO4), pH 7.4, 20 mM DTT) complemented with cOmplete™ EDTA-free protease 
inhibitor cocktail (5µl per 100 ml cell lysate) to prevent protein degradation. Then cells were 
disrupted by using a Microfluidizer LM10 (Unitronics) through applying a pressure of 700 
MPa. The lysate was centrifuged at 4 °C and 30.000 x g for 30 min in a Sorvall WX Ultra 
Series Centrifuge (Thermo Scientific) attached with the Ti50 rotor (Beckmann). The 
supernatant was loaded on two 1 ml GSTrap™ FF (GE Healthcare) column with a flow rate 
of 5 ml/min using the ÄKTAprime plus (GE Healthcare). After loading of the lysate, the 
column was washed with binding buffer, until the absorbance reached the baseline. GST-
Dbp5 was eluted from the column with elution buffer (50 mM Tris-HCl, 40 mM reduced 
Glutathione, 20 mM DTT, pH 8.0) and finally dialyzed (10 mM Na2HPO4, 140 mM NaCl, pH 
7.4) at 8 °C for 2 days including a change of buffer twice. All fractions were collected and 
protein containing fractions were determined via SDS-PAGE (see 3.2.5.7.) and subsequent 
Coomassie staining (see 2.5.5.8.). The final protein concentration was determined with the 
Nano Drop 2000 spectrophotometer (Thermo Fisher Scientific) and the protein was stored 
at -80°C. 
GST-Rli1 and GST-tag alone were expressed as described in this section, but not purified 
by 1 ml GSTrap™ FF columns. Instead, the cells were pelleted (50 ml cell suspension) and 
either stored at -20 °C or directly used after cell harvesting. For experimental approaches, 
the cells were resuspended in lysis buffer (20 mM HEPES, pH 7.5, 100 mM NaCl, 4 mM 
MgCl2, 20% (v/v) Glycerol, 0.5% (v/v) NP-40, 1mM DTT) supplemented with cOmplete™, 
EDTA-free protease inhibitor cocktail (5µl per 100 ml cell lysate) and lysed on ice through 
sonification with the sonifierer cell disrupter S-250A (Branson Ultrasonics). For lysis, the 
cells were resuspended in 5 ml lysis buffer and sonified twice for 5 min to open the cells up. 
Subsequently, the crude extracts were centrifuged at 16000x g and 4 °C for 20 minutes. 
The lysates were used for in vitro assays or in combined in vivo and in vitro studies. 
 
3.2.5.4. Combined in vivo and in vitro studies 
The in vivo produced GFP tagged proteins are immobilized as described in chapter 3.2.5.2.. 
After immobilization, the co-purified proteins are detached from the protein of interest by 
harsh washing. For this, the proteins bound to the GFP beads are washed 5 times with 
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samples were washed again 3 times with in vitro lysis buffer. Afterwards, either purified 
protein or clear cell lysate containing the expressed recombinant protein (see 3.2.5.3.), were 
added to the immobilized protein bound to GFP beads for 2 h. Subsequently, the beads 
were washed again 3 times with in vitro lysis buffer, finally mixed with 30 µl 2x SDS buffer 
and in the last step the proteins were separated by SDS-PAGE. 
 
3.2.5.5. Displacement assay 
The displacement assay used in this study is a combination of an in vivo and in vitro study. 
After binding of the first recombinant protein to the immobilized GFP tagged protein, the 
precipitated tagged protein was washed like as described in chapter 3.2.5.2.. Subsequently, 
a second recombinant protein was added to the preformed complex and incubated for 2 h. 
The second protein was added in the indicated increasing concentrations to investigate a 
possible competition or disassembly ability of the preformed complex. Finally, the beads 
were washed 3 times with in vitro lysis buffer and the samples were then applied to SDS-
PAGE. The displacement activity was evaluated by detection of all proteins via western-
blot. 
 
3.2.5.6. Sucrose-density gradient fractionation 
To analyze protein binding to different ribosomal complexes, sucrose-density gradient 
fractionation experiments were conducted according to Frey et al. (2001) and Masek et al. 
(2011). Yeast cells were inoculated in 200 ml of medium and incubated overnight at 25 °C 
to obtain a pre-culture. On the next day, the cells were counted and diluted in 400 ml 
medium to 0.5x107 cells/ml. After additional incubation reaching the logarithmic growth 
phase (2x107 cells/ml), the cells were shifted to their non-permissive temperature (37 °C) 
for 1 h. To avoid a polysome run-off, the cells were treated with 100 µg/ml of the translational 
inhibitor cycloheximide (Carl Roth) on ice for 15 minutes. Afterwards, the cells were 
harvested, washed once with ice-cold distilled water and then lysed in pre-cooled lysis 
buffer (20 mM HEPES-KOH, pH 7.5, 10 mM KCl, 2.5 mM MgCl2, 1 mM EGTA, 1 mM DTT 
and 100 µg/ml cycloheximide) supplemented with cOmplete™, EDTA-free protease 
inhibitor cocktail (5µl per 100 ml cell lysate). To estimate the protein concentration of each 
sample, absorption of the lysates was measured at 260 nm with the NanoDrop 
spectrophotometer. For ribosome gradients and subsequent protein analysis, 15 OD260 of 
lysates were loaded on top of each linear-sucrose gradient. To prepare linear sucrose-
gradients, 7 % (w/v) sucrose and 47 % (w/v) (%sucrose, 20 mM HEPES-KOH, pH 7.5, 10 
mM KCl, 2.5 mM MgCl2) were mixed, poured with the gradient master 108 (BioComp 
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The lysates were separated in the sucrose-gradients by centrifugation at ~200000x g at 4°C 
for 3 h in a Sorvall WX80 ultracentrifuge with the TH-641 rotor (Thermo Fisher Scientific). 
Thereafter, the gradients were collected in 700 µl fractions with a fraction collector 
(Teledyne Isco). For that, 60 % (w/v) sucrose was pumped to the bottom of the gradient 
upwards to push the gradient past a spectrophotometer into collection tubes. The 
spectrophotometer plotted the ribosomal rRNA by measuring the absorbance at 254 nm. 
For western-blot analysis of the proteins, all proteins were precipitated with 20 % 
trichloroacetic acid (TCA, Carl Roth). For this 700 µl of TCA was mixed with each sample, 
the proteins were pelleted through centrifugation at 16200x g and 4 °C for 15 minutes. The 
supernatant was removed and the pellets were washed twice with 80 % (v/v) acetone and 
afterwards dried at room temperature and resuspended in 30 µl of 2x SDS-sample buffer. 
 
3.2.5.7. SDS-polyacrylamide gel-electrophoresis (SDS-PAGE) 
Proteins were denaturized and separated by size using standard, vertical, discontinuous 
SDS- polyacrylamide- gel- electrophoresis (SDS-PAGE) (Garfin, 2009). 
Table 12 - Formula of SDS-polyacrylamide-gels 
Ingredient Stacking Gel Separation gel 
Bis-/Acrylamide Mixture 37.5:1 5 % (v/v) 10 % (v/v) 
Tris/HCl pH 8.8 -/- 0.375 mM 
Tris/HCl pH 6.8 125 mM -/- 
SDS 0.1 % (v/v) 0.1 % (v/v) 
APS 0.1 % (v/v) 0.1 % (v/v) 
TEMED 0.1 % (v/v) 0.04 % (v/v) 
 
The components listed in table 12 for separation gel were mixed and poured between two 
approx. 25 x 20 cm glass plates, detached by approx. 2 mm thick spacers. The separation 
gel mix was covered with a layer of 1 ml isopropanol. After polymerization, the isopropanol 
was washed off with water and the water was removed. The components of the stacking 
gel were mixed (Table 12) and poured on top of the separation gel. To form sample pockets, 
a comb was inserted immediately. After polymerization, the comb and the spacer at the 
bottom were removed and the gel was placed into a running chamber. The chamber was 
filled with SDS running buffer (25 mM Tris Base, 0.1% (w/v) SDS, 190 mM glycine) and the 
sample wells were washed with running buffer. Before loading, the samples were boiled at 
95 °C for 5 minutes and then loaded side by side with a protein marker  
(PageRuler Prestained protein ladder (Thermo Fisher Scientific) or Cozy Prestained Protein 
Ladder (highQu)) into the sample pockets. The power current was set to 14 mA and the gel 
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3.2.5.8. Coomassie staining 
For the determination of protein containing fractions and protein expression, SDS-
polyacrylamide gels were stained with Coomassie brilliant blue. Upon SDS-polyacrylamide-
electrophoresis, the gels were stained with staining solution (50 % (v/v) methanol, 0.25 % 
(w/v) coomassie brilliant blue R250) for 10 min. Subsequently, the stained gels were 
incubated with de-staining solution (5 % (v/v) Methanol, 10 % (v/v) glacial acetic acid), until 
clear protein bands were visible. For a faster de-staining, a tissue was placed in the solution 
and the gel was heated until boiling in a microwave. For documentation, the gels were 
scanned. 
 
3.2.5.9. Western blot analysis 
Following protein separation via SDS-PAGE, the proteins were transferred to a 
nitrocellulose membrane to make the proteins accessible for antibodies and 
chemiluminescent substrates. This method was first described by Towbin et al. (1979). 
Essentially, for Semi-Dry western blotting, two pieces Whatman® Blotting Paper 
(Hahnemühle) and one piece of Amersham™ Protran® 0.45 µm nitrocellulose Membranes 
(GE Healthcare), both in the size of the gel, were soaked in blotting buffer (25 mM Tris-
Base, pH 8.3, 192 nM Glycine, 20 % (v/v) Methanol). The composition was placed in the 
following order beginning at the anode: Whatman paper, nitrocellulose membrane, SDS-gel 
and Whatman paper. Afterwards, the cathode was installed. The Semi-Dry western-blotter 
was run at 1.5 mA/cm2 for 1.5 h. After that, the blot was incubated with Ponceau S solution 
(0.2 % (w/v) Ponceau S, 5 % (v/v) Glacial acetic acid) for ~10 min to stain rapidly aromatic 
amino acids. After de-staining with distilled water, the protein bands were visible and, in this 
way, confirmed the successful blotting procedure. If required, the membrane was cut into 
pieces to be able to use different antibodies and the stripes were blocked in blocking buffer 
(5% (w/v) non-fat dried milk powder in TBS-T (50 mM Tris-Base pH 7.4, 150 mM NaCl, 0.1 
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Table 13 - Antibodies for western blot analysis 
Primary Antibodies Dilution Source 
Mouse α GFP (Monoclonal, 
GF28R) 
1:5000 Pierce Protein Biology 
Rabbit α GFP 1:2000 Prof. Dr. Heike Krebber, University of 
Göttingen 
Rabbit α GFP (Polyclonal, PABG1) 1:4000 ChromoTek GmbH 
Rabbit α Dbp5 1:3000 Prof. Dr. Heike Krebber, University of 
Göttingen 
Rabbit α Asc1 1:2000 Dr. Oliver Valerius, University of 
Göttingen 
Rabbit α uS3 Peptide Antibody 1:3000 Prof. Dr. Heike Krebber, University of 
Göttingen 
Rabbit α Zwf1 1:5000 Prof. Dr. Ulrich Mühlenhoff, 
University of Marburg 
Mouse α c-MYC (Monoclonal, 
9E10) 
1:750 Santa Cruz Biotechnology 
Mouse α GST (Monoclonal sc-138) 1:2000 Santa Cruz Biotechnology 
   
Secondary Antibodies Dilution Source 
Goat α Rabbit – HRP Conjugated 1:10000 Dianova 
Goat α Mouse – HRP Conjugated 1:10000 Dianova 
 
The primary antibody was diluted (Table 13) in 2 % non-fat dried milk powder solved in 
TBS-T and incubated with the membrane in agitation for 1.5 h at RT or at 8 °C overnight. 
Subsequently, the membrane was washed 3 times with TBS-T and then incubated with the 
secondary antibody, diluted in 2% non-fat dried milk powder in TBS-T for 1.5 h at RT. Upon 
2 times washing with TBS-T, the membrane was washed 2 times in distilled water. Then, 
detection was achieved by WesternBright™ Quantum™ Western Blotting HRP Substrate 
(Advansta), which was converted by the enzyme Horseradish Peroxidase (HRP) coupled 
to the secondary antibody. The resulting chemiluminescence was detected by the Fusion-
SL-3500.WL (Peqlab) chemiluminescence detection system. 
 
3.2.6. Molecular biological methods  
3.2.6.1. Extraction of genomic DNA from S. cerevisiae cells 
For isolation of yeast genomic DNA, cells were grown in 10 ml liquid culture. The saturated 
cell culture was harvested by centrifugation at 4100x g and 4 °C for 5 min. Subsequently, 
the pellet was washed with 1 ml distilled water and resuspended in 300 µl detergent lysis 
buffer (2 % (v/v) Triton X-100, 1 % (w/v) SDS, 100 mM NaCl, 10 mM Tris-HCl pH 8, 1mM 
EDTA) and 300 µl of phenol/chloroform/isoamyl alcohol (P/C/I, 25:24:1). After adding glass 
beads type S 0.4-0,6 mm in the same volume as the sample pellet, the mixture was 
disrupted using the FastPrep-24 machine at 5 m/s for 30 sec. The samples were centrifuged 
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phase was carefully separated from the interlayer and the organic phase and mixed again 
with the same volume of P/C/I and centrifuged again. These steps were repeated until the 
interlayer appeared clear. Then the genomic DNA was precipitated from the aquatic phase 
by treatment with 6 µl of 7.5 M ammonium acetate and 1 ml 100 % ethanol. This mixture 
was vortexed and then centrifuged again at 16200x g and 4 °C for 10 min to precipitate the 
DNA. In the final step, the DNA pellet was washed twice with 70% ethanol and dried at  
65 °C for 5 min, before it was resolved in 100 µl water. 
 
3.2.6.2. RNA Isolation 
RNA from whole cell lysate was purified with silica membrane based NucleoSpin® RNA kit 
(MACHEREY-NAGEL) according to the manufacturer’s instructions, with the modification 
that DNase digest was extended from 15 min to 30 min for an entire DNA removal. 
Alternatively, RNA was purified with TRIzol® reagent (Thermo Fisher Scientific), following 
the manufacturer’s instructions (with modifications). 1 ml TRIzol® was added to the cell 
lysate and incubated with agitation at 65°C for 10 min. In the next step, 200 µl chloroform 
was added and mixed thoroughly. After centrifugation at 16200x g for 10 min, the resulting 
upper phase was transferred into a fresh tube and 1 µl glycogen and 500 µl isopropanol 
were added and mixed for RNA precipitation. The mixture was stored at -20 °C overnight 
and then centrifuged at 16200x g and 4°C for 30 min. After removing the supernatant, the 
RNA pellet was washed twice with 70 % ice-cold ethanol made with DEPC water (0.1% 
(v/v) diethyl pyrocarbonate). Finally, the RNA was dried at 65 °C for 10 min and 
subsequently resuspended in 30 µl DEPC water and dissolved at 65 °C for 10 min and then 
stored at -20 °C or -80 °C. The yield and quality of the isolated RNA was determined with 
the NanoDrop spectrophotometer. 
 
3.2.6.3. cDNA synthesis from RNA  
For the synthesis of cDNA from RNA, the FastGene Scriptase II Kit (NIPPON Genetics) 
was used according to the manufacturer’s instructions. Isolated RNA was diluted to 200 ng 
and then reverse transcribed with random hexamer primers and reverse transcription at a 
temperature of 42 °C. After reverse transcription, the cDNA was diluted to 0.5 ng/µl to be 
suitable for qPCR analysis. For every experiment, a control was prepared in the same way, 
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3.2.6.4. Quantitative polymerase chain reaction (qPCR) 
Quantitative polymerase chain reaction was used to determine the quantitative amount of 
different RNAs in whole cell lysates and relies on fluorescent labeling with molecules that 
bind specifically to double stranded DNA. The fluorescence is measured after each PCR 
cycle and the increase of fluorescence depends on the efficiency of the amplification 
reaction, which can also depend in the chosen primers. The PCR cycle (Cq) in which the 
fluorescent signal exceeds the threshold was used for the calculation of the starting amount 
of DNA. In this study, the primer pairs were designed with the GeneScript Real-time PCR 
(TaqMan) primer designer (Genescript.com) to reach amplification efficiencies of 0.8 -1. All 
samples, except the -RT and negative controls, were prepared in triplicates. Each sample 
was prepared in 10 µl consisting of 5 µl 2x qPCR master mix (qPCRBIO SyGreen Mix Lo-
Rox, Nippon genetics), 4µl cDNA (0.5 ng/µl), 0.08 µl (1000 ng/µl) of forward and reverse 
primers and 0.86 µl nuclease free water. The qPCR was executed in a two-step protocol 
with 95 °C initial denaturation and 45 cycles with 30 s at 60 °C and 10 s at 95 °C. For the 
verification that only one specific product was amplified, the qPCR cycler CFX connect 
(BioRad) recorded a melting curve starting from 65 °C to 95 °C. 
The target cDNA was normalized to 21S cDNA and calculated using the 2-ΔΔCq method 
(Livak and Schmittgen, 2001). 
 
3.2.7. Statistical analysis 
All experiments were performed at least in three independent biological replicates. The 
mean ± standard deviations are shown. All data were finally analyzed for significance by 
Student’s two tailed, two-sample, unequal variance t-test. Significant P-values below 0.05 
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 Results 
Christian Beißel, Bettina Neumann, Simon Uhse, Irene Hampe, Prajwal Karki, Heike 
Krebber, Translation termination depends on the sequential ribosomal entry of eRF1 and 
eRF3, Nucleic Acids Research, Volume 47, Issue 9, 21 May 2019, Pages 4798–
4813, https://doi.org/10.1093/nar/gkz177 
 
My contributions to this project are the results presented in figures 1 C-F, 2 G+H, 3 C-E, 4 
D-H, 5, 6, 7 and the model in Fig 8. 
In the following results section of this thesis the figures are listed as paper figures 
e.g. Fig P1, Fig P2, Fig P3 et cetera. 
This publication identifies Dbp5 as a protein that controls a shielded entry of eRF1 into 
translation termination. This prevents a premature eRF1 and eRF3 contact and thus 
readthrough of the stop codon. 
 
 
Ariyachet, C., Beißel, C., Li, X., Lorrey, S., Mackenzie, O., Martin, P.M., O'Brien, K., 
Pholcharee, T., Sim, S., Krebber, H. and McBride, A.E. (2017), Post-translational 
modification directs nuclear and hyphal tip localization of Candida albicans mRNA-binding 
protein Slr1. Molecular Microbiology, 104: 499-519. doi:10.1111/mmi.13643 
 
My contributions to this project are the results presented in figure 7. 
This publication confirms a function of the RNA binding protein Slr1 from Candida albicans, 
a homolog of yeast Npl3, in translation by sucrose density fractionation experiments. 
 
 
Beißel, C*.; Grosse, S*.; Krebber, H. Dbp5/DDX19 between Translational Readthrough and 
Nonsense Mediated Decay. Int. J. Mol. Sci. 2020, 21, 1085. 
 
*These authors contributed equally. 
This review discusses the function of Dbp5 in translation termination and a potential function 
of this RNA helicase in nonsense mediated decay (NMD). 
 
The published papers are attached in the 9. Appendix section. 
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4.1. Dbp5 is involved in nonsense mediated decay 
We have shown that Dbp5 is involved in regular translation termination, where it controls 
the eRF1-eRF3 interaction and we speculated that it might have a possible function in NMD 
(Beißel et al., 2019, 2020). The following experiment addressed, whether Dbp5 is required 
for the recognition of premature termination codons (PTCs). For this, we used a PTC 
containing reporter construct, which derived from the intron containing gene CBP80 (Figure 
9 A). CBP80 is a typically spliced mRNA in yeast, which contain an intron that is located 
very close to the start codon.  
 
Figure 9 - Dbp5 is required for PTC induced destabilization of CBP80 mRNA. 
(A) Scheme of CBP80 reporter constructs with and without a premature termination codon (PTC). 
(B) RNA levels of CBP80PTC reporter construct in percent to CBP80 without a PTC. The MYC 
sequence was used to discriminate between the reporter transcripts and endogenous CBP80 mRNA. 
RNA levels were determined from the indicated strains containing the PTC-containing or a PTC-free 
NMD reporter. Both mRNA concentrations were normalized to the mitochondrial 21S rRNA and 
quantified by qPCR. In each experiment the NMD reporter sample was normalized to the control 
reporter sample of the same strain. All strains were shifted to 37 °C for 1 h. (wild type (WT) and rat8-
2-myc n=6; upf1Δ and rat8-3 n=4, * indicate significances compared to WT). 
In yeast, mis- or unspliced transcripts are thought to be a major source of NMD targets upon 
leakage of these faulty transcripts into the cytoplasm. Such pre-mRNAs typically contain a 
PTC that is close to the start codon (Christie, 2004). As it is known that Dbp5 plays a crucial 
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translational and mRNA export effects. Furthermore, the PTC is frame dependent and can 
only be recognized during translation. We found that the PTC reduced the RNA level of the 
reporter construct in wild type cells to 56 % after a temperature shift to 37 °C for 1 h (Figure 
9 B). In contrast to that, our internal positive control, cells lacking UPF1, showed a significant 
stabilization of the PTC containing mRNA to 120 % after 1h at 37 °C. These results were 
comparable to unshifted wild type and upf1Δ cells (unpublished data, Laboratory of Prof. 
Dr. Heike Krebber). Interestingly, temperature sensitive mutants of DBP5 that were 
incubated at 37 °C for 1 h showed a similar significant stabilization of the PTC-reporter as 
upf1Δ. We found an accumulation of the reporter mRNA to approximately 104 % in both, 
rat8-2-myc and rat8-3 strains. These results indicate, that Dbp5 is involved in the PTC 
dependent destabilization of NMD targets. Given that the effect of the DBP5 mutants was 
comparable to upf1Δ cells, it is possible that Dbp5 is required for NMD detection, because 
termination has to occur in order to trigger NMD via Upf1. 
 
4.2. Dbp5 is involved in NSD and NGD 
4.2.1. Dbp5 mediates the interaction of Dom34 and Hbs1 and their interaction 
with the ribosome 
For regular translation it is known that Dbp5 mediates the interaction of the canonical 
translation termination factors eRF1 and eRF3. Furthermore, the interaction of both factors 
with the ribosome was reduced in temperature sensitive DBP5 mutants (Fig P3 D+C). 
Interestingly, the decreased Dom34 and Hbs1 interaction was not only seen in DBP5 mutant 
strains but also in strains mutated in the Dbp5 recycling factor Nup159 (Fig P4 F+G). These 
findings suggest that Dbp5 might not only mediate the interaction between eRF1 and eRF3 
but also the binding between their orthologues Dom34 and Hbs1. To investigate this in more 
detail, we immunoprecipitated Dom34-GFP (Figure 10 A) or myc-Hbs1 (Figure 10 B) in 
either wild type cells or strains mutated in DBP5/RAT8 and detected the co-immuno-
precipitated proteins after a temperature shift to 37 °C for 1 h. In this experiment, absence 
of growth suppressor of Cyp1 (Asc1) served as an indicator for a ribosomal interaction. 
Asc1 is a ribosome binding protein that can be detected with ribosomes in wild type strains 
(Kouba et al., 2012). Indeed, we could clearly determine an interaction of Dom34-GFP with 
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Figure 10 -The interaction of Dom34 and Hbs1 is decreased in DBP5 mutants. 
Western-blot analysis of co- immunoprecipitations of Dom34-GFP or myc-Hbs1 are displayed. (A) 
Detection of Dom34-GFP pull down and co-immunoprecipitated proteins (myc-Hbs1, Dbp5, Asc1) in 
different strain backgrounds (RAT8, rat8-2-myc and rat8-3). (B) Detection of co-immunoprecipitated 
proteins (Dom34-GFP, Dbp5, Asc1) of myc-Hbs1 pull downs in different strain backgrounds (RAT8, 
rat8-2-myc and rat8-3). The displayed results were seen in four (left) and three (right) independent 
experiments. 
Interestingly, these interactions were diminished in rat8-2-myc and rat8-3 cells  
(Figure 10 A). A similar decrease in the interaction was detected for the interaction with 
Dom34-GFP and Asc1, when we immunoprecipitated myc-Hbs1 in RAT8 mutant cells 
(Figure 10 B). In wild type cells we detected a clear interaction of myc-Hbs1 with Dom34-
GFP and Asc1 (Figure 10 B). In both experiments, the interaction of Dom-GFP or myc-Hbs1 
with Dbp5 was abolished in RAT8 mutants. (Figure 10 A+B). In contrast, in wild type cells 
Dbp5 co-precipitated with Dom34-GFP and Hbs1-myc. Interestingly, in nup159Δ cells, 
which specifically lack the interaction domain of Dbp5, the binding defect between Dom34-
GFP and its co-purified proteins, myc-Hbs1, Dbp5 and Asc1, was also detectable 
(unpublished data, laboratory of Prof. Dr. Krebber). In summary, Dom34 and Hbs1 require 
Dbp5 for their interaction and association with the ribosome, and they share this behavior 
with the canonical release factor eRF1 and eRF3. 
 
4.2.2. Dbp5 interacts directly with Dom34 and Hbs1 
For canonical translation termination, a direct interaction of eRF1 and Dbp5 was shown. 
This interaction depends on the nucleotide status of Dbp5 (Fig P5 A). In contrast, however, 
a direct interaction of Dbp5 and eRF3 was not detectable, neither in in vivo nor in in vitro 
studies (Fig P5 A) (Gross et al., 2007). Contrary to that, an in vivo interaction of Dbp5 to 
both, Dom34-GFP and myc-Hbs1 was visible (Figure 10). To further investigate the binding 
preference of Dbp5 to Dom34 and Hbs1, we performed combined in vivo and in vitro 
studies. We first immobilized either Dom34-GFP (Figure 11 A) or myc-Hbs1 (Figure 11 B) 
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We determine the nucleotide status of GST-Dbp5 by supplying 1 mM AMPPNP. As shown 
in Fig 11 A, keeping it in its ATP-bound state was necessary for the interaction with Dom34-
GFP but not with myc-Hbs1, as GST-Dbp5 was only able to bind to Dom34 when it is bound 
to AMPPNP. 
 
Figure 11 - Binding of Dbp5 to Dom34 and Hbs1 in regard to its nucleotide associated status. 
Western-Blot analysis of combined in vivo and in vitro studies are depicted. (A) Binding of either 
recombinant GST-Rli1, GST or GST-Dbp5 to immobilized Dom34-GFP is shown. All binding studies 
are performed once with 1 mM AMPPNP and once without 1 mM AMPPNP. (B) Nucleotide (1 mM 
AMPPNP) dependent binding of Dbp5 to immobilized myc-Hbs1 or to MYC-beads incubated with 
buffer only. The displayed results were seen in four (top) and two (bottom) independent experiments. 
Interestingly, our positive control GST-Rli1 could interact with Dom34-GFP independently 
of its bound nucleotide (Figure 11 A). Moreover, the binding of Dbp5 to Hbs1 was 
independent of the nucleotide bound status of Dbp5. These findings reveal that Dbp5 might 
interact with Dom34 in the same manner as with eRF1, but in contrast to eRF3 it also binds 
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4.2.3. Binding of Dbp5 and Hbs1 to Dom34 is not mutually exclusive 
Taking into account that we were able to detect an interaction of Dbp5 with Dom34 and 
Hbs1, we investigated whether the binding of Dbp5 and Hbs1 to Dom34 is mutually 
exclusive. For this, we immobilized Dom34-GFP from whole yeast lysate and added 350 µg 
recombinant GST-Dbp5, which was supplemented with 1 mM AMPPNP. To this pre-formed 
complex, we added increasing concentrations of yeast lysate containing myc-Hbs1. The 
positive controls showed that GST-Dbp5 and myc-Hbs1 alone are able to bind to Dom34-
GFP respectively (Figure 12). Interestingly, even high concentrations of myc-Hbs1 did not 
disrupt this complex, but rather presumably formed a bigger complex composed of Dom34-
GFP, GST-Dbp5-AMPPNP and myc-Hbs1 (Figure 12). This is in contrast to the canonical 
translation termination factors eRF1 and eRF3 and their binding to Dbp5, where the binding 
of either eRF3 or Dbp5 to eRF1 is mutually exclusive (Fig P5 B). The addition of eRF3 did 
not result in its association with eRF1 and Dbp5. 
 
Figure 12 - Dbp5 and Hbs1 interaction with Dom34 is not mutually exclusive. 
Western blot analysis of competition assay is displayed. Increasing concentrations of myc-Hbs1 were 
not able to disrupt a preformed complex of Dom34-GFP and GST-Dbp5, supplemented with 1 mM 
AMPPNP, but rather additionally associated with Dom34-GFP, GST-Dbp5 and AMPPNP.  
The displayed results were seen in four independent experiments. 
4.2.4. Dom34 and Hbs1 co-migrate with Dbp5 and Asc1 in polysomes of 
sucrose-density gradients 
To investigate how Dbp5 might influence the binding of Dom34 and Hbs1 to translating 
ribosomes, we performed sucrose-density fractionation experiments. The experiment was 
either carried out in wild type cells or rat8-2 and rat7ΔN mutants. All strains were shifted to 
the non-permissive temperature of 37°C for 1 h and treated with 100 µg/ml cycloheximide 
to avoid polysome run-off. Polysome profiles of wild type cells showed after 100 µg/ml 
cycloheximide treatment, a non-ribosomal peak of proteins not bound to ribosomes, a peak 
for the 40S and 60S ribosomal subunits, a peak for 80S ribosomes and polysomes reflecting 
actively translating ribosomes (Figure 13 A, left). Also, in rat8-2 and rat7ΔN mutants, 
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However, in contrast to wild type cells these mutants showed increased 80S peaks and 
fewer polysomes (Figure 13 A middle and right). Consistently, Asc1, as a ribosome 
associated protein, reflects this altered distribution in western blots of the gradient fractions 
(Figure 13 B, bottom). Asc1 was found in all polysomal fractions, and in the 80S and 40S 
peaks in wild type cells. 
 
Figure 13 - Stability of Hbs1 and binding of Dom34 to polysomes depends on functional Dbp5. 
(A) Ribosome profiles of wild type, rat8-2 and rat7ΔN strains after sucrose density gradients are 
displayed. Ribosome profiles were recorded via measuring the absorbance at 254 nm. 
(B) Western blot analysis of precipitated proteins after ribosome fractionation are shown. Proteins of 
each fraction are precipitated and detected via different antibodies (GFP, MYC, Dbp5 and Asc1). 
Similar results were obtained in three independent experiments. 
In contrast, in rat8-2 and rat7ΔN mutants, Asc1 was only visible in the 80S fractions of 
ribosomes. Dbp5 migrated with the non-ribosomal, 60S and polysomes fractions in wild type 
cells. Interestingly, in the rat7ΔN mutant the fraction of Dbp5 shifted to the non-ribosomal 
fraction, while in rat8-2 mutants Dbp5 was not longer detectable (Figure 13 B, top), 
suggesting that the helicase is absent from ribosomes or even degraded, respectively. For 
myc-Hbs1, we uncovered its presence in all fraction of the ribosome gradient in wild type 
cells. In contrast, myc-Hbs1 was only slightly detectable in the non-ribosomal fractions of 
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Furthermore, Dom34-GFP was detectable in the polysomes fractions, as well as in the 80S 
and non ribosomal fraction in the wild type strain. Contrary to that, Dom34-GFP was only 
present in 80S and non-ribosomal fractions in rat8-2 and rat7ΔN strains (Figure 13 B, 
middle-top). Together, these data suggest that the stability of Hbs1 might depend on 
functional Dbp5, while Dom34 shows a different behavior. Like Hbs1, it co-migrates with 
Dbp5, but in contrast to Hbs1, Dom34 is able bind to the 80S ribosomes independently of 
Dbp5. 
 
4.2.5. rat8-3 dom34Δ double mutant strains are hypersensitive to oxidative 
stress  
To gain insights into how Dbp5 might act together with Dom34 in NSD and NGD, growth 
analysis of a DOM34 knock out strain combined with rat8-3 mutants was performed. Taking 
into account that dom34Δ showed no growth defect under normal conditions, we 
supplemented the medium with 1 mM of the oxidizing reagent diamide. This drug was 
shown to increase the growth defect of the dom34Δ strain (Jamar et al., 2017). For an even 
stronger phenotype of reduced growth, we combined this experimental setup with NSD and 
NGD reporter constructs (Tsuboi et al., 2012). The general composition of these reporter 
constructs expressed from a GAL1 promoter are depicted in figure 14 A. The reporters are 
composed of a GFP ORF (green) followed by the sequence that is recognized by NSD or 
NGD (red). These sequences are a stem loop (SL) structure, sequence of rare codons 
(GGN)12 or a sequence with an autocatalytically acting self cleavage ribozyme 
(hammerhead ribozyme) (Rz) (Forster and Symons, 1987). Additionally, the NGD and NSD 
sequence is each followed by a FLAG-tag and HIS3 gene. Furthermore, a reporter with the 
same composition, but lacking an NSD or NGD evoking sequence was used as a control 
reporter. The combination of 1 mM diamide with the transcription of NSD and NGD mRNAs 
reporters had no negative effect on the growth of rat8-3 mutants compared to cells that 
contained wild typical RAT8, neither at 25 nor at 35 °C. Rather a small general growth 
rescue effect was visible (Figure 14 B, middle-bottom). Interestingly, in both strains dom34Δ 
RAT8 or DOM34 rat8-3 the presence of the reporter constructs did not negatively affect the 
growth of the strains. Only the double mutant of dom34Δ and rat8-3 was sensitive to the 
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Figure 14 - dom34Δ and rat8-3 double mutants are sensitive to increased amounts of NGD 
and NSD substrates. 
(A) The general composition of the NSD and NGD reporter constructs is displayed. The GFP ORF 
(green) is followed by X (red), which reflects either a stem loop structure (SL), rare codons (GGN)12, 
or a hammerhead ribozyme (Rz). The control reporter had no additional sequence but the FLAG-tag 
sequence directly followed the GFP sequence. 
(B) Growth analysis of wild type, dom34Δ, rat8-3 and a combination of both are shown. The media 
was supplemented with 1 mM diamide and strains were transformed with the indicated reporter 
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4.2.6.NSD reporter construct accumulate in dom34Δ and rat8-3 single and 
double mutant strains 
To investigate whether the growth defect of dom34Δ rat8-3 double mutants, arose from 
potential defects in the degradation of the reporter mRNA, we analyzed the RNA levels via 
qPCRs. 
 
Figure 15 - Accumulation of NSD and NSG reporter constructs in dom34, rat8-3 and the double 
mutant strains. 
All reporter constructs, including the control reporter (pWT) were detected by primers that amplify 
the GFP sequence. All constructs were normalized to 21S rRNA and the control reporter. (n=8). 
After expressing the reporter constructs for 24 h in medium containing 2% galactose, the 
reporter mRNA was detected via qPCR with primers targeting the GFP sequence in the 
middle of the ORF. All measured cDNA concentrations of the reporter constructs were first 
normalized to 21S rRNA and additionally to the wild typical construct that lacks an NSD or 
NGD response sequence. In the wild typical strain with the Rz reporter (NSD) construct the 
mRNA mostly degraded and only ~30 % of it was detectable. In contrast rat8-3 cells showed 
a stabilization of the Rz reporter construct (Figure 15, green bars) to ~60 % compared to 
wild type cells and a similar increase to ~66 % was detectable in dom34Δ cells, indicating 
that Dbp5, like Dom34, functions in NSD. Strikingly, the double mutant of dom34Δ and rat8-
3 stabilized the reporter construct to ~91 %, suggesting additive effects of Dbp5 and Dom34 
in NSD. For the NGD sensed reporters (GGN)12 (Figure 15, red bars) and SL (Figure 15, 
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case of the (GGN)12 sequence and ~60 % for the stem loop structure were comparable to 
the control construct in all tested strains. 
These results indicate that the growth defect of the dom34Δ rat8-3 double mutant (Fig 14) 
might originate from mRNA accumulation of the NSD reporter, which indicate problems in 
their degradation, either through direct or indirect effects. 
 
4.2.7. Overexpression of DOM34 suppresses the growth defect of the rat8-2 
mutant 
To address, whether Dbp5 and Dom34 act in the same pathway, we investigated if growth 
defects of one of the mutants would be rescued by overexpression of the other. Therefore, 
we overexpressed either DOM34 or DOM34-MYC from the strong ADH1 promoter in wild 
type and rat8-2 mutant strains. The sequences were encoded on plasmids that contain the 
URA3 gene. To control, that the rescue effect originates from overexpression of DOM34, 
we spotted all tested strains also on FOA plates (Figure 16). Additionally, we included an 
empty vector in our studies that only encoded URA3. Overexpression of DOM34 did not 
affect the growth rates of the wild type strain. Interestingly, the growth defect of the rat8-2 
strain, was rescued by overexpression of DOM34 at 30 °C and 35 °C. This rescue effect 
was not longer detectable on FOA plates, on which the cells had lost the URA3 marked 
DOM34 plasmids (Figure 16, right). No effects of the DOM34 overexpression plasmids were 
detectable at the permissive temperature of 25 °C and at the non-permissive temperature 
of 37 °C. These finding indicate that mutant strains of Dbp5 that has access to more Dom34 
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Figure 16 - Overexpression of DOM34 rescues growth defect of rat8-2 mutants. 
Wild type and rat8-2 mutants containing either PADHDOM34 or PADHDOM34-myc were spotted in 10-
fold serial dilutions onto -URA or FOA plates. Scanned pictures of plates are displayed after an 
incubation at the indicated temperatures for 3 days (URA) or 5 days (FOA). 
Taken together, we have identified a novel function of Dbp5 in the cytoplasmic quality 
control pathways NSD and NGD. Dbp5 can interact with both, Dom34 and Hbs1. 
Importantly, defects in DBP5 lead to growth defects with dom34Δ in the presence increased 
amounts of both NSD and NGD reporter mRNAs, although only an increase of an NSD 
reporter RNA was indeed detectable. Strikingly, overexpression of DOM34 partially rescued 
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 Discussion 
5.1. Translation termination depends on the sequential ribosomal entry 
of eRF1 and eRF3 
5.1.1. Dbp5 binding to the ribosome, depends on functional eRF1 
Previous studies revealed that Rli1 is involved in translation termination, recycling and 
initiation (Dong et al., 2004; Khoshnevis et al., 2010; Pisarev et al., 2010). However, it is 
not clear when Rli1 is recruited to the ribosome. A further involvement of Rli1 in ribosome 
biogenesis suggested that Rli1 might stay associated with the ribosome during its complete 
life cycle (Kispal et al., 2005). Instead, Dbp5 seems to act only in translation termination 
and it might also interact with the ribosome only at late steps of translation (Gross et al., 
2007). In our study we accumulated evidence that the binding of Rli1 to the termination 
complex is independent of eRF1, while the binding of Dbp5 to the ribosome clearly depends 
on functional eRF1. Quantitative analysis (Fig P1 D) of co-immunoprecipitation experiments 
(Fig P1 C) revealed that binding of mutant sup45-2 protein to the ribosome was significantly 
decreased to about ~50% after a temperature shift to the non-permissive temperature for 1 
hour. This is consistent with earlier findings in which it was shown that the mutated sup45-
2 protein loses its ribosome binding ability (Song et al., 2000; Stansfield et al., 1995). 
However, the binding of Rli1 to the ribosome was not negatively affected by the binding 
defect of sup45-2 (Fig P1 A+D). In contrast, we detected an even stronger binding of Rli1 
to the 40S ribosomal subunit. Given the fact, that AMPPNP arrests Rli1 in a conformation 
that mainly binds to the 40S but not the 60S subunit (Andersen and Leevers, 2007), it is 
tempting to speculate that a large fraction of Rli1 is ATP-bound in sup45-2 mutants. 
Interestingly, the binding of Dbp5 to the ribosome decreased in sup45-2 mutants similar to 
eRF1 (Fig P1 B-D), indicating that Dbp5 requires functional eRF1 for its association with 
the ribosome. Taken together, these findings indicate that Rli1 is bound to the ribosome 
before eRF1 is recruited and binding of Dbp5 with the ribosome requires the binding of 
eRF1.  
To get further evidence for such a sequential recruitment, we took advantage of the tef2-9 
mutant, encoding mutant eEF1A. Mutations of eEF1A lead to defects in translation 
elongation, causing a detectable polysome fraction in strains that were not treated with 
cycloheximide (Fig P1 E and (Dinman and Kinzy, 1997)). In contrast to that the ribosome 
run off the mRNA in wild type cells, which is represented by no detectable polysomes. 
Quantitative analysis (Fig P1 G) of Rli1 binding to the polysomes in wild type and tef2-9 (Fig 
P1 F) demonstrated that Rli1 was present in the arrested polysomes in tef2-9 mutants, to 
an even greater extend than of Asc1. Taking earlier findings into account in which it was 
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ribosome (Becker et al., 2012), it is possible that their binding might be mutually exclusive 
and Rli1 takes over the binding site of eEF1A. In contrast to that, Dbp5 binding to the 
polysomes was almost not detectable in wild type and tef2-9 strains (Fig P1 G), indicating 
that Dbp5 binds to the ribosome after translation elongation.  
 
5.1.2. Dbp5 and Rli1 interact in translation termination 
It is known for more than a decade that Rli1 and Dbp5 act in translation termination (Gross 
et al., 2007; Khoshnevis et al., 2010), but it was still unclear whether they interact during 
translation termination. Our results showed, that Rli1 interacts with Dbp5 and Gle1 in wild 
type cells (Fig P2 A and Fig P1S). However, both proteins are also involved in ribosome 
biogenesis (Dong et al., 2004; Kispal et al., 2005; Neumann et al., 2016). To distinguish 
between a possible interaction during ribosome maturation and translation termination, we 
investigated whether Dbp5 and Rli1 interact in sup45-2 mutants and upon cycloheximide 
treatment of wild type cells. In fact, the interaction of Dbp5 and Rli1 was diminished to ~42% 
in sup45-2 cells (Fig P2 B+C) in which eRF1 and Dbp5 are not able to enter the ribosome 
(Fig P1 D). Furthermore, the treatment of wild type cells with cycloheximide led to ribosome 
stalling during elongation and the interaction of Dbp5 and Rli1 was decreased to 
approximately 41% (Fig P2 D+E). Thus, most of the interaction of Dbp5 and Rli1 
presumably takes place during translation termination. Interestingly, the interaction of Rli1 
with the small ribosomal subunit was not affected in cycloheximide treated cells (Fig P2 D). 
This stays in contrast to earlier findings showing that mutations in SUP45 lead to an 
increased binding of Rli1 to the 40S subunit (Fig P1 D and P2 B). This phenomenon 
indicates that the accumulation of Rli1, presumably in its ATP bound state, to the small 
ribosomal subunit increases if eRF1 is not able to hydrolyze the peptidyl-tRNA (Stansfield 
et al., 1997). However, as Rli1 might be the earliest translation termination factor to be 
recruited to the ribosome, it could be possible that Rli1 helps to fetch other translation 
termination factors. Indeed, we detected that overexpression of RLI1 could partially rescue 
the growth defect of sup45-2 mutants (Fig P2 F). This rescue defect might have two possible 
reasons. Either, Rli1 might help the residually bound sup45-2 protein (~44%) to hydrolyze 
the peptidyl-tRNA or it might recover the binding defect of sup45-2 to the ribosome, or both. 
However, our results rather indicate that the latter assumption is more likely, because 
overexpression of Rli1 also rescued the binding defect of sup45-2 to the 40S ribosomal 





                                                                                                                                                        Discussion 
5.1.3. eRF1 and eRF3 enter the termination complex independently 
In contrast to Rli1, the binding of Dbp5 to the ribosome requires functional eRF1 (Fig P1). 
It was already suggested earlier that Dbp5 might mediate the positioning of eRF1 at stop 
codons and dissociate from the termination complex to facilitate the interaction of eRF1 and 
eRF3 (Gross et al., 2007). To get further evidence for this idea, we took advantage of the 
sup45-2 mutant, in which mutant eRF1 has lost its ability to bind to the ribosome. In this 
mutant, eRF1 is freely available in the cytoplasm at the non-permissive temperature (Fig 
P1 C+D). Strikingly, in this mutant the binding between Dbp5 and eRF1 was increased to 
~217 % (Fig P3 A+C) and the interaction of eRF3 and eRF1 was diminished to ~32 % (Fig 
P3 B+C). Moreover, this increased binding of Dbp5 and eRF1 was visible, although the 
stability of eRF1 was impaired in sup45-2 mutants (Fig P1 A+B, lysate lanes). These results 
indicate, that the cytoplasmic eRF1 is preferentially bound to Dbp5 and that the interaction 
of eRF1 and eRF3 is rather prevented by Dbp5 in the cytoplasm or only takes place upon 
eRF1 entry to the stop-codon bound ribosome. If the interaction of eRF1 and eRF3 would 
indeed be blocked by a pre-formed eRF1-Dbp5 complex, we expected to see a similar 
outcome for a disturbed eRF1 and eRF3 interaction, in rat8-2 mutants. If mutant Dbp5 would 
not be able to deliver eRF1, an accidental contract of eRF1 and eRF3 might immediately 
lead to a GTP recruitment of eRF3, its subsequent hydrolysis and the consecutive 
dissociation of the two proteins. 
Indeed, in the DBP5 mutant strain rat8-2, we detected a decreased interaction of eRF1 with 
eRF3 to ~ 30 % and to ~34% with the ribosomal subunit (Fig P3 D+E). This finding supports 
the hypothesis that ribosome delivery of eRF1 through Dbp5 is important for correct 
translation termination. In fact, eRF3 and Dbp5 do not interact in vivo (Gross et al., 2007). 
Thus, a model is probable in which the binding of eRF1 and eRF3 takes place only at the 
ribosome and after Dbp5 release. In line with our model, a previous study showed that the 
interaction of eRF1 and eRF3 in rat8-2 mutants is decreased after a temperature shift to 37 
°C for 20 minutes (Gross et al., 2007). This observed binding defect was not as prominent 
as in our study, which might originate from the shorter shifting time. 
 
5.1.4. The function of Dbp5 in translation termination requires its ATPase 
cycle 
The ATPase activity of Dbp5 is essential for its function in mRNA export, but not for its role 
in ribosomal export (Hodge et al., 2011; Neumann et al., 2016; Tieg and Krebber, 2013). 
However, for translation termination Gross et al. (2007) showed that only the 
overexpression of wild type DBP5 and not of the ATPase deficient DBP5 mutant (E240Q) 
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Furthermore, Dbp5 requires its co-factors Gle1 and IP6 for its ATPase cycle and mutations 
of both showed increased readthrough of stop codons (Alcázar-Román et al., 2010; Bolger 
et al., 2008). For mRNA export, Nup159 was identified as the recycling factor of Dbp5 at 
the nuclear pore complex (Noble et al., 2011). Indeed, by using a dual reporter ß-
galactosidase luciferase assay (Fig P4 A) our study revealed that different mutants of 
NUP159 (RAT7) showed increased readthrough defects. Both the temperature sensitive 
rat7-1 mutant and the rat7ΔN mutant, which specifically lacks the interaction domain of 
Dbp5, showed a ~20 % and 21 % reduced stop codon recognition, respectively. The 
observed readthrough defects are comparable to those detected in rat8-2 mutant, which 
showed ~25 % readthrough activity (Fig P4 B). Although wild type cells were not fully 
readthrough resistant for the reporter construct, readthrough was really low with ~13 %. 
Similarly, an independent mutant of the karyopherin that is not involved in mRNA export or 
translation, kap123Δ (karyopherin 123), was also unaffected in its stop codon recognition 
and equal to wild type with ~13 % (Fig P4 B). Interestingly, overexpression of wild type 
DBP5 could rescue the increased readthrough defects seen in rat7ΔN mutants from 
approximately 25 % to wild typical levels (~12 %). These findings indicate that Nup159 is 
required to recycle Dbp5 and maintain the functionality of Dbp5 in translation termination. 
When Dbp5 is not recycled, as it is the case at the non-permissive temperature of RAT7, 
elevated amounts of Dbp5, which thereby also provide elevated levels of ATP-bound Dbp5, 
sustain a larger pool of active Dbp5, which can function in translation termination. This 
explains why an overexpression of DBP5 in this recycling defective mutant suppresses the 
Nup159 defect. Further insight into the role of Nup159 in sustaining active Dbp5 were 
obtained from co-immunoprecipitation experiments. In rat7ΔN strains, the binding of Dbp5 
to eRF1 is reduced to ~54 % and the interaction of eRF1 to eRF3 decreases even further 
to ~12 % as compared to wild type cells (Figure P4 D-G). These results suggest that only 
recycled, probably ATP bound Dbp5 is able to interact with eRF1 and regiment the 
interaction of eRF1 and eRF3. To investigate more directly whether Dbp5 in only its ATP 
bound form can interact with eRF1, we performed an in vitro binding study. Clearly, only in 
the presence of 1 mM AMPPNP Dbp5 was able to interact with eRF1 (Fig P4 H). In contrast, 
the binding affinity of eRF3 to eRF1 was not affected by the presence or absence of the 
ATP-analogon (Fig P4 H). Taken together, these in vivo and in vitro assays led to a model 
in which eRF1 and Dbp5-ATP interact in the cytoplasm. Dbp5 delivers eRF1 to the ribosome 
and places eRF1 correctly in the termination complex. Subsequent dissociation of Dbp5 
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5.1.5. Binding of Dbp5 and eRF3 to eRF1 is mutually exclusive 
We have shown that ATP-bound Dbp5 and eRF1 interact in the cytoplasm (Fig P3 A+C, Fig 
P4 H) and our results further indicate that the interaction of eRF1 and eRF3 is Dbp5-ATP 
dependent (Fig P3 D+E; Fig P4 F+G) and it is conceivable that the function of Dbp5 is to 
prevent an early contact between eRF1 and eRF3. In this case, the binding of Dbp5 and 
eRF3 to eRF1 would be mutually exclusive. Indeed, our results from an in vitro binding 
assay clearly showed that eRF1 lacking the last 25 amino acids of its C-terminus (His-
eRF1Δ25C) neither interacts with Dbp5 nor with eRF3 (Fig P5 A). These findings indicate, 
that eRF3 and Dbp5 share the same binding site within eRF1 and that the last C-terminal 
amino acids of eRF1 mediate the interaction with both, the helicase and eRF3. The 
interaction domain of eRF1, responsible for the eRF3 contact, was already determined 
earlier to be within the last 25 amino acids residues (Eurwilaichitr et al., 1999). Given that 
Dbp5 does not interact with eRF3 in vivo (Gross et al., 2007), and Dbp5 and eRF3 share 
the same binding site on eRF1, eRF3 should not be able to disrupt a preformed complex of 
Dbp5 and eRF1. This was indeed the case as shown in our in vitro displacement assay. 
Even high amounts of eRF3 were not able to disrupt a preformed Dbp5-eRF1 complex (Fig 
P5 B).  
 
5.1.6. Dbp5 mediates the interaction of eRF1 and eRF3 
In a model, in which one function of Dbp5 in translation termination prevent an early eRF1-
eRF3 contact, one has to assume that eRF3 enters the termination complex in a different 
way and should already be present when eRF1 is delivered. Indeed, in the elongation factor 
mutant tef2-9 (see 5.1.1.) the binding of eRF3 to the polysomal fraction was even stronger 
than the binding of Asc1 to the polysomes when compared to wild type cells (Fig P6 A+B). 
However, eRF1 was almost absent in the polysomes in both wild type and tef2-9 strains 
(Fig P6 A+B). These findings suggest, that eRF3 binds to the ribosome prior to eRF1 and 
is already bound to the ribosome during translation elongation. This is in line with the finding, 
that the binding of eRF3 to the small (uS3-GFP) and large (uL23-GFP) ribosomal subunits 
was increased in sup45-2 mutants compared to wild type cells (Fig S6 C+D). Taken 
together, these findings indicate that eRF3 is already bound to the ribosome prior to eRF1 
and Dbp5 association. Furthermore, the data also show that binding of eRF1 is necessary 
for the release of eRF3 from the termination complex. Since we could also detect a binding 
for Rli1 to the ribosome at that early time point (Fig P1 G+F), we investigated a potential 
direct interaction of eRF3 and Rli1. In our in vitro binding study, we detected that GDP-
bound but not GTP bound eRF3 directly interacts with Rli1 (Fig P6 E). This finding 
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productively interact with ABCE1/Rli1. Moreover, they found that Rli1 in its nucleotide free 
state is only partially bound to the 40S ribosomal subunit. In our in vitro assay (Fig P6 E), 
we did not supplement the buffer system with ATP. Thus, Rli1 is in its nucleotide free state 
when it interacts with eRF3. Furthermore, the binding might take place prior to the binding 
of Rli1 to the 40S ribosomal subunit, leading to a model in which Rli1 changes its position 
during translation termination through the stepwise entry of eRF3 and eRF1. Indeed, 
conformational changes in Rli1 upon its binding to eRF1 increases the binding affinity of 
Rli1 to the 80S ribosome (Pisarev et al., 2010). Such a model implicates that eRF1 and 
eRF3 would not enter the termination complex together and their premature contact must 
be prevented. Therefore, we analyzed situations in which this sequential entry is impaired. 
This could either be the case when Dbp5 itself is defective, or when its re-charging with 
ATP is impaired, such as in RAT7 mutants, because the helicase needs ATP-hydrolysis for 
its function (Fig P4 B-G). Therefore, we investigated the binding of eRF3, Dbp5 and eRF1 
to the small ribosomal subunit (uS3-GFP) in rat7ΔN and rat8-2 mutants after a temperature 
shift to 37°C for 1h (Fig P6 F-I). In both cases, the binding of eRF1, eRF3 and Dbp5 to the 
ribosome was significantly decreased, indicating that recycled (rat7ΔN) and functional (rat8-
2) Dbp5 is required to form the termination complex at the ribosome. Possibly, eRF1 and 
eRF3 are less present at the ribosome, because the termination complex disassembles 
instantly upon the uncontrolled contact of eRF1 and eRF3. Generally, interaction of eRF1 
and eRF3 initiate GTP-binding of eRF3 (Pisareva et al., 2006). Premature contact 
stimulates GTP binding of eRF3 prematurely and culminates in the subsequent GTP 
hydrolysis by eRF3, which in turn triggers the dissociation of eRF1 and eRF3 from each 
other and the ribosome. Such a model is strongly supported by the observed readthrough 
defects, seen in both Dbp5-impaired strains (Fig P4 B+C).  
Not only canonical, but also near cognate stop codons such as the UGG tryptophan codon 
that is comparable to the stop codon UGA, can erroneously lead to translation termination. 
For this type of codons, it was often observed that translation elongation stalls or is slowed 
down and increased rate of translation termination occurs. In this context, it might be 
conceivable that increased readthrough defects seen in yeast strains with impaired Dbp5, 
might suppress the growth defects of strains disturbed in their UGG-recognizing tRNA 
synthesis. To investigate this, we combined a rat8-2 mutant with the knock out of the 
tryptophan synthetase gene (trp5Δ) and monitored the growth at different temperatures (Fig 
P6 J). Indeed, we found a partial rescue effect of the double mutant strain at 16°C and 37°C, 
suggesting that mutations in DBP5, which reduce the termination efficiently, provide more 
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5.1.7. Hcr1 and eIF3 enter at late steps of translation termination 
In addition to eRF1, eRF3, Rli1, Dbp5 and some additional factors (see 2.1.4.), eIF3 and 
Hcr1 participate in translation termination (Beznosková et al., 2013, 2015). Mutations in 
eIF3 reduce the rate of stop codon readthrough, while hcr1Δ shows the opposite effect. 
Interestingly, the increased readthrough defects seen in HCR1 deletion strain are fully 
suppressed by overexpression of Rli1 (Beznosková et al., 2013). From these data a model 
was proposed in which Hcr1 promotes the ejection of GDP-eRF3 from the ribosome. 
Because Hcr1, in such a model, joins the termination complex at late stages, it should not 
interact with Dbp5 because in our studies no interaction of eRF3 and Dbp5 was detected 
an we suggested that Dbp5 has to leave the complex to allow eRF1 to interact with eRF3 
(Beißel et al., 2019; Gross et al., 2007). Indeed, co-immunoprecipitation experiments with 
eRF1 and Hcr1 showed that both proteins bind eRF3. Moreover, only eRF1 but not Hcr1 
interacts with Dbp5 (Fig P7 A). It was also suggested that eIF3 acts in late steps of 
translation termination and might promote ribosome recycling. As such it would be an 
additional factor that connects translation termination and ribosome recycling (Beznosková 
et al., 2015). Furthermore, Beznoskova et al. (2015) were able to show an interaction of 
eRF1, eRF3 and Rli1 with subunits of eIF3 in vivo. In our co-immunoprecipitation assay we 
chose Prt1 as one protein from the eIF3 complex and in co-IPs we could clearly verify the 
interaction of Prt1 with Rli1, eRF1 and eRF3. Indeed, their interactions were clearly 
diminished in sup45-2 mutants in which the termination event does not occur (Fig P7 B). 
Interestingly, neither in wild type nor in sup45-2 mutants an interaction of Prt1 with Dbp5 
could be detected, indicating that eIF3 binds to the termination complex after Dbp5 has 
delivered eRF1. If eIF3, like Rli1, connects late steps of translation termination and 
ribosome recycling it should bind to Rli1 independently of the nucleotide status of Rli1, which 
was indeed the case (Fig P7 C). 
 
5.1.8. Dbp5 ensures the stepwise entry of eRF1 and eRF3 to translation 
termination complexes 
Translation termination is a highly regulated process that depends on the three key factors 
eRF1, eRF3 and Dbp5 (Gross et al., 2007; von der Haar, 2007). Moreover, translation 
termination is connected with ribosome recycling by the factors Rli1 and eIF3 (Beznosková 
et al., 2015; Khoshnevis et al.; Shoemaker et al., 2011). However, the order in which the 
termination complex assembles was unclear. Polysome gradient fractionation experiments 
and co-immunoprecipitation assays revealed that nucleotide free Rli1 and eRF3 are bound 
to the ribosome prior to stop codon recognition through eRF1 (Fig P1+P6). Together with 
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termination (Fig P2 A-E), these results suggest that Rli1 might help to recruit eRF1 and 
Dbp5 to termination complexes. Indeed, we could show that overexpression of RLI1 
rescues the binding defect of the sup45-2 protein (Fig P2 G+H). For this function, it is 
tempting to speculate that Rli1 is still bound to ADP, because it was shown that translation 
termination occurs independently of the ATPase activity of Rli1. (Khoshnevis et al., 2010; 
Shoemaker et al., 2011). This correlates with our finding that Rli1 interacts with eRF3 even 
in the absence of ATP (Fig P6 E). Binding of Rli1 in its nucleotide free state to the ribosome 
and to eRF3 are in agreement with other models in which Rli1 takes over the position of 
eRF3 upon GTP hydrolysis, because eRF1 interaction with Rli1 increases its binding affinity 
to ATP and to the 80S ribosome (Pisarev et al., 2010).  
In earlier models it was suggested, that eRF1 and eRF3 together with GTP enters the 
termination complex as a ternary complex once the ribosome reaches a stop codon 
(Jackson et al., 2010). However, we have shown that eRF3 is already bound to the ribosome 
prior to the eRF1-entry at a stop codon in the A-site (Fig P6 A-D). This early binding of eRF3 
to the ribosome lead to the speculation that an additional factor might be present that 
regulate the interaction of eRF3 and eRF1 only if a stop codon is reached. Considering the 
total protein abundance of Dbp5:eRF1:eRF3 of ~1:2:4 (yeastgenome.org), it is tempting to 
speculate that Dbp5 which is also involved in other cellular process, is the limiting regulator 
of the interaction between eRF1 and eRF3. Excess of eRF1 over Dbp5 might be required, 
because eRF1 also participates in ribosome recycling (Preis et al., 2014; Shoemaker et al., 
2011). The high amount of eRF3 might be explained in a model in which eRF3 binds to all 
ribosomes engaged in translation, to wait for entry of eRF1. Such a model is supported by 
the finding that a 20 % reduction of basal Dbp5 and eRF1 protein concentration impairs 
protein synthesis, while a 60 % decrease of eRF3 had no effect (Mikhailova et al., 2017). 
Interestingly, our in vivo results indicate that Dbp5 is not bound to the ribosome during 
translation elongation (Fig P1 F+G, Fig P2 D+E). This seems to be in contrast to findings 
with the human homolog DDX19, which was shown to stabilize translation elongation in 
vitro (Mikhailova et al., 2017). This might either be due to functional differences of the yeast 
and human helicase, or might simply not reflect the in vivo situation, because Dbp5 binding 
to elongating ribosomes was in vivo not detected and recruitment might only be possible 
together with eRF1. Our results furthermore indicate that Dbp5-ATP and eRF1 interact 
already in the cytoplasm (Fig P3 A+C, Fig P4 D) and that the decoding capability of eRF1 
is necessary to recruit the Dbp5-eRF1 complex to the ribosome. Either placement of eRF1 
on the stop codon might in turn require the ATPase activity of Dbp5 or the dissociation of 
the helicase from the termination complex might require the energy. Finally, however, Dbp5-
ADP dissociates and needs to be recycled at the NPC via Nup159 (Fig P4). This mode of 
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Figure 17 - Stepwise entry model for translation termination. 
(Top) Step 1: Nucleotide free Rli1 is already bound to the ribosome and eRF3-GDP as soon as the 
ribosome reaches a stop codon and the A-site is free. eRF3 joins Rli1 in its GDP-bound form Step 
2: Rli1 supports the entry of ATP-Dbp5-eRF1 and Gle1/IP6 stimulated ATP-hydrolysis of Dbp5 leads 
to proper positioning of eRF1 on the stop codon. ATP-hydrolysis also leads to the dissociation of 
Dbp5-ADP. Recycling of the helicase occurs at the NPC by Nup159. Step 3: Dissociation of Dbp5-
ADP allows the controlled interaction of eRF1 and eRF3, which in turn triggers the GTP binding of 
eRF3. Subsequent GTP hydrolysis leads to a conformational change in eRF1 that places the GGQ 
motif in the peptidyl-transferase center. eRF3-GDP is displaced by Hcr1, which was initially delivered 
by eIF3. Step4: After eRF3-GDP dissociation, eRF1 binds to Rli1-ATP and locks it in a position 
required for peptidyl-tRNA hydrolysis. Step5: Upon peptide release, Rli1 and its ATPase activity 
separates the ribosomal subunits from each other and in this way recycle them for further translation 
events. 
(Bottom) Situation in which Dbp5 does not control the eRF1-eRF3 interaction. 
Step1: Nucleotide free Rli1 and eRF3-GDP are already bound to the ribosome when the ribosome 
reaches a stop codon and the A-site is free. Step2: Premature binding of eRF1 to eRF3 is not 
protected by Dbp5. eRF3 binds to eRF1 before it was properly positioned, leading to GTP binding, 
subsequent hydrolysis of the nucleotide and their dissociation from each other and the ribosome. 
This occurs before the polypeptide and the tRNA was released. Step 3: A near cognate tRNA gets 
access to the A-site, the stop codon is wrongly translated and elongation continues until the next 
stop codon is reached. Adopted from Beißel et al. (2019). 
Indeed, in our study, we could show that the last 25 amino acid residues are important for 
the interaction of eRF1 with either Dbp5 or eRF3 and their binding to eRF1 is mutually 
exclusive (Fig P5). Moreover, a separated entry of eRF1 and eRF3 is supported by the 
finding that decreased eRF3 expression does not impair the ribosomal association of eRF1 
(Salas-Marco and Bedwell, 2004). In situations, in which the sequential entry is impaired 
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recycling as seen in the rat7ΔN strain, a premature interaction of eRF1 and eRF3 leads to 
a rapid disassembly of the termination complex (Fig P6 F-I, Fig P3 D+E Fig P4 F+G). This 
might be because eRF1 is not properly placed and rearranged on the stop codon prior to 
its interaction with eRF3 and/or because it has to pass eRF3 to get into the A-site and the 
random contact without the Dbp5-shield provokes premature GTP binding and subsequent 
hydrolysis and dissociation. Such a model seems plausible, because it was shown earlier 
that the binding of eRF3 to eRF1 increases the binding affinity of eRF3 to GTP (Frolova et 
al., 1996; Pisareva et al., 2006). Therefore, we suggested that Dbp5 is an important 
regulator of the eRF1-eRF3 interaction and as such responsible for the timely trigger of 
translation termination (Fig 15). Notably, a reduced binding of eRF3 to the polysomal 
fraction was already described in rat8-2 mutants after a relatively short temperature shift to 
37 °C for 20 min (Gross et al., 2007). Moreover, gle1-4 temperature sensitive mutants of 
the Dbp5 co-factor Gle1 likewise exhibit polysome binding defects of eRF3 (Bolger et al., 
2008). In our model, a premature interaction of eRF1 and eRF3 leads to their immediate 
dissociation and thus shorter time, bound to the ribosomes. This model also explains that 
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5.2. Dbp5 plays a crucial role in cytoplasmic mRNA quality control 
5.2.1. Dbp5 is required for initial steps of NMD 
NMD is activated after the recognition of a premature termination codon. This requires the 
action of the regular termination factors eRF1 and eRF3 (Amrani et al., 2006; Kervestin and 
Jacobson, 2012). We found that Dbp5 is required for the stop-codon recognition, which 
suggests also an involvement of the helicase in NMD (Beißel et al., 2019, 2020). We 
investigated that assumption by using NMD reporter constructs (Fig 9 A), and indeed 
detected a stabilization of the PTC containing reporter construct in rat8-2-myc and rat8-3 
mutants (Fig 9 B). Remarkably, the stabilization effect reached similar levels of our upf1Δ 
strain which was shown to be essential for NMD (Kervestin and Jacobson, 2012). These 
findings indicate that Dbp5 and Upf1 are both required for NMD (Fig 9). Since NMD leads 
to PTC-containing RNA degradation, we investigated the effects only on mRNA level. 
However, it would be interesting to analyze if a similar effect through stabilization of NMD 
transcripts would also be detectable on protein level. There we expected to detect full-length 
proteins which might be expressed from PTC containing transcripts that were not eliminated 
through the Upf-pathway. However, we found that Hsp104-RFP accumulates in rat8-2-myc 
and rat8-3 mutants, which indicates a high number of defective proteins (unpublished data, 
Laboratory Heike Krebber). In fact, mutations in cytoplasmic quality control factors lead to 
an increased number of protein aggregated, which are bound by the chaperone protein 
Hsp104 and visibly accumulate in cytoplasmic foci (Jamar et al., 2018). Cytoplasmic mRNA 
quality control not only includes defects in NMD, but also in NSD and NGD. Presumably, 
the detected Hsp104 foci in the RAT8 mutants might also result from impaired function of 
Dbp5 in Dom34-Hbs1 regulated functions on NSD and NGD. Nevertheless, our results 
show that the Dbp5-mediated delivery of eRF1 is not only important for regular termination, 
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Figure 18 - Initial NMD activation with and without the Dbp5 mediated control of the eRF1-
eRF3 interaction. 
(Top) The Initial PTC recognition requires Dbp5, which controls the eRF1 and eRF3 interaction. 
Dbp5 promotes the stop codon recognition of a PTC by eRF1 and eRF3. UPF1 that is bound to the 
3’ region of the transcript can interact with eRF3 and recognize that termination occurs prematurely. 
Upf1 assembles the Upf1-2,3 complex, which is responsible for the degradation of the faulty 
transcript. Translation is inhibited and downstream factors are recruited to promote mRNA decay. 
Xrn1 acts in 5’ to 3’ direction and the Ski complex recruits the exosome which degrades the PTC 
mRNA in 3’ to 5’ direction. 
(Bottom) Loss of Dbp5 mediated delivery of eRF1, as it is the case in the RAT8 mutants, leads to 
readthrough of the PTC and the generation of a full-length protein. A near cognate peptidyl-tRNA 
enters the A site of the ribosome and translation elongation continues. Translation is terminated at a 
regular termination codon (RTC). The resulting full-length protein has at most one amino acid 
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5.2.2. Dbp5 promotes no-stop mRNA detection by Dom34 and Hbs1 
It is known that Dom34 and Hbs1 as well as Rli1 are necessary to separate ribosomal 
subunits stalled on mRNAs that are truncated or contain translation inhibiting sequences or 
secondary structures (Shoemaker et al., 2011; Tsuboi et al., 2012). Furthermore, Dom34-
Hbs1 mediates the dissociation of inactive 80S-like ribosomes to restart translation after 
stress (Van Den Elzen et al., 2014). During stress, ribosomes are stored in 80S-like 
complexes to avoid subunit degradation and provide a pool of translation competent 
ribosomes after stress release. Interestingly, van den Elzen et al. (2014) observed that 
mutations of HBS1 located within the binding domain of Dom34 has a lesser impact on 
recovery from stress then a mutation in DOM34, which was located within the binding site 
of Hbs1. To explain the observed phenomenon, they speculated that an additional factor 
might be required to separate 80S-like ribosomes and may bind to the same domain in 
Dom34 as Hbs1 or to an additional binding sequence of the protein. Furthermore, the 
similarities of Dom34 and eRF1 in their sequence and structure at their C-termini (Lee et 
al., 2007) led us to postulate that Dbp5 might be the missing factor. To investigate that, we 
carried out co- immunoprecipitation experiments and found that Dom34 and Hbs1 interact 
with Dbp5 (Fig 10). Importantly, the binding of Dom34 to Dbp5, Hbs1 and the ribosome, as 
determined by interaction with Asc1, is abolished in rat8-2-myc and rat8-3 mutants  
(Fig 10 A). The same interaction pattern was also detected when the co-IP was done with 
Hbs1. While Hbs1 pull downs precipitated Dom34, Dbp5 and Asc1 in wild type cells, 
mutations in RAT8 disassembled the complex (Fig 10 B). This stays in contrast to the 
formed Dbp5 complex with the canonical release factors, where Dbp5 interacts only with 
eRF1 and protects if from premature eRF3 contact. However, van den Elzen et al. (2010) 
could show that only domain 3 of Hbs1 participates in Dom34 binding. This is different from 
eRF3, in which domains 2 and 3 are necessary for eRF1 binding (Paushkin et al., 1997). In 
an additional experiment, we could confirm the interaction of Dbp5 and Hbs1 in a combined 
in vivo and in vitro assay (Fig 11 B). We could show that immobilized Hbs1 bound to 
recombinant Dbp5, independently of the nucleotide status of Dbp5. In contrast, the binding 
of Dbp5 to immobilized Dom34 was only detectable if 1 mM AMPPNP was present  
(Fig 11 A). Furthermore, we found that the binding of Dom34 to Rli1 was independent of its 
ATP bound state (Fig 11 A). These results suggest, that the function of Dbp5 in NSD and 
NGD might be similar to that in regular translation termination. In both processes, the 
helicase (Dbp5) delivers the proteins Dom34 and eRF1, respectively. However, in regular 
termination Dbp5 prevents through its presence an early eRF1-eRF3 contact, while in NSD 
and NGD this does not seem necessary and Dbp5 delivers both proteins (Dom34 and Hbs1) 
to the ribosome, which might make this process more efficient, as the protein abundance of 
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numbers Hbs1 is unlikely to binds continuously to all translating ribosomes and waits for the 
entry of Dom34 on approximately 200.000 ribosomes per cell (Warner, 1999)). Such a 
model would suggest that Dbp5 does not interact with Dom34 and Hbs1 in separate 
complexes. To test this, we performed a displacement assay and found that a preformed 
complex of Dom34 and Dbp5 was not disrupted by increasing concentrations of Hbs1. 
Instead, Hbs1, Dom34, and Dbp5 rather formed a ternary complex (Fig 12). This finding 
suggests, that Dbp5 delivers Dom34 and Hbs1 together to the ribosome. Moreover, the 
binding ability of Hbs1 to ribosomes, detected via Asc1, and its overall stability were 
significantly decreased in rat8-2 and rat7ΔN mutants (Fig 13 B). This finding cannot be 
explained by a secondary effect, such as defects in the function of Dbp5 in translation 
termination or mRNA export, because the half-life time of Hbs1 is ~10,4 h (Christiano et al., 
2014). It seems more likely that Dbp5 has a stabilizing effect on Hbs1, maybe due to 
mediating the interaction with Dom34. Another possibility is that Hbs1 co-migrates with 
Dbp5 into cytoplasmic foci, as it is described for Dbp5 in rat8-2 mutants (Scarcelli et al., 
2008). The foci might not be accessible for antibody-based detection, because the foci were 
not disrupted by SDS treatment and the proteins were not accessible for antibody binding. 
For Dom34 we did not detect such a strong decrease in overall protein abundance and in 
the Dbp5 affecting mutants, Dom34 was still bound to the 80S ribosomes (Fig 13 B). This 
80S-accumulation of Dom34 seems to independent of Dbp5, because Dbp5 was hardly 
detectable in 80S ribosomes in the examined mutant strains (Fig 13 B). This finding shows 
that Dom34 accumulates on 80S ribosomes if Dbp5 is absent, which could also suggest 
that Dom34 requires the helicase and ATPase activity of Dbp5 also for its dissociation. It is 
likely that the observed 80S ribosomes are 80S-like ribosomes which form because the 
translational shutdown evokes cellular stress (Van Den Elzen et al., 2014). This finding is 
corroborated by the observation that overexpression of DOM34 rescues the growth defect 
of rat8-2 mutants at 35°C (Fig 16). Overexpression of DOM34 might release more 80S-like 
ribosomes into translational competent 40S and 60S ribosomal subunits. To analyze this 
more directly, polysome gradient fractionation experiments of rat8-2 and rat7ΔN mutants in 
the presence of high copy DOM34 would be helpful. Interestingly, overexpression of HBS1 
showed no rescue of the growth defect of rat8-2 mutants (unpublished data, AG Prof. Dr. 
Heike Krebber), indicating that Dom34 is the main player in releasing of 80S-like ribosomes 
into their subunits, which was already suggested elsewhere (Van Den Elzen et al., 2014). 
Additional support for a novel role of Dbp5 in NSD and NSD came from growth analyses 
that were carried out in the presence of 1 mM diamide, which enhances the phenotype of 
growth defect in dom34Δ (Jamar et al., 2017). To provoke even more NSD and NGD events 
we additionally expressed NGD and NSD reporter containing plasmids (Tsuboi et al., 2012) 
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defect when expressing the reporter constructs on diamide plates, growth of the double 
mutant rat8-3 dom34Δ, at 35°C was inhibited in contrast to the strain without any reporter 
construct (Fig 14). These findings suggest that mutations in one of the genes can be 
compensated through the presence of the other. To investigate, whether this growth defect 
originates from defects in the degradation of the reporter mRNA, we analyzed the GFP 
transcript levels of the reporter in qPCR. It was already described that both, the NSD and 
NGD reporter transcripts accumulated in dom34Δ knock out strains, in particular when 
dom34Δ was combined with knock outs of other factors required to degrade the truncated 
mRNA, such as mutants of SKI2, XRN1 and HBS1 (Tsuboi et al., 2012). Indeed, the mRNA 
of the NSD reporter Rz accumulated already in the RAT8 and DOM34 single mutants. 
Interestingly, this stabilization effect was even stronger in the double mutants of rat8-3 
dom34Δ, indicating that Dbp5 and Dom34 act in concert to sense and degrade truncated 
NSD mRNA. Surprisingly, the NGD reporter constructs showed no accumulation, neither in 
the single mutants nor in the double mutant. This might originates from the fact that our 
primer pair bind to the middle domain of the GFP ORF, while Tsuboi et al. (2012) showed 
that particularly the 5’- intermediate of the NGD reporters were stabilized in either DOM34 
or HBS1 knock outs. To further investigate if this might also be the case for our experimental 
setup a primer pair that specifically binds to the 5’- end of the GFP ORF could be used. In 
addition to the detection of the increased transcript levels Tsuboi et al.(2012) were also able 
to show that not only truncated mRNA but also truncated proteins that originate from the 
reporter construct were stabilized in mutated NSD and NGD genes. Thus, it would be 
interesting to investigate whether the growth defect detectable in DOM34 and RAT8 
mutants might originate from the accumulation of 5‘- intermediates of NGD reporters or 
stabilization of the resulting truncated proteins. Furthermore, it would be worthwhile to 
combine DBP5 mutants with mutants of late acting factors in NGD and NSD e.g. SKI2, SKI7 
or XRN1, to get a more global view of the function of Dbp5 in NGD and NSD. From the data 
presented so far, a model comparable to canonical translation termination, in which Dbp5 
recruits Dom34 to the stalled ribosome is likely but in contrast Dbp5 might in addition also 
recruit Hbs1 to the ribosome (Figure 19). From our data, only a function of Dbp5 in NSD 
could be confirmed, but due to the functional similarities of the processes an involvement 
of Dbp5 also in NGD is likely. 
In particular, because only the 5’ fragment of NGD mRNAs are sensed, repetition with 
appropriate primes is necessary. Although, additional experiments as discussed above 
might further elucidate the function of Dbp5 in NGD and NSD, this work has uncovered a 
novel function of the DEAD-box RNA helicase in the cytoplasmic ribosome-dependent 
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Figure 19 - New Model of no-stop decay and no-go decay. 
The ribosome stalls because of e.g. a stem loop or sequence of rare codons. The mRNA is 
endonucleolytically cleaved, probably via Cue2, which leads to emerging of 3’ and 5’ fragments. The 
ribosome on the 3’ fragment is dissociated by the ribosome quality control (RQC) machinery. The 
mRNA is rapidly degraded by Xrn1 and the truncated protein is degraded via the RQC pathway. The 
5’ fragment is recognized as non-stop mRNA, which can also be originated from e.g. truncated 
transcripts. However, the mRNA is still occupied by stalled ribosomes which are marked as faulty by 
ubiquitination of the stalled ribosomes via Hel2. This is recognized by a complex of Dom34 and Hbs1, 
which is delivered through the helicase Dbp5, which places the complex in the A-site of the ribosome. 
ATP-hydrolysis of Dbp5 and GTP hydrolysis by Hbs1 accommodates Dom34 into the active site and 
lead to the subsequent dissociation of Dbp5 and Hbs1. This allows Rli1 to bind to Dom34. This 
contact might trigger ATP hydrolysis of Rli1, which initiates the splitting of the ribosome into ribosomal 
subunits. The mRNA is rapidly degraded by the Ski complex and exosome. The non-released 
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Post-translational modification directs nuclear and hyphal
tip localization of Candida albicans mRNA-binding
protein Slr1
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Summary
The morphological transition of the opportunistic
fungal pathogen Candida albicans from budding to
hyphal growth has been implicated in its ability to
cause disease in animal models. Absence of SR-like
RNA-binding protein Slr1 slows hyphal formation
and decreases virulence in a systemic candidiasis
model, suggesting a role for post-transcriptional reg-
ulation in these processes. SR (serine–arginine)-rich
proteins influence multiple steps in mRNA metabo-
lism and their localization and function are frequently
controlled by modification. We now demonstrate that
Slr1 binds to polyadenylated RNA and that its intra-
cellular localization is modulated by phosphorylation
and methylation. Wildtype Slr1-GFP is predominantly
nuclear, but also co-fractionates with translating ribo-
somes. The non-phosphorylatable slr1-6SA-GFP pro-
tein, in which six serines in SR/RS clusters are
substituted with alanines, primarily localizes to the
cytoplasm in budding cells. Intriguingly, hyphal cells
display a slr1-6SA-GFP focus at the tip near the Spit-
zenk€orper, a vesicular structure involved in molecu-
lar trafficking to the tip. The presence of slr1-6SA-
GFP hyphal tip foci is reduced in the absence of the
mRNA-transport protein She3, suggesting that
unphosphorylated Slr1 associates with mRNA–pro-
tein complexes transported to the tip. The impact of
SLR1 deletion on hyphal formation and function thus
may be partially due to a role in hyphal mRNA
transport.
Introduction
Candida albicans is a common human commensal fun-
gus as well as an opportunistic pathogen that can cause
a wide range of diseases from relatively mild mucosal
infections to systemic infections with mortality rates up
to 37% (Wisplinghoff et al., 2004). C. albicans pathoge-
nicity is linked to a switch between budding yeast and
filamentous hyphal morphologies (Lo et al., 1997; Saville
et al., 2003). While the compact yeast form may facili-
tate dissemination in the bloodstream, interaction of
yeast cells with host epithelia leads to a transition to the
hyphal form, which increases host–cell adherence and
promotes invasion into host tissues (Filler et al., 1995;
Dalle et al., 2010). The yeast-to-hyphal transition is
accompanied by many changes in gene expression that
facilitate invasive infection such as the upregulation of
cell-surface adhesins and secreted hydrolases (De
Groot et al., 2013; Schaller et al., 2005). Whereas the
signaling molecules and transcription factors required for
this transition have been studied intensively (Nantel
et al., 2002; Kadosh and Johnson, 2005; Whiteway and
Bachewich, 2007; Bruno et al., 2010; Sellam et al.,
2010), much less is known about proteins with roles in
post-transcriptional events that could influence hyphal
development and function.
Post-transcriptional processes are critical for cellular
differentiation in diverse eukaryotic systems, from
mRNA transport and turnover during Drosophila
embryogenesis (Lasko, 2011), to splicing during meiosis
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in Saccharomyces cerevisiae (Spingola and Ares,
2000), to hyphal mRNA transport during filamentation of
the corn smut fungus Ustilago maydis (Becht et al.,
2005, 2006). The eukaryotic serine–arginine (SR) family
of RNA-binding proteins has numerous roles in the con-
trol of gene expression, from ubiquitous roles in splicing
to impacts on mRNA transport, translation and stability
(Shepard and Hertel, 2009; Long and Caceres, 2009;
Zhong et al., 2009) and SR protein activity can influence
metazoan cellular differentiation (Baker et al., 1989; Sen
et al., 2013). SR proteins are characterized by the pres-
ence of one or two RNA-recognition motifs (RRMs) and
clusters of serine–arginine/arginine–serine (SR/RS)
dipeptides. SR protein function and localization are fre-
quently modulated by phosphorylation of the SR/RS
dipeptides (Long and Caceres, 2009). While Schizosac-
charomyces pombe has SR proteins (Srp1 and Srp2),
neither S. cerevisiae nor C. albicans has canonical SR
proteins; rather, these yeasts encode SR-like proteins
that also include one or two RRMs, but which have
repetitive arginine (R)-rich domains with fewer SR/RS
dipeptides (Plass et al., 2008). These R-rich domains
are often targets for arginine methylation (Henry and Sil-
ver, 1996; McBride et al., 2007; Ariyachet et al., 2013).
The most thoroughly studied yeast SR-like protein, S.
cerevisiae Npl3, has been implicated in many aspects of
mRNA metabolism from transcription and splicing to
mRNA export and translation (Kadowaki et al., 1994;
Lee et al., 1996; Bucheli and Buratowski, 2005; Der-
mody et al., 2008; Kress et al., 2008; Baierlein et al.,
2013). Both ScNpl3* and its S. pombe ortholog, SpSrp2,
are essential, whereas SpSrp1 is not essential (Bossie
et al., 1992; Gross et al., 1998; Lutzelberger et al.,
1999).
Our recent work identified a C. albicans SR-like RNA-
binding protein, Slr1, that lacks an apparent ortholog in
S. cerevisiae (Ariyachet et al., 2013). Absence of this C.
albicans SpSrp1 ortholog decreases C. albicans growth
rate more than deletion of the ScNPL3/SpSRP2 ortho-
log CaNPL3. SLR1 deletion slows hyphal formation,
leads to a defect in host cell damage in vitro and lowers
virulence in a murine model of disseminated candidiasis
(Ariyachet et al., 2013). Absence of Slr1 also increases
exposure of hyphal-specific adhesin Als3 on the cell sur-
face, suggesting the importance of Slr1 for proper
hyphal structure (Ariyachet et al., 2013).
Given the importance of Slr1 for C. albicans hyphal
formation and virulence and its sequence similarity to
other yeast SR and SR-like proteins, we sought to
address whether the sequence similarities reflect func-
tional similarities, including identifying the molecular
interactions and modifications of Slr1 and testing the
impact of post-translational modifications on Slr1 intra-
cellular localization. Interestingly, we find that C-terminal
S-to-A mutations that block Slr1 phosphorylation also
cause Slr1 to accumulate not only in the cytoplasm of
yeast-form cells, but also at the hyphal tip in a region
close to the Spitzenk€orper, a vesicular structure involved
in trafficking lipids and proteins to the tip. The hyphal tip
localization of mutant Slr1 is also partially dependent on
the presence of mRNA transport protein She3. Com-
bined with additional evidence that wildtype Slr1 inter-
acts with polyadenylated RNA and mRNA-binding
proteins, these results suggest a model in which
unphosphorylated Slr1 associates with mRNA–protein
complexes transported to the hyphal tip where the
mRNA is locally translated and that phosphorylation
facilitates release of Slr1 from such transport com-
plexes. In fact, Slr1 is detected in polysomes, supporting
a potential role in translation. The impact of SLR1 dele-
tion on hyphal formation and function thus may be due
in part to a role in hyphal mRNA transport and
translation.
Results
Structural and functional similarity of Slr1 and SR-like
proteins
The amino acid sequence of C. albicans Slr1 shows dis-
tinct similarity to that of other fungal SR-like proteins,
including the presence of an RNA-recognition motif
(RRM) N-terminal to an arginine (R)-rich region (Fig.
1A). BLASTP searches with the RRM of Slr1 revealed
its similarity to RRMs of SR-like proteins S. pombe Srp1
and Aspergillus nidulans SwoK (Fig. 1B); similar RRMs
were also identified in other fungi from Lachancea ther-
motolerans to Ustilago maydis (Supporting Information
Fig. S1), but not in S. cerevisiae. A motif common to
many metazoan SR proteins that overlaps with RNP-1
(EFEDxRDAEDA), however, is better conserved in
AnSwoK and SpSrp1 than in CaSlr1 (Fig. 1B, boldface).
The amino acid composition within the low complexity
R-rich region also differs among these proteins: RG
dipeptides predominate in Slr1, RD dipeptides in
AnSwoK and RS dipeptides in SpSrp1 (Fig. 1C). In
addition, AnSwoK and SpSrp1 have regions C-terminal
to this R-rich domain (Fig. 1A and C). Thus, the RRM is
more highly conserved among Slr1-related proteins than
the C-terminal region.
Whereas S. cerevisiae does not encode a protein with
an Slr1-like RRM, the predominance of glycine and
bulky hydrophobic residues in the R-rich region of Slr1
*As this study focuses onC. albicans, for clarity when dis-
cussing other proteins from different species, the first letters
of genus and species names are included before protein
names.
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Fig. 1. C. albicans Slr1 sequence similarity to fungal SR-like proteins.
A. Domain comparison of S. pombe Srp1, A. nidulans SwoK, C. albicans Slr1 and S. cerevisiae Npl3. RNA-recognition motifs (RRM) and
arginine-rich (R-rich) domains, as well as non-conserved N- and C-terminal domains, are shown.
B. ClustalW sequence alignment of Slr1, AnSwoK and SpSrp1 RRM domains. Conserved RNP-2 and RNP-1 motifs are indicated. Residues in
boldface within the boxed region are identical to a conserved motif found in metazoan SR proteins (Birney et al., 1993). The 50 splice site for
the first intron in SpSRP1, AnswoK and SLR1 genes is located after the second nucleotide in the codon for the underlined residue. Identical
(*) and conserved (:) residues are indicated.
C. Comparison of arginine-rich C-termini. C-terminal sequences starting at the first arginine following the RRM are shown. Arginine-rich
(boldface) regions, SR/RS dipeptides (solid underlining) and a C-terminal SR/RS-containing heptapeptide (dashed underlining) are indicated.
Note the similarity between ScNpl3 and Slr1 C-termini. Amino acids deleted in mutant Slr1 proteins are marked with brackets [slr1D151-192]
and parentheses (slr1D123-194); asterisks mark serines mutated to alanine in slr1-6SA.
D. Partial functionality of the C. albicans Slr1 C-terminus in S. cerevisiae Npl3. S. cerevisiae cells lacking chromosomal NPL3 and bearing a
ScNPL3 URA3 CEN plasmid were transformed with LEU2 plasmids expressing chimeric forms of ScNpl3 or the vector plasmid without NPL3.
White boxes indicate ScNpl3 domains; black boxes indicate equivalent CaSlr1 domains that are replaced within ScNpl3 (C@C-terminus). To
test for chimeric ScNpl3 function, cells were grown to mid-log-phase and serial ten-fold dilutions plated on medium lacking leucine and
containing 5-FOA (selecting for loss of the ScNPL3 URA3 plasmid). Cells were also plated on medium lacking leucine and uracil to confirm
equal cell numbers. Plates were incubated at 308C for 2 days prior to imaging.
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does resemble this region of S. cerevisiae Npl3 (Fig.
1C). In addition, the C-terminus of ScNpl3 (ReRSPtR)
(Fig.1C), which influences cellular localization of ScNpl3
through its phosphorylation (Yun and Fu, 2000; Gilbert
et al., 2001), resembles that of Slr1 (RsRSPeRy). This
region is critical for ScNpl3 function: deletion of the
R-rich region and C-terminus severely abrogates S. cer-
evisiae growth (McBride et al., 2009). Therefore, to
determine whether this sequence similarity is function-
ally relevant, the ability of the R-rich region of Slr1 to
substitute for that of ScNpl3 was tested. As shown in
Fig. 1D, chimeric ScNpl3 proteins bearing the Slr1
R-rich domain supported growth of S. cerevisiae cells
lacking Npl3 (npl3D). The Slr1 R-rich region linked to
the ScNpl3 C-terminus supported only slightly more
growth of npl3D cells than when it was linked to the
Slr1 C-terminus (Fig. 1D, compare rows 3 and 4). These
results suggest that the Slr1 R-rich region can mediate
similar molecular interactions to those mediated by the
ScNpl3 R-rich region, but that these regions of the two
proteins are not functionally identical.
Slr1 is present in mRNPs
Given the structural similarity of Slr1 to proteins with
known roles in mRNA metabolism, we tested whether
Slr1 interacts physically with polyadenylated mRNA and
mRNA-binding proteins. To assess whether Slr1 associ-
ates with poly(A) RNA, cells expressing Slr1 with a C-
terminal tandem affinity purification (TAP) tag were
exposed to UV light to crosslink RNA with bound pro-
teins. Poly(A) RNAs were purified from cell lysates
through two rounds of binding to oligo(dT) sepharose.
Proteins bound to poly(A) RNAs were released by
RNase treatment and Slr1-TAP was detected by anti-
Protein A immunoblot. As shown in Fig. 2A, Slr1-TAP
did co-purify when crosslinked to poly(A) RNA. In con-
trast, Slr1-TAP was not purified from untreated cell
lysates (Fig. 2A), indicating that Slr1-TAP does not bind
non-specifically to the oligo (dT) resin. Therefore, C.
albicans Slr1 associates with poly(A) RNA and is likely
an mRNA-binding protein.
To test whether Slr1 interacts with known RNA-
binding proteins, we isolated proteins bound to Slr1-TAP
from lysates of yeast-form C. albicans cells by purifica-
tion on IgG-sepharose and subsequent elution by cleav-
age of the tag with tobacco etch virus (TEV) protease
(Fig. 2B). Lysates from cells expressing untagged Slr1
were used to detect background binding to the beads.
Zinc staining of purified proteins revealed two major pro-
teins that co-purify specifically with Slr1-TAP (Fig. 2B).
Mass spectrometric analysis identified the lower band
as Slr1-calmodulin-binding protein, the expected product
following cleavage of the TAP-tagged protein from the
IgG beads. The other specific protein (100 kDa) corre-
sponded to the C. albicans ortholog of Cbc1/Cbp80, the
Fig. 2. Slr1 binds to mRNA.
A. Slr1-TAP binds to polyadenylated RNA. Cells expressing Slr1-
TAP (SLR1-TAP/slr1D) were exposed to UV light to crosslink RNA
with bound proteins. Following lysis, polyadenylated RNA was
isolated through two rounds of isolation with oligo(dT)-sepharose.
Proteins were released from the RNA by RNase digestion and
resolved by SDS-PAGE; the presence of Slr1-TAP was determined
by anti-Protein A (PrA) immunoblotting. Samples not exposed to
UV light were processed in parallel to test for non-specific binding
of Slr1-TAP to the oligo(dT) resin.
B. Cap-binding complex protein 1 (Cbc1; Orf19.387) co-precipitates
with Slr1-TAP. Protein lysates (65 mg total protein) from C. albicans
strains expressing untagged Slr1 (SLR1/slr1D) or Slr1-TAP (SLR1-
TAP/slr1D) were incubated with IgG beads. Bound proteins were
eluted with TEV protease and resolved by SDS-10% PAGE. Proteins
were visualized by zinc staining and identified by mass spectrometry.
C. RNA dependence of Slr1-cap-binding complex interaction. Protein
lysates (5 mg total protein) were prepared from cells expressing Slr1-
TAP and Cbc1-GFP (lanes 2–3;ORF19.387-GFP/ORF19.387 SLR1-
TAP/slr1D) or Cbc2-GFP (lanes 5–6;ORF19.763-GFP/ORF19.763
SLR1-TAP/slr1D). Lysates were either treated with RNase (lane 3, 6)
or not treated (lane 2, 5) before IgG bead incubation. Slr1-TAP-bound
proteins were eluted and analyzed by anti-GFP immunoblotting.
Lysates from Cbc-GFP-expressing strains that did not express Slr1-
TAP (ORF19.387-GFP/ORF19.387 SLR1/slr1D andORF19.763-
GFP/ORF19.763 SLR1/slr1D) were also incubated with IgG beads to
test for non-specific binding of Cbc-GFP proteins to the beads (Cbc1,
lane 1; Cbc2, lane 4).
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large subunit of the nuclear mRNA cap-binding complex
(CBC) (Lewis et al., 1996).
To confirm the interaction of Slr1 with the nuclear cap-
binding complex, large and small subunits of the com-
plex were tagged with green fluorescent protein (GFP)
in the Slr1-TAP-expressing strain. Anti-GFP immuno-
blots following IgG purification of Slr1-TAP from these
strains supported an interaction between Slr1 and the
CBC (Fig. 2C). The mRNA-binding activity of Slr1 (Fig.
2A) suggested that the co-purification of the cap-binding
complex proteins might be due to simultaneous binding
of Slr1 and the CBC to the same mRNA. Consistent
with this model, RNase treatment of lysates prior to
Slr1-TAP isolation eliminated co-purification of the Cbc-
GFP proteins (Fig. 2C). Slr1 therefore interacts indirectly
with Cbc proteins in an RNA-dependent manner, sup-
porting the conclusion that Slr1 can interact with mRNA.
The C-terminus of Slr1 influences its subcellular
localization
To begin to address which mRNA metabolic processes
might involve Slr1, we sought to determine the steady-
state subcellular localization of Slr1 by integrating a
GFP tag at the 30 end of SLR1. Wild type Slr1-GFP
expressed from its native promoter localizes predomi-
nantly to the nucleus of C. albicans, as detected by
colocalization with DAPI (Fig. 3A, panel c). This steady
state nuclear localization contrasts with the whole cell
localization of SpSrp1 (Tang et al., 2007), but is similar
to that seen for ScNpl3-family proteins and the CBC
(Shen et al., 2000; Yun and Fu, 2000; Gilbert et al.,
2001; McBride et al., 2007; Tang et al., 2007). In addi-
tion, Slr1-GFP appears in brighter puncta with slightly
fainter fluorescence throughout the nucleus (Fig. 3B),
reminiscent of the localization of metazoan SR proteins
to nuclear speckles (Gui et al., 1994). This localization
supports a model in which Slr1 has functions within the
nucleus, but does not rule out cytoplasmic functions, as
many SR-like proteins are dynamic and shuttle between
the nucleus and cytoplasm (Flach et al., 1994; Hacker
and Krebber, 2004; Tang et al., 2007).
The arginine-rich domain of ScNpl3 modulates its
nucleocytoplasmic transport (Senger et al., 1998;
McBride et al., 2005; Baierlein et al., 2013). To test
whether the R-rich domain influences the nuclear local-
ization of Slr1, we deleted parts of this domain in Slr1-
GFP. Removal of 42 amino acids in the middle of this
domain decreased the percentage of Slr1-GFP found in
the nucleus (%N) and the ratio of mean nuclear to
mean cytoplasmic fluorescence intensity (N/C), indicat-
ing a slight shift to the cytoplasm at steady state (Fig.
3A, C, slr1D151-192). Slr1 lacking an additional 30
residues primarily within the N-terminal half of this
domain, however, showed more distinct cytoplasmic
localization than slr1D151-192 (Fig. 3A, C; slr1D123-
194). These results were confirmed in two additional
independent experiments. The increased detection of
the mutant proteins in the cytoplasm did not result from
protein instability: the mutant proteins were expressed
at comparable levels to wildtype Slr1-GFP (Supporting
Information Fig. S2). In addition, the slight cytoplasmic
localization of wildtype Slr1-GFP was not due to
autofluorescence: cells that did not express GFP had
significantly lower mean cytoplasmic fluorescence than
Slr1-GFP-expressing cells (Supporting Information
Fig. S3). These results indicate the importance of the C-
terminal R-rich domain in proper Slr1 localization.
Post-translational modification of Slr1
Throughout eukaryotes, SR protein function and local-
ization are modulated by phosphorylation at RS/SR
dipeptides (Long and Caceres, 2009); in addition, argi-
nine methylation within R-rich domains influences sub-
cellular localization and molecular interactions of many
RNA-binding proteins (Thandapani et al., 2013). The
extensive R-rich domain and the clustering of SR/RS
dipeptides at the C-terminus of Slr1 suggest that this
region could be a target for modification.
To test for Slr1 phosphorylation, we constructed cells
that expressed two different GFP-tagged Slr1 proteins
from the endogenous SLR1 promoter. In one set of
strains, GFP was linked to the C-terminus of wild type
Slr1 (Slr1-GFP); in the second set of strains, GFP inte-
gration was coupled with the introduction of mutations to
substitute all six serines in C-terminal SR/RS dipeptides
with alanines (slr1-6SA-GFP; Fig. 1C, asterisks). These
mutations did not affect log-phase growth of C. albicans
in rich medium at 308C or 378C (308C generation time:
WT5 19866 min (standard error of the mean SEM);
6SA5 2036 8 min SEM; 378C generation time:
WT5 18266 min SEM; 6SA519068 min SEM;
n511, unpaired student’s t-test, p > 0.05). Anti-GFP
immunoblot analysis of Slr1-GFP isolated from mid-log
phase yeast-form cells revealed faster migration of the
slr1-6SA-GFP mutant protein than the Slr1-GFP wild
type protein (Fig. 4A, compare lanes 1 and 4); the
apparent difference (8 kDa) was much greater than
would be expected based solely on the molecular
weights of serine and alanine (difference <0.1 kDa)
and could reflect phosphorylation of the wild type pro-
tein. The S-to-A mutations also led to an apparent
increase in steady-state levels of slr1-6SA-GFP com-
pared with Slr1-GFP (Fig. 4A, compare lanes 2 and 7).
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To test phosphorylation directly, immunopurified GFP-
tagged proteins were incubated at 378C with or without
calf intestinal phosphatase. Phosphatase treatment of
Slr1-GFP resulted in two additional bands, one of which
comigrated with untreated slr1-6SA-GFP (Fig. 4A, lanes
3 and 4), whereas no change in the migration of slr1-
6SA-GFP was detected following phosphatase treatment
(Fig. 4A, lanes 5 and 6). These results support a model
where the phosphorylation of SR/RS dipeptides occurs
in the C-terminus of Slr1.
Purification of arginine-methylated proteins from
yeast-form C. albicans cells also indicated that Slr1 is
methylated (Fig. 4B). Anti-methylarginine immunopreci-
pitation of proteins from wildtype C. albicans cell lysates
Fig. 3. The C-terminal arginine-rich domain affects Slr1 nuclear localization.
A. Localization of WT and mutant Slr1-GFP proteins. Cells expressing Slr1-GFP were grown to mid-log phase at 308C and stained with DAPI
in PBS prior to fluorescence microscopy. Wildtype Slr1-GFP (panels a–d; SLR1-GFP/slr1D) and slr1-GFP proteins with deletions within the
arginine-rich domain from tyrosine 151 to glycine 192 (panels e–h; slr1D151-192-GFP/slr1D) or from aspartate 123 to arginine 194 (panels i–l;
slr1D123-194-GFP/slr1D) were expressed from the native locus. Exposure times were equivalent for all strains and GFP images were merged
with DAPI and DIC images in Adobe Photoshop CS5. Arrow5 cell enlarged in B. Scale bar55 mm.
B. WT Slr1-GFP is present in nuclear puncta. The cell indicated by an arrow in panels a–d of (A), is shown. The arrow indicates one region of
brighter GFP fluorescence. Scale bar5 2 mm.
C. Quantification of subcellular localization. GFP, DAPI and DIC images of cells from the experiment in (A) were stacked in ImageJ (Schneider
et al., 2012), the mean GFP fluorescence intensity and area of each cell (defined by DIC) and nucleus (defined by DAPI) were measured and
used to calculate percent nuclear GFP fluorescence (%N) and the ratio of mean nuclear and mean cytoplasmic fluorescence intensity (N/C).
Significant differences were detected among the cells of different genotypes (n5100–110 per genotype; Kruskal–Wallis test, p < 0.0001).
Significant differences by pairwise Mann–Whitney–Wilcoxon tests (*p < 0.0001) and the minimum, maximum, median and first and third
quartiles are shown.
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revealed one major protein (Fig. 4B, lane 2) that was
not seen in immunoprecipitates from cells lacking the
major arginine methyltransferase, Hmt1 (lane 1). Mass
spectrometric analysis identified this protein as CaNpl3,
a known target of arginine methylation (McBride et al.,
2007). Immunoprecipitation from npl3D/D lysates, how-
ever, increased detection of a second, slightly smaller
arginine-methylated protein, which was identified by
mass spectrometry as Slr1 (Fig. 4B, lane 3). This modi-
fication of Slr1 was confirmed by immunoprecipitating
Slr1-GFP from strains with and without the methyltrans-
ferase and immunoblotting with the anti-dimethylarginine
antibody (Fig. 4C). The recognition of Slr1-GFP by the
anti-methylarginine antibody in strains with Hmt1 indi-
cated that its precipitation in Fig. 4B did not result from
coprecipitation with another arginine-methylated protein.
Therefore, Slr1 is both phosphorylated and arginine-
methylated in C. albicans.
Modification of Slr1 influences its subcellular localization
Post-translational modifications affect subcellular local-
ization of a number of yeast SR proteins including
SpSrp1 and ScNpl3-family proteins ScNpl3, CaNpl3 and
SpSrp2. All these RNA-binding proteins move between
the nucleus and the cytoplasm, but phosphorylation of
ScNpl3-family proteins facilitates their nuclear import
(Yun and Fu, 2000; Gilbert et al., 2001; McBride et al.,
2007; Tang et al., 2007), whereas phosphorylation of
SpSrp1 enhances its nuclear export (Tang et al., 2007).
In light of the sequence similarities between the N-
termini of Slr1 and SpSrp1 and the C-termini of Slr1
and ScNpl3 proteins, we tested the impact of post-
translational modifications on Slr1 localization using
mutational approaches.
Given the multiplicity of kinases that target SR pro-
teins in other species (Yun and Fu, 2000; Gilbert et al.,
2001; Tang et al., 2007; Dermody et al., 2008), to deter-
mine whether phosphorylation of Slr1 impacts its intra-
cellular localization, localization of wildtype Slr1-GFP
was compared with that of slr1-6SA-GFP. Introduction of
the 6SA mutations caused a shift in the steady-state
localization: slr1-6SA-GFP is more cytoplasmic than
wildtype Slr1-GFP (Fig. 5A, compare panels a-c and e-
g), with a significantly lower percent nuclear localization
(%N) and ratio of mean nuclear to cytoplasmic fluores-
cence intensity (N/C) than WT Slr1-GFP (Fig. 5D).
These findings were confirmed in two additional inde-
pendent experiments. The increased cytoplasmic local-
ization of slr1-6SA-GFP was not due to the release of
GFP from the fusion protein, as indicated by the
absence of<40 kDa proteins detected by an anti-GFP
antibody (Fig. 5E). In addition, slr1-6SA-GFP appeared
in cytoplasmic foci, most notably at the bud neck of
post-mitotic cells (Fig. 5B and C). These results sug-
gested that Slr1 phosphorylation may facilitate nuclear
import, but may also have roles beyond regulation of
Slr1 nucleocytoplasmic transport.
Fig. 4. Slr1 post-translational modification.
A. Slr1 phosphorylation. Slr1-GFP and slr1-6SA-GFP were
immunoprecipitated from SLR1-GFP/slr1D and slr1-6SA-GFP/slr1D
yeast-cell lysates and incubated with or without calf intestinal
phosphatase for 1 h at 48C or 378C. Treated (1) and untreated (2)
samples (precipitated from 1.6 mg or 0.32 mg total protein) were
resolved by SDS-PAGE and relative migration of Slr1 proteins detected
by immunoblotting with anti-GFP antibodies.
B. SR-like proteins Npl3 and Slr1 are major targets for arginine
methylation inC. albicans. Lysates from yeast cells expressing the
major arginine methyltransferase Hmt1 with (HMT1/hmt1D) or without
(HMT1/hmt1D npl3D/D)Npl3 were incubated with anti-methylarginine
antibody Ab412 (Abcam) and bound proteins purified with Protein G-
sepharose. Proteins were resolved by SDS-PAGE and visualized by
Coomassie staining. Cells lacking Hmt1 (hmt1D/D) were used to detect
non-specifically bound proteins.
C. Slr1-GFP is arginine-methylated. Cells expressing Slr1-GFP with (1)
and without (2) Hmt1 (SLR1-GFP/slr1D and SLR1-GFP/slr1D hmt1D/
D) were lysed and Slr1-GFP precipitated with anti-GFP antibody.
Methylation of Slr1-GFP was detected by immunoblot with Ab412.
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Arginine methylation facilitates nuclear export of both
ScNpl3 and CaNpl3 (Shen et al., 1998; McBride et al.,
2007). To test whether methylation affects nucleocytoplas-
mic transport of Slr1, Slr1-GFP was expressed in cells
lacking the methyltransferase Hmt1 (Fig. 5). The predomi-
nantly nuclear localization of Slr1-GFP in the absence of
Hmt1 indicates that methylation is not required for nuclear
import (Fig. 5A, panels i–k). No significant difference in the
Fig. 5. Serine mutation and arginine methylation affect Slr1 localization.
A. Localization of WT and mutant Slr1-GFP proteins. Slr1-GFP and slr1-6SA-GFP were expressed in cells with (SLR1-GFP/slr1D, panels a–d;
slr1-6SA-GFP/slr1D, panels e–h) or without (SLR1-GFP/slr1D hmt1D/D, panels i–l; slr1-6SA-GFP/slr1D hmt1D/D, panels m–p) the arginine
methyltransferase Hmt1 and visualized as in Fig. 3A. Exposure times were equivalent for all genotypes. Arrows indicate examples of post-
mitotic cells with slr1-6SA-GFP foci at the bud neck. Scale bar5 5 mm.
B. Bud-neck localization of slr1-6SA-GFP in post-mitotic cells with Hmt1. Examples of cells with 1 (arrow, panels a, c, e), 2 (arrows, panels b,
d, f) or no (asterisk, panels b, d, f) bud-neck slr1-6SA-GFP focus from panels h, g and e in Fig. 5A are shown. Scale bar55 mm.
C. Bud-neck localization of slr1-6SA-GFP in post-mitotic cells without Hmt1. Examples of cells from panels p, o and m in Fig. 5A are shown
(arrow5bud-neck focus). Scale bar55 mm.
D. Quantification of subcellular localization. GFP, DAPI and DIC images of cells from the experiment in Fig. 5A were analyzed as in Fig. 3C to
determine percent nuclear GFP fluorescence (%N) and the ratio between the mean nuclear and mean cytoplasmic GFP fluorescence intensity
(N/C). Significant differences were detected among the cells of different genotypes (n559–66 for each genotype; Kruskal–Wallis test, p <
0.0001). Significant differences by pairwise Mann–Whitney–Wilcoxon tests (*p < 0.0001) and the minimum, maximum, median and first and
third quartiles are shown. WT5wildtype Slr1-GFP, 6SA5 slr1-6SA-GFP.
E. Absence of arginine methylation does not decrease Slr1 protein levels. Cells in Fig. 5A were grown to mid-log phase in YPD, lysed and
levels of GFP proteins in 17 mg total protein analyzed by SDS-10% PAGE and anti-GFP immunoblot.
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%N and N/C ratio of WT Slr1-GFP was detected between
cells with and without Hmt1 (Fig. 5A, compare panels a–c
and i–k; Fig. 5D). Both measures of nuclear slr1-6SA-GFP
localization, however, were significantly increased by dele-
tion of HMT1 (Fig. 5D). This subtle increase in nuclear slr1-
6SA-GFP in the absence of Hmt1 was confirmed in two
additional independent experiments (N/C) and one of two
additional experiments (%N). The apparent decrease in
cytoplasmic slr1-6SA-GFP was not due to lower levels of
expression of slr1-6SA-GFP in the absence of Hmt1 (Fig.
5E, compare lanes 2 and 4). The percentage of post-mitotic
cells with slr1-6SA-GFP foci at the bud neck, however, was
not significantly different in the presence (53%68%SEM)
and absence (47%61%SEM) of arginine methylation (>
55 cells per strain in three independent experiments; p >
0.05, student’s t-test). Thus, the R-rich domain, arginine
methylation and phosphorylation of Slr1 affect its intracellu-
lar localization.
Slr1 is not required for bulk mRNA export
The binding of Slr1 to mRNA in a complex with the
CBC, combined with its ability to move between the
nucleus and cytoplasm, suggested that Slr1, like
ScNpl3, might play a role in nuclear export of mRNA
(Singleton et al., 1995; Lee et al., 1996; Shen et al.,
2000). We, therefore, developed a fluorescence in situ
hybridization (FISH) assay with an oligo(dT) probe to
detect the localization of bulk mRNA in cells with and
without Slr1 (Fig. 6). In S. cerevisiae, such assays
detect the cytoplasmic localization of polyadenylated
mRNA, which becomes predominantly nuclear in the
presence of mutations that block mRNA export (Single-
ton et al., 1995). In addition, heat shock treatment of S.
cerevisiae at 428C blocks bulk mRNA export while not
affecting export of heat shock mRNAs (Saavedra et al.,
1996; Tani et al., 1996).
To ascertain that our assay could detect a block to
nuclear mRNA export, we tested whether heat shock
treatment at 428C also resulted in nuclear localization of
bulk poly(A) RNA in C. albicans (Fig. 6). Polyadenylated
RNA was found throughout C. albicans cells at 308C
and 378C (Fig. 6, panels B, F), but accumulated in the
nucleus at 428C (panel J). In the absence of Slr1, how-
ever, no nuclear accumulation of bulk poly(A) RNA was
detected (Fig. 6, panels D, H) except during heat-shock
conditions (panel L). Therefore, although Slr1 moves
between nuclear and cytoplasmic compartments, it is
dispensable for nuclear export of the majority of polya-
denylated mRNAs under standard conditions.
Slr1 co-fractionates with translating ribosomes
The detection of a fraction of wildtype Slr1-GFP outside
the DAPI-stained nucleus (Fig. 5D), in addition to the
cytoplasmic localization of slr1-6SA-GFP, suggested that
Fig. 6. SLR1 deletion does not
block bulk mRNA export.
Cells with (SLR1/SLR1; AMC79)
and without (slr1D/slr1D; AMC89)
Slr1 were grown at 308C, 378C, or
shifted to 428C for 30 min. after
growth at 308C before fixation.
Fixed cells were hybridized with
digoxigenin-conjugated oligo(dT),
and stained with DAPI and FITC-
conjugated anti-digoxigenin
antibody. Nuclei and bulk poly(A)
mRNAs were visualized by
fluorescence microscopy using the
DAPI and GFP filters respectively.
Exposure times were equivalent for
all strains and growth conditions.
Scale bar5 5 mm.
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Slr1 might function in part in the cytoplasm. S. cerevi-
siae SR-like protein Npl3 is required for monosome for-
mation during translation initiation and co-fractionates
with polysomes (Windgassen et al., 2004; Baierlein
et al., 2013). We, therefore, compared the migration of
wildtype Slr1-GFP with that of ribosomal protein Rps3
through sucrose density gradients (Fig. 7). While the
majority of Slr1-GFP was detected in non-ribosomal and
ribosomal subunit fractions (79%; Fig. 7B), 21% was
found in fractions that contained the 80S ribosome and
polysomes. This association of Slr1-GFP with 80S and
translating ribosomes was abrogated by treatment of
lysates with RNase A prior to centrifugation (Fig. 7C).
These results indicated that wildtype Slr1 is present in
the cytoplasm and suggested that wildtype Slr1 may
play a role in translation through binding to mRNA (Fig.
2A).
slr1-6SA localizes to the hyphal tip
The deletion of SLR1 decreases hyphal growth and
function (Ariyachet et al., 2013), raising the question of
whether Slr1 is present in hyphal cells. When cells were
induced to form hyphae, wildtype Slr1-GFP localized to
both mother cell and hyphal nuclei (Fig. 8A, panels c–
e). Interestingly, slr1-6SA-GFP appeared not only in the
nuclei and cytoplasm, but also in cytoplasmic foci along
the hypha, including an intense spot near the tip of the
hypha (Fig. 8B, panel c–e, arrow). In addition, slr1-6SA-
GFP accumulated at the tip of hyphal branches (Fig.
8C, arrowhead), another region of polarized growth, and
at some septa (Fig. 8D, arrowhead), similar to its
appearance at the bud neck of yeast-form cells (Fig.
5B). The predominant slr1-6SA-GFP hyphal tip focus
was reminiscent of the Spitzenk€orper, a structure found
near hyphal tips of filamentous fungi (Riquelme, 2013).
The vesicles that comprise the Spitzenk€orper deliver
protein and lipid cargoes to the growing hyphal tip
(Riquelme, 2013).
We therefore tested for colocalization of the hyphal tip
slr1-6SA-GFP focus and the Spitzenk€orper (Fig. 9, Table
1). Cells incorporate the lipophilic dye FM4-64 into
endocytic vesicles, leading to rapid accumulation in
vacuolar membranes (Vida and Emr, 1995). In growing
hyphae, however, FM4-64 can be seen in the Spit-
zenk€orper in a brief window after exposure to the dye
(Crampin et al., 2005). Yeast-form cells expressing slr1-
6SA-GFP were diluted in hyphal-inducing medium, incu-
bated at 378C and exposed to FM4-64 three hours after
hyphal induction. In 65% of cells with distinct Spit-
zenk€orper FM4-64 staining, this fluorescence partially
colocalized with a slr1-6SA-GFP focus at the hyphal tip
(Fig. 9A, panels b–d) and in 4%–8% of hyphae, an slr1-
6SA-GFP focus was adjacent to the Spitzenk€orper
Fig. 7. Slr1-GFP co-fractionates with 80S and translating ribosomes.
A. Log-phase yeast cells expressing Slr1-GFP (SLR1-GFP/slr1D) were treated with cycloheximide prior to lysis. Lysates were loaded on linear
7%–47% sucrose gradients and fractionated following centrifugation. RNA absorbance at 254 nm was measured during fractionation to detect
40S and 60S ribosomal subunits, 80S ribosomes and polysomes.
B. TCA-precipitated fractions were resolved by SDS-10% PAGE and tested for the presence of Slr1-GFP and ribosomal protein Rps3 by
immunoblot (GFP, uS3). The percent of each protein present in non-ribosomal and ribosomal fractions was determined using Image StudioLite
software (LI-COR).
C. Lysates were treated with RNase A prior to sucrose-density gradient centrifugation and then analyzed as in (B).
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(Table 1). The ability of FM4-64 to stain the Spit-
zenk€orper was confirmed by hyphal tip colocalization of
FM4-64 with a fluorescent myosin light-chain 1 fusion
protein (Mlc1-YFP), a known Spitzenk€orper protein
(Crampin et al., 2005) (Fig. 9B, Table 1). Line scans
demonstrating the partial colocalization of slr1-6SA-GFP
and Mlc1-YFP with the Spitzenk€orper are shown in Sup-
porting Information Fig. S4. The localization of slr1-6SA-
GFP to a region of the hypha near the Spitzenk€orper
suggested that this protein might associate with
Fig. 8. Serine mutations shift localization of Slr1-GFP to hyphal foci.
A. Cells expressing wildtype Slr1-GFP (SLR1-GFP/slr1D) were grown in RPMI at 378C to induce hyphal formation. After 3 h, cells were
stained with DAPI to visualize nuclei and localization of Slr1-GFP proteins was determined by fluorescence microscopy using GFP and DAPI
filters. Arrowhead5mother cell nucleus; arrow5hyphal nucleus.
B. Cells expressing slr1-6SA-GFP (slr1-6SA-GFP/slr1D) were grown and imaged as in (A). Arrow5hyphal tip focus.
C. Cells expressing slr1-6SA-GFP were grown and imaged as in (B). Arrowhead5hyphal branch focus.
D. Cells expressing slr1-6SA-GFP were grown and imaged as in (B). Arrowhead5 septal focus. Exposure times were equivalent for both
genotypes. Scale bar510 mm.
Fig. 9. The slr1-6SA-GFP hyphal
tip focus partially overlaps with
the Spitzenk€orper.
A. Cells expressing slr1-6SA-GFP
(SLR1-GFP/slr1D) were induced
to form hyphae as in Fig. 8. After
3 h, FM4-64 was added and cells
incubated at 378C for 4 min. Cells
were quickly washed with warm
PBS and visualized by
fluorescence microscopy with
Texas Red (FM4-64) and GFP
(slr1-6SA-GFP, Mlc1-YFP) filters.
Arrows in panels a–e indicate
hyphal tips enlarged in panels f–j.
Scale bars: panels a–e55 mm,
panels f–j51 mm.
B. Cells expressing Mlc1-YFP
(MLC1/MLC1-YFP) were grown,
stained, visualized and labeled as
in (A).
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transport complexes, for example by binding to mRNAs
that are transported to the hyphal tip.
In S. cerevisiae, the She3 protein complex transports
a set of mRNAs to the bud tip (Shepard et al., 2003).
The C. albicans She3 ortholog binds to at least 37
mRNAs during hyphal growth (Elson et al., 2009). At
least 12 of these transcripts localize to the hyphal tip
and this localization requires the CaShe3 protein (Elson
et al., 2009). We hypothesized that the accumulation of
the mRNA-binding protein slr1-6SA at the hyphal tip
might depend on mRNA transport to the tip. We there-
fore expressed slr1-6SA-GFP in C. albicans strains with-
out CaShe3 (Fig. 10). In cells lacking She3, many fewer
cells contained slr1-6SA-GFP foci at the hyphal tip (Fig.
10A, panels g–l); the percentage of hyphal tips contain-
ing slr1-6SA-GFP foci is over three times lower in
strains without She3 than in strains bearing a single
copy of SHE3 (Fig. 10B). In contrast, slr1-6SA-GFP
formed cytoplasmic foci in the presence or absence of
She3 (Fig. 10A). The average percentage of hyphal tips
with slr1-6SA-GFP foci in the presence of She3
(70.3%6 2.6%SEM) was consistent with the average
percentage of hyphae with slr1-6SA-GFP foci that par-
tially overlapped with (65%) or were adjacent to (4%–
8%) the Spitzenk€orper (Table 1). These results indicated
that slr1-6SA-GFP localization specifically to the hyphal
tip is partially dependent on She3, suggesting the asso-
ciation of slr1-6SA-GFP with She3-transported mRNAs.
Discussion
Post-transcriptional regulation of gene expression has
been linked to cellular differentiation throughout eukar-
yotes. The absence of putative RNA-binding protein Slr1
delays hyphal formation in C. albicans, lowers virulence
and alters exposure of a hyphal cell-wall-associated pro-
tein involved in host–cell interactions, suggesting the
involvement of Slr1 in post-transcriptional processes
that influence hyphal formation and function (Ariyachet
et al., 2013). We now demonstrate that Slr1 is a
component of an mRNP complex and is found in both
the nucleus and the cytoplasm. Slr1 shares primary
structural features with two different fungal SR-like RNA-
Table 1. Partial overlap of slr1-6SA-GFP hyphal tip foci with the Spitzenk€orper.
slr1-6SA-GFP Mlc1-YFP
Experimenta A B A B
GFP/YFP focusb
Partial overlap with Spitzenk€orper 65% (43) 65% (15) 98% (63) 95% (21)
Adjacent to Spitzenk€orper 8% (5) 4% (1) 0% (0) 0% (0)
No GFP/YFP focus at hyphal tip 27% (18) 30% (7) 2% (1) 5% (1)
Total # hyphae scored 66 23 64 22
a. FM4-64 staining of the Spitzenk€orper was compared with slr1-6SA-GFP and Mlc1-YFP hyphal tip fluorescence in two experiments (A, B).
b. GFP/YFP foci for all hyphae with distinct FM4-64 staining of the Spitzenk€orper were scored as partially overlapping with or adjacent to the
Spitzenk€orper, or absent from the hyphal tip. The absolute number of hyphae in each category is noted in parentheses.
Fig. 10. Absence of RNA-binding protein She3 decreases slr1-
6SA-GFP hyphal tip localization.
A. Deletion of SHE3 decreases hyphal tip localization of slr1-6SA-
GFP. Cells expressing slr1-6SA-GFP in the presence (slr1-6SA-
GFP/SLR1 SHE3/she3D) and absence (slr1-6SA-GFP/SLR1
she3D/she3D) of She3 were grown and visualized as in Fig. 8.
Arrows indicate the most distal slr1-6SA-GFP focus in each hypha.
Scale bar55 mm.
B. Quantification of slr1-6SA-GFP hyphal tip localization. Cells
containing distal GFP foci either within 2 mm of the hyphal tip or
farther than 2 mm from the hyphal tip were counted ( 65 cells per
strain). Percentages of cells with slr1-6SA-GFP at the hyphal tip
were significantly different between the two strains (*p < 0.0001;
student’s t-test). Mean values from three independent trials and
standard error of the mean are shown.
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binding protein families: the Npl3/Srp2 proteins, which
are essential in S. cerevisiae and S. pombe, and
SpSrp1-like proteins, which have not previously been
identified in the Saccharomycetale lineage (Plass et al.,
2008).
Fungal SR-like protein divergence
Comparison of the primary sequence of Slr1 to other
fungal proteins revealed that whereas the C-terminal
arginine-rich domain is most similar to Ascomycete
Npl3-like proteins, the N-terminal RNA-recognition motif
is homologous to that of SpSrp1 (Fig. 1). BLAST
searches with the single RRM of SpSrp1 and Slr1
revealed the wider presence of potentially related pro-
teins than initially suggested (Plass et al., 2008; Sup-
porting Information Fig. S1). The absence of the
identification of these putative SpSrp1 homologs in pre-
vious work may be due in part to the divergence within
a peptide found in SR proteins that overlaps with RNP-1
(Fig. 1B; Supporting Information Fig. S1; Birney et al.,
1993). The conservation of the 50 splice site among the
intron-containing SRP1 homologs (after the second
nucleotide of the codon for the underlined residue in
Fig. 1B), however, supports an evolutionary relationship
among these genes.
SR-like protein modification and localization
Although the predominance of RG dipeptides in the Slr1
arginine-rich C-terminal domain more closely resembles
ScNpl3 than SpSrp1, the clustering of SR/RS dipeptides
in C-terminal 20 amino acids of Slr1 (Fig. 1C) is more
similar to SpSrp1 and many metazoan SR proteins (Wil-
son-Grady et al., 2008). This clustering of SR/RS dipep-
tides in Slr1 raises the question of whether the
regulation of Slr1 by phosphorylation may be more simi-
lar to that of SpSrp1 family proteins than that of ScNpl3.
Phosphatase treatment of Slr1-GFP and slr1-6SA-GFP
indicated that Slr1 is likely phosphorylated at multiple
sites within the SR region (Fig. 4A). Phosphorylation of
one or more residues may control additional phosphoryl-
ation events, as seen in the sequential phosphorylation
of serine residues in human SR protein ASF/SF2
(Ngo et al., 2008). Whereas wildtype Slr1-GFP is pre-
dominantly nuclear, the S-to-A substitutions increase
cytoplasmic levels of Slr1-GFP, suggesting that phos-
phorylation promotes import of Slr1 (Fig. 5), potentially
by facilitating interaction with a conserved Mtr10 import
receptor complex, as seen for S. cerevisiae Npl3 (Yun
and Fu, 2000). Phosphorylation of the SR domain of
multiple metazoan SR proteins similarly allows binding
to the importin transportin-SR (Lai et al., 2000). The
cytoplasmic localization of slr1-6SA-GFP in C. albicans
decreases in the absence of arginine methyltransferase
Hmt1 (Fig. 5), supporting a role for methylation in
nuclear export of Slr1, as seen for ScNpl3 and CaNpl3
(Shen et al., 1998; McBride et al., 2007). Therefore, the
impact of post-translational modification on Slr1 nucleo-
cytoplasmic transport is more similar to the effects of
modifications on Npl3 family proteins than on SpSrp1,
correlating with greater similarity of the Npl3 and Slr1 R-
rich domains rather than with the clustered arrangement
of SR/RS motifs.
Interestingly, subcellular localization of slr1-6SA-GFP
was also detected in cytoplasmic foci in both budding
and hyphal cells, including near the bud neck and
hyphal tip. These foci could reflect increased interaction
of cytoplasmic unphosphorylated slr1-6SA-GFP with
ribonucleoprotein complexes in subcellular domains
such as RNA-processing bodies (P-bodies), stress gran-
ules (Buchan and Parker, 2009), or target regions for
mRNA transport. P-bodies accumulate during C. albi-
cans hyphal induction (Jung and Kim, 2011), but they
are not specifically detected at the hyphal tip; the less
intense slr1-6SA-GFP foci present throughout the hypha
(e.g., Fig. 10A) may indicate association of slr1-6SA-
GFP with these RNA-rich cytoplasmic regions. Lack of
phosphorylation of an SR motif in the severe acute
respiratory syndrome coronavirus (SARS CoV) nucleo-
capsid protein has been implicated in accumulation of
this viral SR protein in stress granules (Peng et al.,
2008). The localization of slr1-6SA-GFP to cytoplasmic
foci suggests that phosphorylation may prevent accumu-
lation of this SR-like protein in similar mRNA-rich
structures.
We hypothesize that Slr1 may aid in transport of
mRNAs in C. albicans and that its phosphorylation may
promote its dissociation from mRNP complexes in dis-
tinct cytoplasmic sites such as the bud neck and the
hyphal tip. In S. cerevisiae, the absence of the kinase
ScSky1 or the presence of an S-to-A mutation in ScNpl3
increases the binding of ScNpl3 to poly(A) RNA, indicat-
ing a role for phosphorylation in promoting cytoplasmic
mRNA release as well as in nuclear ScNpl3 import (Gil-
bert et al., 2001). CaShe3 is the primary C. albicans
protein known to facilitate mRNA transport to the hypha
(Elson et al., 2009); this fungus lacks an ortholog of
ScShe2, a key mRNA-binding protein in S. cerevisiae
that couples nuclear export of ASH1 mRNA to formation
of the She3 mRNA transport complex in the cytoplasm
(Bohl et al., 2000). While slr1-6SA-GFP still forms cyto-
plasmic foci in hyphal cells lacking CaShe3, the absence
of CaShe3 reduces the number of cells with foci at the
hyphal tip (Fig. 10). This result suggests that slr1-6SA-
GFP may travel with CaShe3 mRNA transport com-
plexes to the hyphal tip.
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The localization of the slr1-6SA-GFP focus at the
hyphal tip is remarkably similar to that of the Spit-
zenk€orper, a vesicular structure found in filamentous
fungi thought to aid in transport of proteins and lipids to
and from the hyphal tip (Riquelme, 2013). FM4-64 stain-
ing of the Spitzenk€orper in strains expressing slr1-6SA-
GFP indicated that these two structures partially overlap
(Fig. 9A; Supporting Information Fig. S4). Sudbery and
colleagues recently demonstrated that the C. albicans
Sec2 protein, a Guanine Exchange Factor involved in
vesicular transport to the hyphal tip, binds to the Sec2
mRNA and that wildtype Sec2 mRNA and protein coloc-
alize in the Spitzenk€orper (Caballero-Lima et al., 2014).
A phosphomimetic mutation in Sec2 decreases Sec2
protein binding to and colocalization with Sec2 mRNA in
the Spitzenk€orper (Caballero-Lima et al., 2014). These
results support a model in which phosphorylation of
Sec2 helps regulate Sec2 mRNA transport to the hyphal
tip (Caballero-Lima et al., 2014). Phosphorylation of
She3, Khd1 and Puf6 RNA-binding proteins in S. cerevi-
siae has also been linked to polarized ASH1 mRNA
transport and translation regulation (Paquin et al., 2007;
Deng et al., 2008; Landers et al., 2009). The colocaliza-
tion of slr1-6SA-GFP with the Spitzenk€orper suggests
both that mRNA-binding proteins in addition to Sec2
and She3 could influence transport of mRNAs to the
hyphal tip and that such mRNP complexes could be
regulated similarly by phosphorylation of RNA-binding
proteins including Slr1.
SR-like protein function
SR proteins have been implicated in many steps of
mRNA metabolism, from linking transcription to splicing,
controlling constitutive and alternative splicing, and
directing mRNA nuclear export to affecting mRNA turn-
over and translation in the cytoplasm (Long and
Caceres, 2009; Shepard and Hertel, 2009; Zhong et al.,
2009). The RNA-dependent interaction of Slr1 with the
nuclear mRNA cap-binding complex, which affects
mRNA splicing, transport, stability and translation in S.
cerevisiae (Topisirovic et al., 2011; Garre et al., 2012),
suggests that Slr1 may also have complex roles in Can-
dida RNA metabolism. The cytoplasmic localization of
bulk mRNA in slr1D/D cells indicates that Slr1 is not cru-
cial for bulk mRNA transport (Fig. 6), yet the
co-fractionation of wildtype Slr1-GFP with 80S and
translating ribosomes on sucrose-density gradients (Fig.
7) suggests that Slr1 may have a cytoplasmic role in
translation. In addition, the localization of slr1-6SA-GFP
raises the question whether Slr1 might also function in
mRNA transport to the bud neck (Fig. 5) or hyphal tip
(Figs. 8–10).
Although deletion of SLR1 in C. albicans, like the C-
terminal truncation of its ortholog SwoK in Aspergillus
nidulans, causes defects in polarized growth of these fil-
amenting fungi (Shaw and Upadhyay, 2005; Ariyachet
et al., 2013), the six S-to-A substitutions in Slr1 do not
disrupt its critical functions. Yeast cells expressing
mutant and wildtype Slr1-GFP proteins have similar
growth rates and the slr1-6SA-GFP mutant cells can
form hyphae. These results, combined with the pres-
ence of low levels of slr1-6SA-GFP in hyphal nuclei, are
consistent with a model in which Slr1 shuttles between
the nucleus and the hyphal tip and Slr1 phosphorylation
facilitates, but is not absolutely required for, release of
mRNAs at the hyphal tip.
In conclusion, the unphosphorylated slr1-6SA protein
is the first C. albicans protein with a defined RNA-
binding domain to be found at the hyphal tip and this
localization depends on the known mRNA transport pro-
tein CaShe3. The importance of Slr1 for hyphal forma-
tion and function may therefore be due in part to Slr1
having a role in hyphal mRNA transport. For example, in
the absence of a C. albicans She2 ortholog, Slr1 might
link export of mRNAs required at the hyphal tip to cyto-
plasmic She3 mRNP formation. The slr1-6SA mutant
protein will serve as a particularly useful tool for future
studies to identify the protein and mRNA components of
ribonucleoprotein complexes that could impact hyphal
growth and function.
Experimental procedures
C. albicans strains and growth conditions
Genotypes and important features of the strains, plasmids
and oligonucleotides used in this study are described in
Supporting Information Tables S1, S2 and S3 respectively.
Most C. albicans strains in this study were derived from the
arginine-, histidine-, uridine-auxotrophic strain BWP17 (Wil-
son et al., 1999). The other uridine-auxotrophic parental
strains with SHE3 deletions are described in (Elson et al.,
2009). All oligonucleotides were synthesized at Integrated
DNA Technologies. Strain construction is described in detail
in Supporting Information.
C. albicans strains were grown in YPD medium (1%
yeast extract, 2% bactopeptone, 2% glucose) supple-
mented with 80 mg ml21 uridine (Uri) or in synthetic dropout
media with 2% glucose and lacking the appropriate
nutrients to select for integrated markers. Generation times
for strains expressing wildtype SLR1-GFP or slr1-6SA-GFP
as the sole copy of SLR1 (11 replicate cultures per strain)
were calculated from 24 h growth curves as described in
(Ariyachet et al., 2013). For optimal filamentation in broth
cultures, strains were grown overnight in YPD1Uri, diluted
to 3 3 106 cells ml21 into pre-warmed HEPES-buffered
RPMI 1640 (Life Technologies) and incubated at 378C with
shaking for 3 h.
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SR-like protein sequence analysis
A BLASTP search with amino acids 5–51 of Slr1, repre-
senting the core of the RNA-recognition motif from RNP-2
through RNP-1 (Birney et al., 1993), identified proteins simi-
lar to Slr1 in many fungi. The following sequences were
used to align the RRMs of twelve of these representative
fungal SR-like proteins: XP_002553256.1 (L. thermotoler-
ans), XP_452519.1 (K. lactis), NP_985205.1 (A. gossypii),
XP_500797.1 (Y. lipolytica), CAA22007.1 (C. albicans),
XP_459563.2 (D. hansenii), XP_956575.2 (N. crassa),
XP_663406.1 (A. nidulans), NP_596398.1 (S. pombe Srp1),
XP_758616.1 (U. maydis) and XP_001731715.1 (M. glo-
bosa). A BLASTP search of the L. kluyveri genome also
revealed a similar protein encoded by SAKL0H05192
(http://www.genolevures.org/blast.html). RNA-recognition
motifs were identified using an InterProScan sequence
search (HMMPfam, PF00076; http://www.ebi.ac.uk/Tools/
pfa/iprscan/; Zdobnov and Apweiler, 2001) and aligned
using Clustalw2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/;
Larkin et al., 2007; Goujon et al., 2010). Given the shorter
length of other predicted Slr1-like RRMs, up to 5 residues
were removed from the C-terminus of the predicted RRM
domains of M. globosa, U. maydis, A. nidulans, N. crassa
and K. lactis Slr1-like proteins in the alignments shown in
Fig. 1B and Supporting Information Fig. S1.
Testing Slr1 R-rich domain function in S. cerevisiae Npl3
To study the functional similarity between ScNpl3 and Slr1,
the R-rich domain (codons I279-R402) of ScNpl3 with or with-
out the C-terminal heptapeptide (codons T403-R414) was
replaced with that of Slr1. To take advantage of the high level
of homologous recombination in S. cerevisiae to construct
these hybrid plasmids, the coding region for the R-rich
domain of Slr1 was amplified from BWP17 genomic DNA
using AM322/AM323 (codons Q90-G233, lacking the Slr1 C-
terminus) or oligos AM322/AM324 (codons Q90-Y263,
including the Slr1 C-terminus). Each fragment was co-
transformed into wildtype S. cerevisiae strain FY23 with ApaI/
NsiI-cut pAM463 (PrA-ScNPL3-ApaI) (McBride et al., 2007)
and plasmids were rescued from Leu1 cells. Resulting plas-
mids pAM471 (encoding ScNpl3 with the Slr1 R-rich domain
and the ScNpl3 C-terminus) and pAM472 (encoding ScNpl3
with the Slr1 R-rich domain and Slr1 C-terminus) were
sequenced at Geneway Research to ensure proper fusion.
To monitor the ability of the Slr1 C-terminus to support S.
cerevisiae Npl3 function, plasmids encoding chimeric
ScNpl3 proteins fused to Protein A, or the PrA LEU2 vector
pNOPPATA (Hellmuth et al., 1998), were transformed into
an S. cerevisiae npl3D strain bearing a wildtype NPL3
URA3 plasmid (PSY814; npl3D::HIS3 ade2 ade8 can1 ura3
leu2 his3 lys1 trp11YCp50-NPL3-3 MATa (Henry et al.,
1996)). The ability of transformed cells to lose the ScNPL3
plasmid was detected on plates containing 5-fluoro-orotic
acid as previously described (McBride et al., 2007).
Cell lysis for protein expression and purification
C. albicans cells were grown to mid-log phase at 308C.
Cells were harvested and resuspended in minimal lysis
buffer. All lysis buffers contained protease inhibitors:
phenylmethylsulfonyl fluoride (1 mM), pepstatin, leupeptin,
aprotinin, antipain and chymostatin (2.5 lg ml21 each).
Lysis buffers included: RIPA buffer (radio immunoprecipita-
tion assay buffer: 50 mM Tris-HCl (pH 8), 50 mM NaCl, 1%
Triton X-100, 0.1% sodium dodecyl sulfate (SDS), 0.5%
sodium deoxycholate); phosphate-buffered saline (PBS)
with 2.5 mM MgCl2, 3 mM KCl and 0.5% or 1% Triton X-
100 (PBSMT0.5% or PBSMT1%), TAP lysis buffer (150 mM
potassium acetate, pH 7.4, 20 mM HEPES-KOH pH 7.4,
2 mM magnesium acetate, 1 mM EDTA, pH 8.0, 1 mM
EGTA, pH 8.0, 0.5% or 1% Triton X-100, 2 mM dithiothre-
itol, 1 mM PMSF and one mini EDTA-free protease inhibitor
cocktail tablet (Roche) per 50 ml; Blackwell and Brown,
2009) and UV-crosslinking lysis buffer [ULB: 20 mM Tris pH
7.5, 50 mM LiCl, 1% SDS, 1 mM EDTA, 1% ß-
mercaptoethanol, 1 mg ml21 heparin (Sigma-Aldrich),
20 mM ribonucleoside vanadyl complexes (New England
Biolabs)]. Cells were lysed with glass beads using a Fast-
Prep FP120 (Thermo Savant) cell disruptor at 48C (speed
6.5 for 30 s for all experiments except phosphatase treat-
ment, which used 4 cycles of 4 s disruption), then mixed
with additional lysis buffer. Crude lysate was obtained by
centrifugation at 16,000g for 10 min at 48C, and superna-
tants were clarified with an additional round of centrifuga-
tion under the same conditions.
Poly(A) RNA binding assay
To test whether Slr1 binds to polyadenylated mRNA, a UV
crosslinking assay developed to detect mRNA-binding pro-
teins in S. cerevisiae (Marfatia et al., 2003) was adapted for
C. albicans. Briefly, Slr1-TAP-expressing cells (SLR1-TAP/
slr1D; AMC94) were grown to mid-log phase in 1 L YPD,
washed and irradiated in a petri dish on ice with UV light in
a Stratalinker 2400. Following lysis in ULB as described
above, clarified lysates were adjusted to 0.5 M LiCl and
bound to oligo (dT) cellulose resin (GE Healthcare) for 2 h
at 48C. After washing, oligo (dT)-bound complexes were
eluted and subjected to a second round of purification. To
collect RNA–protein complexes, eluates were concentrated
and precipitated prior to resuspension in RSB buffer
(10 mM Tris, pH 7.4, 100 mM NaCl, 2.5 mM MgCl2, 1 mM
CaCl2) with protease inhibitors. Following RNA digestion,
the presence of Slr1-TAP in oligo (dT)-bound material was
analyzed by immunoblotting with a horseradish peroxidase-
conjugated anti-Protein A (PrA) antibody. Detailed methods
are available in Supporting Information.
Identification of Slr1-interacting proteins
To detect Slr1-interacting proteins, SLR1-TAP/slr1D
(AMC94) and SLR1/slr1D (AMC91) cells were grown in
300 ml YPD1Uri to OD600  2. Cells were lysed with glass
beads in TAP lysis buffer as described above. Slr1-TAP and
interacting proteins were precipitated with immunoglobulin
G (IgG)-Sepharose (Pharmacia) at 48C overnight, washed
four times in TAP lysis buffer with 1% Triton X-100 and 0,
0.5, 1 and 1.25 M potassium acetate, respectively, eluted
with tobacco etch virus (TEV) protease (Invitrogen)
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(Blackwell and Brown, 2009), precipitated with trichloroace-
tic acid, and analyzed by SDS-10% PAGE and blue silver
(Candiano et al., 2004) or zinc staining (Bio-Rad). Protein
bands that were not precipitated from the untagged strain
were excised from the blue-silver stained gel for protein
identification by mass spectrometry at The University of
Texas Health Science Center at San Antonio.
To detect interactions with GFP-tagged nuclear mRNA
cap-binding complex (CBC) proteins Cbc1 and Cbc2,
orf19.387-GFP/ORF19.387 SLR1-TAP/slr1D (Cbc1-GFP;
AMC108) and orf19.763-GFP/ORF19.763 SLR1-TAP/slr1D
(Cbc2-GFP; AMC109) cells were grown in 50 ml YPD to
OD6005 1–2 and lysed in TAP lysis buffer with 1% Triton X-
100 before IgG bead precipitation as described above. Fol-
lowing washing, Slr1-TAP and interacting proteins were
eluted with 3 M MgCl2, precipitated with trichloroacetic acid,
and co-precipitation of CBC proteins with Slr1-TAP ana-
lyzed by anti-GFP immunoblotting. For the RNase sensitiv-
ity experiment, lysates were pretreated with 10 mg ml21
RNase A (Sigma-Aldrich) for 15 min at 258C. To test for
background binding of Cbc1-GFP and Cbc2-GFP to the
beads, orf19.387-GFP/ORF19.387 SLR1/slr1D (Cbc1-GFP;
AMC106) and orf19.763-GFP/ORF19.763 SLR1/slr1D
(Cbc2-GFP; AMC107) cells were employed for the pulldown
experiment.
Phosphatase treatment
Cells expressing Slr1-GFP (SLR1-GFP/slr1D; AMC96) and
slr1-6SA-GFP (slr1-6SA-GFP/slr1D; AMC99) as the sole
copy of Slr1 were grown to mid-log phase in medium lack-
ing uridine at 308C. Cells were lysed with glass beads in
minimal RIPA buffer prior to resuspension in PBSMT0.5%
buffer, as described above. Lysates (12 mg) were incubated
with 4 mg anti-GFP (Roche Diagnostics) for 1 h at 48C.
GFP fusion proteins were precipitated with 40 ll Protein G
PLUS-Agarose beads (Santa Cruz Biotechnology) by over-
night incubation at 48C. Beads were washed four times with
PBSMT0.5% and divided into three aliquots, each resus-
pended in 50 ll NEB3 buffer. For each strain, one aliquot
was incubated with 5 U calf intestinal phosphatase (New
England Biolabs) at 378C, and two controls were incubated
without phosphatase at 08C or 378C. All samples were incu-
bated for 60 min with agitation every 10 min. Slr1-GFP pro-
teins were eluted by boiling in SDS-PAGE sample buffer.
Purified proteins were resolved by SDS-8% PAGE and ana-
lyzed by immunoblotting.
Identification of major arginine-methylated proteins in C.
albicans
Major arginine methylated proteins in Candida albicans
were identified by immunoprecipitation with an anti-
dimethylarginine antibody. Cells from YPD cultures of
hmt1D/D (AMC11), hmt1D/D1HMT1 (AMC14) and npl3D/D
(AMC18) grown at 308C to mid-log phase were lysed in
PBSMT1% as described above. Lysates (5 mg total protein)
were incubated with 25 ml anti-methylarginine antibody
(Ab412; Abcam) overnight with rotation at 48C. Protein G
beads (40 ml packed volume; GE Lifesciences) were added
to each lysate prior to 4 h incubation at 48C with rotation.
Beads were washed with PBSMT0.5% extensively prior to
addition of protein sample buffer. Proteins isolated from
3 mg total protein were resolved by SDS-12% PAGE and
visualized by Coomassie staining. Major proteins not
detected in cell lysates lacking the arginine methyltransfer-
ase were identified by mass spectrometry at the University
of Texas San Antonio Health Sciences Center.
To confirm Slr1 methylation, mid-log-phase wildtype and
hmt1D/D cells expressing Slr1-GFP (AMC85 and AMC86)
were lysed in PBSMT0.5% as described above. Slr1-GFP
was precipitated from lysates (2.7 mg total protein) by incu-
bation with 5 ml of monoclonal a-GFP antibody (Roche Life
Sciences) followed by protein G-agarose incubation as
above. The beads were washed in lysis buffer, and bound
proteins eluted in SDS-PAGE sample buffer, resolved by
SDS-10% PAGE and analyzed by immunoblotting.
Immunoblot analysis
GFP-tagged proteins were recognized with a monoclonal a-
GFP antibody (Roche; 1:1000) and arginine methylation
was recognized with a monoclonal a-mono and dimethyl
arginine antibody (Ab412, Abcam; 1:500), followed by a
secondary a-mouse-horseradish peroxidase (HRP) anti-
body (GE Lifesciences; 1:5000). Slr1-TAP was recognized
with an HRP-conjugated goat anti-Protein A (PrA) antise-
rum (Rockland; 1:10,000). Ribosomal protein Rps3 was
recognized with a polyclonal rabbit antibody against Rps3
(1:1000). Proteins were visualized through enhanced chem-
iluminescence (Pierce) and autoradiography.
Anti-rabbit IgG (H1 L)-HRPO and anti-mouse IgG
(H1 L) HRPO (Dianova) secondary antibodies were used
for sucrose density gradient fraction immunoblots. The sig-
nals were detected with Amersham ECL Prime Western
Blotting Detection Reagent (GE Healthcare) and the
FUSION-SL chemiluminescence detection system (Peqlab)
and the Western blot analyses were quantified using the
Image StudioLite software (LI-COR).
Fluorescence microscopy
To visualize wildtype and mutant Slr1-GFP proteins in
yeast-form cells, cells were grown to log phase in synthetic
minimal medium lacking uridine (Uri2) at 308C. Cells were
washed with PBS and subsequently incubated with 10 mg
ml21 DAPI (40,6-diamidono-2-phenylindole; Molecular
Probes) in PBS for 4 min at 308C. Cells were washed with
Uri2 medium and visualized by Nomarski (differential inter-
ference contrast, DIC) and widefield epifluorescence
microscopy (Olympus BX51: 1003 objective, GFP and
DAPI filters). Images were captured with an EvolutionVF
color digital camera (noncooled, 12-bit; MediaCybernetics)
and QCapture Pro 5.0 software. Exposure times were the
same for cells of all genotypes in the same experiment.
To visualize Slr1-GFP in filamenting cells, cells were col-
lected by centrifugation after 3 h growth in RPMI at 378C,
washed with PBS and visualized on agarose-coated slides.
To test for nuclear localization of wildtype and mutant Slr1-
GFP proteins in hyphal cells, cells were incubated for 1 min
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in 10 mg ml21 DAPI in PBS prior to visualization. To deter-
mine whether slr1-6SA-GFP colocalized with the Spit-
zenk€orper, after 3 h of hyphal induction in RPMI, FM4-64
was added to slr1-6SA-GFP/slr1D (AMC99) and MLC1-
YFP/MLC1 (YJB7139) cells to a final concentration of 0.25
mg ml21 and cultures incubated at 378C for 4 min. Cells
were rapidly collected by centrifugation, washed in PBS at
378C and visualized immediately to allow detection of FM4-
64 in the Spitzenk€orper. A Texas Red filter was used to
detect FM4-64 and a GFP filter was used to detect
slr1-6SA-GFP and Mlc1-YFP. Colocalization of the Spit-
zenk€orper and GFP/YFP proteins was determined by stack-
ing the FM4-64 and GFP/YFP images in ImageJ v1.49
(Schneider et al., 2012), selecting the hyphal tip foci and
noting overlap of selections between red and green images.
Given the transitory nature of Spitzenk€orper staining with
FM4-64, in one experiment 64–66 cells with distinct Spit-
zenk€orper staining were analyzed and in additional experi-
ments at least such 20 cells were analyzed. Line scans of
FM4-64, slr1-6SA-GFP and Mlc1-YFP focal fluorescence
that demonstrate partial colocalization of proteins with the
Spitzenk€orper at the hyphal tip are included in Supporting
Information Fig. S4.
Fluorescence image analysis
To quantify subcellular localization of Slr1-GFP proteins, the
brightness/contrast levels of all DAPI images were first
adjusted equivalently in Adobe Photoshop CS5 to lower
background cytoplasmic fluorescence. GFP, DAPI and DIC
images were then stacked in ImageJ v1.49 (Schneider et al.,
2012) and cells with in-focus nuclei were identified. The
method of Hood-DeGrenier (Hood-DeGrenier et al., 2007)
was modified to calculate two metrics of subcellular localiza-
tion: percent nuclear fluorescence intensity (%N) and mean
nuclear-to-cytoplasmic fluorescence intensity (N/C). For each
cell, the whole cell and the nucleus were selected on DIC
and DAPI images, respectively, and area and average pixel
intensity (API) were measured for each selection on the GFP
image. Selection was performed in triplicates for each cell
using a Wacom Cintiq 13HD touch tablet; the mean of the
three area and API measurements was used for subsequent
calculations. For each image, the API of background regions
lacking cells was subtracted from the whole-cell and nuclear
API measurements. The total nuclear and whole cell pixel
intensities (TPIN and TPIWC) were calculated by multiplying
the average area (A) by the background-adjusted API. Per-
cent nuclear fluorescence (%N) was calculated by dividing
TPIN by TPIWC. The ratio of the API of the nucleus to the
API of the cytoplasm (N/C) was calculated as follows: N/
C5APIN/[(TPIWC2TPIN)/(AWC2AN)]. Three independent
experiments were performed for each set of strains and the
data analyzed in R (R Core Team, 2016). Differences among
cells of different genotypes in a single experiment were eval-
uated by the Kruskal-Wallis rank sum test (p < 0.0001 for all
experiments), given the non-normal distribution of the data.
Pairwise Mann–Whitney–Wilcoxon tests with Bonferroni cor-
rection for multiple comparisons were then used to determine
whether the localization of specific Slr1-GFP proteins differed
from each other. Box plots were generated with GraphPad
Prism 7.0 software. The presence of slr1-6SA-GFP foci at
the bud neck of post-mitotic cells was quantified in three trials
(> 55 post-mitotic cells per genotype).
To quantify localization of slr1-6SA to the hyphal tip in
cells with and without She3, two independent cultures each
of she3D/SHE3 slr1-6SA-GFP/SLR1 (AMC138) and she3D/
she3D slr1-6SA-GFP/SLR1 (AMC139) were induced to fila-
ment in RPMI and prepared for microscopy as above. GFP
and DIC images were overlaid and hyphal cells were
divided into two categories: cells with the most distal slr1-
6SA-GFP focus (a) within 2 mm (one hyphal width) of the
hyphal tip or (b) farther than 2 mm from the tip. Exposure
times were equivalent for all strains in a single experiment
and images were overlaid using Adobe Photoshop CS5. At
least 65 hyphal cells of each genotype were analyzed in
three independent trials. Differences in hyphal tip localiza-
tion of slr1-6SA-GFP between cells with and without She3
were evaluated by an unpaired student’s t-test.
Fluorescence in situ mRNA hybridization
A protocol to detect localization of bulk mRNA in S. cerevi-
siae was adapted for use in C. albicans cells (Green et al.,
2002). Wildtype (AMC79) and slr1D/D (AMC89) cells were
collected from 1 mL synthetic dropout culture (OD600  0.2)
grown at 30 or 378C. For heat shock, cells were grown at
308C to  0.2 OD600 and shifted to 428C for 30 min. Cells
were then fixed in 5% formaldehyde for 1 h, washed twice
in P solution (1.2 M sorbitol in 0.1 M potassium phosphate
buffer, pH 6.8), and resuspended in 1 ml P solution. Cells
from 20 ll suspension were placed on a multiwell slide
coated with 0.1% poly-L-lysine (Sigma-Aldrich), sphero-
plasted in P solution containing 500 lg ml21 Zymolyase
(100T, US Biological) and 1% b-mercaptoethanol, permeab-
ilized by addition of 0.5% Triton X-100 in P solution for 10
min, equilibrated with 0.1 M triethanolamine (pH 8.0), and
polar groups blocked with 0.25% acetic anhydride. Cells
were incubated in prehybridization buffer (1 mg ml21 yeast
tRNA (Sigma-Aldrich), 0.005% BSA, 10% dextran sulfate,
25% deionized formamide and 23 SSC) and hybridized
overnight with 250 nM digoxigenin-labeled oligo(dT) probe
(IDT). Cells were washed with 23 and 43 SSC, incubated
with FITC-conjugated anti-digoxigenin antibody (Roche;
1:200 dilution in 23 SSC) at room temperature for 1–2 h,
and briefly stained with DAPI and washed with 23 SSC.
Cells were examined by Nomarski (DIC) and fluorescence
microscopy as described above.
Sucrose-density fractionation experiments
The preparation and fractionation of sucrose-density gra-
dients was carried out in three replicate experiments follow-
ing published protocols for S. cerevisiae, modified for use
with C. albicans (Gross et al., 2007; Baierlein et al., 2013).
Briefly, 300 ml SLR1-GFP/slr1D (AMC96) yeast cell cultures
were grown to log phase in YPD at 308C. Cycloheximide
(Sigma-Aldrich) was added to a final concentration of 100
mg ml21 and cells were incubated for 15 min on ice. After
harvesting, the cell pellets were lysed with the same
amount of glass beads in lysis buffer (20 mM HEPES-KOH
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pH7.5, 10 mM KCl, 2.5 mM MgCl2, 1 mM EGTA, 1 mM
DTT, 100 mg ml21 cycloheximide) supplemented with Com-
plete, EDTA-free protease inhibitor cocktail (Roche). Cells
were lysed with 5 cycles of 1.5 min in a BeadBeater (Bio-
spec) followed by 2 min on ice. The lysates were centri-
fuged at 48C once for 5 min at 16,000g and the
supernatant cleared by additional centrifugation for 10 min
at 16,000g. If indicated, the lysates were treated with
0.25 mg ml21 RNase A (AppliChem) for 20 min on ice. For
protein and ribosomal profile analyses 30 OD260 nm units of
lysates were loaded onto a linear 7%–47% (w/v) sucrose
gradients (20 mM HEPES-KOH pH 7.5, 10 mM KCl,
2.5 mM MgCl2, 1 mM EGTA) poured with the Gradient
Master machine (Biocomp) and centrifuged for 3 h at
40,000 rpm and 48C in a TH-641 rotor and Sorvall WX80
ultracentrifuge (Thermo Scientific). The gradients were frac-
tionated with a density-gradient fractionator (Teledyne Isco)
while the absorbance at 254 nm was documented.
Protein fractions were precipitated with 10% trichloroace-
tic acid (TCA), washed two times with 70% acetone and
subjected to SDS-PAGE and Western blotting. To be able
to load the whole gradient on one gel and to increase the
signal strength, some fractions were pooled as indicated.
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ABSTRACT
Translation termination requires eRF1 and eRF3 for
polypeptide- and tRNA-release on stop codons. Addi-
tionally, Dbp5/DDX19 and Rli1/ABCE1 are required;
however, their function in this process is currently
unknown. Using a combination of in vivo and in vitro
experiments, we show that they regulate a stepwise
assembly of the termination complex. Rli1 and eRF3-
GDP associate with the ribosome first. Subsequently,
Dbp5-ATP delivers eRF1 to the stop codon and in this
way prevents a premature access of eRF3. Dbp5 dis-
sociates upon placing eRF1 through ATP-hydrolysis.
This in turn enables eRF1 to contact eRF3, as the
binding of Dbp5 and eRF3 to eRF1 is mutually ex-
clusive. Defects in the Dbp5-guided eRF1 delivery
lead to premature contact and premature dissoci-
ation of eRF1 and eRF3 from the ribosome and to
subsequent stop codon readthrough. Thus, the step-
wise Dbp5-controlled termination complex assem-
bly is essential for regular translation termination
events. Our data furthermore suggest a possible role
of Dbp5/DDX19 in alternative translation termination
events, such as during stress response or in develop-
mental processes, which classifies the helicase as a
potential drug target for nonsense suppression ther-
apy to treat cancer and neurodegenerative diseases.
INTRODUCTION
When a ribosome arrives at a stop codon on the mRNA,
protein synthesis is terminated and the peptide is released
(1). In eukaryotes, two essential release factors are well
known to mediate translation termination. The eukaryotic
release factor 1 (eRF1), in Saccharomyces cerevisiae en-
coded by SUP45, is the only class I termination factor in
eukaryotes that recognizes all three different stop codons
(UAG, UAA, UGA) and subsequently mediates the hy-
drolysis of the peptidyl-tRNA in the ribosomal peptidyl-
transferase center (PTC). In addition, the class II eukary-
otic release factor 3 (eRF3), in S. cerevisiae encoded by
SUP35, enhances translation termination efficiency with its
GTPase activity (2,3). Most termination models (Supple-
mentary Figure S1A) anticipate that eRF1 and eRF3–GTP
enter the ribosome together as a ternary complex once the
stop codon is reached (1,2,4), as both factors strongly in-
teract with each other via their C-terminal domains (5,6).
Supposedly, successful stop codon recognition by eRF1 in-
duces GTP-hydrolysis of eRF3, which in turn leads to a
conformational rearrangement in eRF1 resulting in its ac-
tive form, which positions its GGQ-motif in the PTC and
mediates hydrolysis of the ester bond of the peptidyl-tRNA
(7–9).
In light of these mostly in vitro studies, nothing seems to
be missing; however, novel factors essential for translation
termination in vivowere discovered and need to be incorpo-
rated into a comprehensive model: The DEAD-box RNA
helicase Dbp5, encoded by RAT8 (human DDX19) (10),
its stimulating co-factors Gle1 plus inositol hexakisphos-
phate IP6 (11,12), the iron-sulfur containing ATP-binding
cassette protein Rli1 (human ABCE1) (13,14) and the initi-
ation factor eIF3, including Hcr1 (15). Dbp5 and Gle1 are
well known for their function in mRNA-export through nu-
clear pore complexes (NPCs) (16). Using its regulated AT-
Pase cycle, Dbp5 remodels RNA–protein complexes at the
cytoplasmic side of the NPC on emerging mRNAs (17).
By dissociation of the export receptorMex67-Mtr2 (human
TAP-p15) from the arriving mRNAs, its backsliding is pre-
vented and directionality of the transport event established.
Its co-factors Gle1 and IP6 stimulate ATP-hydrolysis lead-
ing to RNP-release and binding of Dbp5-ADP to the NPC-
protein Nup159 (human Nup214). Importantly, this bind-
ing leads to ADP-release, a conformational change and the
binding of ATP (16,17). The ATPase activity of Dbp5 is
also essential for efficient translation termination (10,12).
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In addition to these functions, Dbp5 plays also a role in the
export of both ribosomal subunits (18). However, in con-
trast, to mRNA export and translation termination, Dbp5
acts independently of itsATPase activity in ribosome export
(18).
Rli1 functions in biogenesis and nuclear export of pre-
ribosomal subunits (19–21), translation initiation (22), ter-
mination (13) and in particular in ribosome recycling (23).
Rli1 is a solublemember of theATP-binding cassette (ABC)
protein superfamily that contains two nucleotide-binding
domains (NBDs) and two N-terminal iron-sulfur clusters.
A hinge domain connects both NBDs forming a cleft,
which is open in the ADP-bound state, while ATP-binding
induces its closure with a concomitant movement of the
iron-sulfur domain allowing ATP-hydrolysis. This ATP-
dependent tweezers-like motion converts chemical energy
into mechanical power, which is important for splitting the
ribosome into its ribosomal subunits (24). The protein is
highly conserved in eukaryotes and essential in all organ-
isms tested (22). Interestingly, Rli1 acts ATP-hydrolysis in-
dependent during translation termination (13,25). It was
suggested that Rli1 associates with the termination complex
upon dissociation of eRF3–GDP, taking over its position to
keep eRF1 in its favourable position to facilitate peptidyl-
tRNA hydrolysis (4,26).
The initiation factor eIF3 has recently been associated
with translation termination, because mutations in its sub-
units reduce the rate of stop codon readthrough (15). In-
terestingly, deletion of the substoichiometric component
HCR1 shows an increased readthrough activity and this
phenotype was suppressed by high copyRLI1. Amodel was
proposed in which Hcr1 is not a bona fide translation ini-
tiation factor, but rather acts in termination by promoting
GDP–eRF3 ejection from the ribosomes (15).
So far, no translation termination model is available that
includes all of these factors that support termination and
many results were obtained from in vitro assays with pu-
rified components. Therefore, we analysed the process in
S. cerevisiae in vivo and in vitro with all participating fac-
tors and uncovered a sequential recruitment mechanism, in
which Rli1 and eRF3 wait at the ribosome for the entry of
Dbp5 that delivers eRF1 and at the same time shields it from
premature access of eRF3. Upon proper positioning Dbp5
dissociates, allowing eRF3 to contact and stimulate eRF1
activity. This stepwise entry of the termination factors and
in particular the Dbp5 controlled eRF1–eRF3 interaction,
prevents premature and inefficient translation termination.
MATERIALS AND METHODS
Yeast strains and plasmids
All S. cerevisiae strains, plasmids and oligonucleotides used
in this study are listed in the ExpandedView Supplementary
Tables S1, S2 and S3, respectively. For growth analyses, cells
were spotted in 10-fold serial dilutions onto selective agar
plates and grown for 3 days at the indicated temperatures.
The strains, HKY1622 and HKY1623, were gener-
ated by crossing HKY1271 (RLI1-GFP) and HKY446
(sup45-2). Crossing the strains HKY445 (WT of HKY446)
or HKY446 with the strain HKY1122 (Prt1-GFP) pro-
duced the strain HKY1915 and the corresponding WT
HKY1914. The strain HKY1921 was generated by crossing
the strains HKY477 (rat8-2-myc) and HKY1907 (trp5Δ)
and exchange of pHK629 with pHK693. For the genera-
tion of plasmid pHK1292, the GFP ORF was amplified
by polymerase chain reaction using the primers HK1194
and HK1195 and inserted via XhoI and PstI sites into
pHK887 (2μRli1-HALEU2) replacing the HA-tag. To cre-
ate pHK1474 and pHK1475, theRLI1-GFPORFwith pro-
moter and terminator was amplified from pHK1292 with
the primers HK2136 and HK2137 and inserted via Gib-
son assembly reaction into pHK86 and pHK87, respec-
tively, which were linearized by SacI and SalI digestion.
The GLE1 ORF was amplified from gDNA with HK1398
and HK1399 and inserted via BamHI site into pHK825
(CEN PADH13xMYC URA3) to generate pHK1323. For
the generation of pHK1283, the SUP35 ORF was ampli-
fied with the primers HK1109 and HK1110 and inserted
via EcoRI and XhoI sites into pGEX-4T-1. The SUP45
ORFwas amplified with the primers HK1144 and HK1156
and inserted via NdeI and XhoI sites into pET28a to cre-
ate pHK1280. The SUP45Δ1237-1311 ORF was amplified
with the primers HK1146 and HK1147 and inserted via
BamHI and XhoI sites into pET15b to generate pHK1278.
To generate pHK1394, the GLE1 ORF was amplified with
the primers HK1613 and HK1614 and inserted via Gibson
assembly reaction into pETMBP1 1a that was linearized by
SacI and NcoI digestion.
Co-immunoprecipitation experiments
In vivo interactions studies were carried out following the
protocols published previously (18,27). For immunoprecip-
itation ofGFP-tagged proteins, 10l slurry ofGFP-Trap A
beads (Chromotek) and for TAP-tagged proteins, 20 l
slurry of IgG-Sepharaose beads (GEHealthcare) were used
per reaction and incubated with 200 (high abundant pro-
teins) and up to 2000 l (for low abundant proteins) of the
clarified lysate for 3 h rotating at 4◦C. If indicated, the sam-
ples were treated with 0.2 mg/mlRNase A (AppliChem) for
additional 30 min at 4◦C. Finally, the eluted proteins were
separated on 10% SDS-polyacrylamide gels and analysed
by western blotting.
Sucrose-density gradient fractionation
The experiments were essentially performed as described
previously (18) with the following modifications. For elon-
gation factor mutants, no cycloheximide treatment was per-
formed meaning that cells were directly harvested upon 1 h
temperature shift, cycloheximide was omitted from the ly-
sis buffer. For protein analyses, 15 OD260nm units of lysates
were loaded onto the top of linear 7–47% (w/v) sucrose gra-
dients and centrifuged for 2 h and 40 min at 40 000 rpm and
4◦C in a TH-641 rotor and Sorvall WX80 ultracentrifuge
(Thermo Scientific). After gradient fractionation, protein
fractions were precipitated with 10% trichloroacetic acid,
washed twice with 80% aceton and subjected to sodium
dodecylsulphate-polyacrylamide gel electrophoresis (SDS-
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Western blot analyses and quantification
Polyclonal rabbit antibodies against Dbp5 (dilution
1:1000), eRF1 and eRF3 (kindly provided by D. Bedwell,
dilution for both 1:1000), uL29 = Rpl35 and uS3 =
Rps3 (kindly provided by M. Seedorf, dilution 1:5000
and 1:10 000 respectively, or anti-Rps3 peptide antibody
1:500), Aco1, Hem15, Por1 and Zwf1 (kindly provided
by R. Lill, dilution 1:1000, 1:7000, 1:2000, and 1:4000,
respectively), Asc1 (kindly provided by G. Braus, dilution
1:2000) and Cdc28 (sc-28550; Santa Cruz, dilution 1:2000)
were used. GFP-tagged proteins were detected with anti-
GFP antibodies (sc-8334; Santa Cruz, dilution 1:1000),
or GF28R (Pierce Protein Biology, 1:5000), or (ab183734;
Abcam; 1:10 000), MYC-tagged proteins with an anti-
MYC antibody (sc-789; Santa Cruz, dilution 1:750) and
HA-tagged proteins with an anti-HA antibody (sc-57592
and sc-7392; Santa Cruz, dilution 1:750) and GST-tagged
proteins with an anti-GST antibody (sc-138; Santa Cruz,
dilution 1:2000). Secondary anti-rabbit IgG (H+L)-HRPO
and anti-mouse IgG (H+L)-HRPO (Dianova) antibodies
were used and detected with Amersham ECL Prime
Western Blotting Detection Reagent (GE Healthcare)
or WesternBright Chemilumineszenz Substrat Quantum
(Biozym) and the FUSION-SL chemiluminescence detec-
tion system (Peqlab). Quantification of western blot signals
was performed with the Bio1D software (Peqlab) or with
ImageStudio Lite (Li-COR Biosciences). For statistical
analyses of co-immunoprecipitation studies, the intensity of
co-precipitated bands was related to that of the pull-down
and finally, the ratio of the mutant or treated strains was
compared to the wild typical ratio. For quantification of
the sucrose density gradient fractionation experiments, the
intensity of each fraction was measured and the polysomal
fractions were compared to the sum of the 80S, 60S, 40S
and non-ribosomal fractions.
In vitro binding studies
GST-Dbp5, GST-eRF1 and GST-eRF3N65, a more sta-
ble version of eRF3 that has a truncated C-terminus,
were expressed in Escherichia coli Rosetta 2 cells, purified
by affinity chromatography with GSTrap 4B Glutathione
Sepharose (GE Healthcare) and stored at −80◦C in elution
buffer (for GST-Dbp5: 50 mM Tris pH 7.5, 150 mMNaCl,
30 mM Glutathione reduced) (for GST-eRF1 and GST-
eRF3: 20 mMHEPES pH 7.5, 500 mMNaCl, 5% glycerol,
4 mM -MeOH, 30 mM Glutathione reduced). To obtain
untagged Dbp5, eRF1 and eRF3, the purified GST-tagged
proteins were cleaved with PreScission protease overnight
at 4◦C. Afterwards, GST was removed by performing a sec-
ond affinity chromatography with GSTrap 4B Glutathione
Sepharose (GE Healthcare). The proteins were further pu-
rified by running the collected flow through over a gel filtra-
tion chromatography. Purified GST–Dbp5 and Dbp5 were
stored in 50mMTris pH 7.5, 150mMNaCl, 10% glycerol at
−80◦C, whereas GST-eRF1, eRF1, GST- eRF3 and eRF3
were stored in 50 mM NaCl pH 7.5, 20 mM HEPES, 5%
glycerol and 4 mM -MeOH at 80◦C.
For binding studies either purified proteins as indicated
above were used or Rosetta II (DE3) cells were trans-
formed with pET15b-HIS6-SUP45 delta 25 (eRF1 lacking
25aa at the C-terminus), pET28a-HIS6-SUP45, pGEX4T1-
GST-SUP35, pGEX-6P-1-GST-RLI1 and pGEX6P1-GST.
Overexpression was induced by growing the cells for 3 days
in auto-inducingmedia (LBmedia with 0.5% (v/v) glycerol,
0.05% (v/v) Ggucose and 0.2% (v/v) lactose plus 25 mM
K2HPO4, 25 mM NaH2PO4, 50 mM NH4Cl and 0.5 mM
Na2SO4) at 16◦C. Cells were harvested and resuspended in
lysis buffer (50mMTris–HCl, pH 7.5, 150mMNaCl, 2mM
MgCl, 5% (v/v) glycerol, 1 mMDithiothreitol (DTT), 0.2%
(v/v) NP-40 and ethylenediaminetetraacetic acid (EDTA)-
free protease inhibitor mix (Roche)). After cell lysis by soni-
cation and centrifugation, the supernatant was used for fur-
ther analysis. The used GSTrap 4B Glutathione Sepharose
(GE Healthcare) beads were pre-incubated with 3% Albu-
min Fraction V (Roche) and mixed with lysis buffer. Next,
the GST tagged proteins or only GST were incubated with
15 l slurry of GSTrap for 2 h at 4◦C. After several washing
steps with buffer (excluding protease inhibitor), the beads
were incubated with the protein lysates for additional 2 h
at 4◦C. For the competition assay, the eRF1 lysate was first
incubated with GST-Dbp5 bound to the GSTrap for 20 min
at 4◦C, before adding purified eRF3N65 in the indicated
amounts and further incubation for 1 h at 4◦C. After five
washing steps with lysis buffer, the proteins that were bound
to the beads were analysed by SDS-PAGE andwestern blot.
Prt1-GFP and Nip1-GFP were purified from yeast cells
before the in vitro binding assay was carried out with recom-
binantly expressed GST-Rli1.
Readthrough assay
The dual reporter -galactosidase luciferase assay was basi-
cally performed as described previously (10,28). Briefly, all
analysed yeast strains were transformed with the reporter
plasmids pHK607 or pHK608, respectively. Yeast cells were
grown at 25◦C to mid-log phase, shifted for 30 min to 37◦C
and afterward divided: 20OD600 were used for the luciferase
assay and 50 ml that were split for triplicates for the -
galactosidase assay,
The luciferase assay was performed with the ‘Beetle-Juice
Luciferase Assay Firefly’ kit (p.j.k GmbH) according to the
manufacturer’s protocol. For that, cell pellets were lysed
with 300 l glass beads in a FastPrep-24 machine (MP
Biomedical) in 400 l lysis buffer (77 mM K2HPO4, 23
mM KH2PO4, 0.2% Triton X-100, 1 mM DTT) supple-
mentedwithComplete, EDTA-free protease inhibitor cock-
tail (Roche). The lysates were centrifuged twice for 5 min at
21 000 × g and 4◦C. Afterwards, 20 l of the cleared lysate
was transferred in triplicate into a white 96-well plate, sup-
plemented with always 50 l substrate and measured with
the luminometer (Victor X3 2030 multilabel reader from
Perkin Elmer).
For the -galactosidase assay, all cell pellets were resus-
pended in 300 l of Z-buffer (100 mM phosphate buffer
pH 7.0, 10 mM KCl, 1 mM MgSO4) and lysed with the
freeze-and-thaw method (1 min in liquid nitrogen, 2 min in
37◦C water bath, four times repeated). Afterwards, 700 l
of Z-buffer with 1 mM DTT and 160 l of the substrate
ONPG (4 mg/ml of o-Nitrophenyl--D-galactopyranosid
in Z-buffer) were added and incubated at 30◦C until colour
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tion of 1 M Na2CO3 and the OD420nm was measured with
a spectrophotometer (UV-1601 from Shimadzu). The rela-
tive readthrough activity was calculated from the ratio of lu-
ciferase to -galactosidase activity measured with the stop
codon-containing reporter related to the ratio from the in-
frame control.
Statistical analysis
Quantification was performed for at least three independent
experiments. Quantification of co-immunoprecipitation ex-
periments shown in Figures 1D, 2C, E, 3C, E, 4B, C, E, G
6D,G and I were analysed for significance by Student’s two-
tailed, two-sample, unequal variance t-test. In all cases, each
dataset was normalized and only compared to wild-type.
The mean ± standard deviations are displayed. The same
was done for Figures 1G, 2H and 6B, with the exception
that the differences were analysed by a Student’s one-tailed,
two-sample, unequal variance t-test. In Figures 1G and 6B,
the signal intensity of the analysed proteins in the polysomal
fraction of the tef2-9 strain was subtracted from the wild-
type signals in the polysoms of the respective protein and
normalized to the Asc1/uS3 protein content that reflected
the amount of polysomes. All data were finally analysed for
significance by Student’s two tailed, two-sample, unequal
variance t-test. Significance P-values below 0.05 were indi-
cated by asterisks (*P < 0.05; **P < 0.01; ***P < 0.001).
RESULTS
Binding of Dbp5, but not Rli1, to the termination complex
depends on eRF1
Previous studies of the translation termination process have
not revealed, how and when Rli1 and Dbp5 are recruited
to the terminating ribosome. Crystal structure and in vitro
analyses with purified proteins proposed that Rli1 and
eRF3 bind to the same position on the terminating ribo-
some so that their association seemed to be mutually ex-
clusive and it was suggested that Rli1 might take over the
binding site of eRF3 after its dissociation to catalyse the
subsequent ribosome recycling (4,29) (Supplementary Fig-
ure S1B). However, a potentially earlier association of Rli1
with the ribosome before ribosome recycling has not been
investigated. The same is unclear for Dbp5. The helicase
might already be associated with elongating ribosomes or it
could be recruited at a later step together with eRF1 upon
arrival of the ribosome at the stop codon. To address these
questions, we analysed the ribosomal association of Rli1
and Dbp5 in the temperature-sensitive eRF1mutant sup45-
2 that is defective in translation termination and in ribo-
some binding. Upon a temperature shift to 37◦C, ribosome
binding of the mutated eRF1 protein sup45-2 is disturbed,
resulting in stop codon recognition defects and subsequent
readthrough activity in which near-cognate tRNAs are in-
corporated at the termination codon and translation elon-
gation continues to the next stop codon (30). If Rli1 would
enter the termination process after eRF1 has entered, one
would expect to see a reduced binding of Rli1 to ribosomes
in that mutant. However, co-immunoprecipitation experi-
ments (co-IPs) show that the binding of Rli1 to the large
ribosomal protein uL29 (yeast Rpl35) is unchanged and
its association with the small ribosomal protein uS3 (yeast
Rps3) is even increased in sup45-2 cells (Figure 1A and D).
These results indicate that Rli1 binds ribosomal particles
without functional eRF1 and that it is possibly associated
with ribosomes before eRF1 enters. The increased binding
of Rli1 to the 40S subunit in sup45-2might represent an en-
hanced presence of 43S pre-initiation complexes, which are
stabilized by Rli1 (22). In contrast to Rli1, the interaction
of Dbp5 and the mutated eRF1 protein with both riboso-
mal proteins is reduced in sup45-2 (Figure 1B–D) suggesting
that Dbp5 requires functional eRF1 for its association with
terminating ribosomes. This reduced ribosomal association
might be due to the fact that mutant eRF1 is rather unstable
and only∼50%of the protein amount is detectable in lysates
on western blots (Figure 1C). Thus, while the association of
Rli1 with the ribosome rather increases in sup45-2 cells, the
association of Dbp5 and mutant eRF1 decreases. These re-
sults might indicate that Rli1 associates with the ribosome
before Dbp5 and eRF1.
To verify this sequential recruitment, we analysed
whether Rli1, but not Dbp5 associates with ribosomes ar-
rested in translation elongation and found that this is indeed
the case (Figure 1E–G). Mutations in eEF1A (such as in
tef2-9) lead to defects in translation elongation (31), which
is reflected in polysomal profiles of sucrose-density gradi-
ent fractionations that were prepared without the usual ad-
dition of cycloheximide. Under such conditions, wild-type
cells continue elongation, leading to a complete polysome
run-off, while elongation factor mutants stall ribosomes
during elongation on the mRNA, thereby preventing their
arrival at the stop codon (Figure 1E) (32). Western blot
analyses of the corresponding protein fractions show that
high amounts of Rli1 are present in the mono- and polyso-
mal factions in tef2-9 cells, similar to the ribosome-bound
protein Asc1 (Figure 1G). This finding is in agreement with
structural analyses of the human homolog of Rli1, ABCE1
at the ribosome, which show that the protein binds to the
intersubunit space of the ribosome where aEF1 also asso-
ciates (29), suggesting that their binding is mutually exclu-
sive. However, as stalled ribosomes have free A-sites when
the elongation factor is inactivated as in the tef2-9 mutant,
different factors can stochastically go there, among them
Rli1. These findings suggest that Rli1 can bind to the ribo-
some as soon as the A-site is free and thus might be the first
termination factor that enters the ribosome, which is clearly
earlier than anticipated. In contrast to that, Dbp5 is almost
absent in the polysome fractions of tef2-9 cells (Figure 1F
and G), indicating that Dbp5 is recruited to ribosomes only
after translation elongation. Thus, our results suggest that
the ribosomal association of Dbp5 not only requires a free
A-site like this is the case for Rli1, because in contrast to
Rli1 Dbp5 is not associated with ribosomes in an elonga-
tion mutant, but Dbp5 recruitment also seems to depend
on a stop codon and functional eRF1.
Dbp5 and Rli1 interact with each other during translation ter-
mination
Although both Rli1 and Dbp5 were identified as transla-
tion termination factors (10,13), it is unclear whether they
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Figure 1. Dbp5, but not Rli1, requires eRF1 to associate with the ribosome at a stop codon. (A) The interaction of Rli1 with the ribosome is not dependent
on eRF1. Western blot analysis of Rli1 co-IPs in wild-type and sup45-2 cells shifted to 37◦C for 1 h reveal co-precipitation of the small ribosomal protein
uS3 ( = Rps3) and the large ribosomal protein uL29 ( = Rpl35). Detection of Zwf1 served as non-binding control. (B) The interaction of Dbp5 with
ribosomal subunits is decreased in sup45-2. Western blot analysis shows co-precipitation of uS3 and uL29 with Dbp5 IPs in wild-type and sup45-2 cells,
shifted to 37◦C for 1 h. (C) The interaction of mutant eRF1 with the ribosome is decreased. Western blot analysis of the co-precipitation of mutant eRF1
(sup45-2) with uL23 (top) or with uS3 (bottom) is shown. Aco1 served as a negative control. (D) Quantification of at least three independent experiments,
one of which is shown in panels (A–C), which determine the amount of the co-precipitated proteins, measured with the Fusion SL detection system. (E)
Ribosome profiles of wild-type and the translation elongation defective strain tef2-9 reflects the translational run-off in wild-type and a translational arrest
in the elongation mutant. Wild-type and tef2-9 cells were shifted to 37◦C for 1 h before the lysates were analysed in linear sucrose-density gradients without
cycloheximide. (F) Rli1, but not Dbp5, is bound to ribosomes during translation elongation. Western blot analysis of the fractions, representing the total
cellular amount of the indicated proteins, reveals their ratio in the 80S, polysomal or non-ribosomal, 40S and 60S fractions. Asc1 as a ribosome binding
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Figure 2. Rli1 supports the recruitment of Dbp5 and eRF1 to the ribosome. (A) Dbp5 interacts RNA-independently with Rli1. Immunoprecipitation of
TAP-Dbp5 in the presence of RNase A shows co-precipitation of Rli1-HA in western blot analysis. Detection of eRF1 served as positive and of Por1 as
negative control. (B) The interaction between Rli1 and Dbp5 is decreased in sup45-2, shifted to 37◦C for 1 h. Western blot analyses of Rli1-IPs reveal
less co-precipitation of Dbp5, but no reduction of the ribosomal protein uS3 in sup45-2 compared to wild-type. Cdc28 served as negative control. (C)
Quantification of four different experiments shown in panel (B). (D) Inhibition of translation elongation leads to a reduced interaction between Rli1
and Dbp5. Western blot analyses of co-IPs of Dbp5 with Rli1 upon treatment with 0.5 mg/ml cycloheximide (CHX) for 30 min are shown. Hem15 was
detected as non-binding control. (E) Quantification of three different experiments shown in panel (D). (F) Overexpression of RLI1 partially rescues the
growth defects of sup45-2, while the wild-type growth is not influenced. Serial dilutions of the indicated strains are shown upon growth on selective plates
for 3 days at 35◦C. (G) Overexpression of RLI1 suppresses the binding defect of eRF1 to the ribosome in sup45-2 cells. Co-IPs of eRF1 with uS3-GFP are
shown in the indicated strains with or without high copy (HC) RLI1. (H) Quantification of four different experiments shown in panel (G); *P < 0.05; **P
< 0.01; ***P < 0.001.
precipitated Rli1 with Dbp5 in vivo (Figure 2A) and vice
versa Dbp5 as well as its co-factor Gle1 with Rli1 (Supple-
mentary Figure S1B) unrevealing a physical interaction be-
tween Dbp5 and Rli1 that might be direct or mediated by
other proteins. To verify that this interaction actually occurs
during translation termination and not for instance dur-
ing pre-ribosomal subunit export from the nucleus in which
Rli1 and Dbp5 are both involved (18,19,21), we compared
their interaction in sup45-2 cells in which the termination
process is inhibited and Dbp5 does not enter the ribosome.
Our results show that in sup45-2 the interaction of Rli1 and
Dbp5 is indeed reduced to more than half, while its inter-
action to the ribosome is not decreased (Figure 2B and C).
Moreover, we treated wild-type cells with the antibiotic cy-
cloheximide, which inhibits translation elongation and thus,
prevents ribosomes from arriving at stop codons, reflected
in the ribosomal profiles. Also in this case the prevention of
translation termination leads to a significantly decreased as-
sociation ofRli1 andDbp5 (Figure 2DandE). These results








oettingen user on 19 M
ay 2020
4804 Nucleic Acids Research, 2019, Vol. 47, No. 9
A B
C D E
Figure 3. Not eRF1 and eRF3 enter the ribosome together, but eRF1 and Dbp5. (A) The binding of Dbp5 with the ribosome-binding defective protein
sup45-2 is increased, while its ribosome association is decreased. Western blot analyses of co-IPs with mutated eRF1 (sup45-2) and Dbp5 or uL29 are
shown. Detection of Hem15 served as a non-binding control. (B) The interaction between eRF3 and eRF1 is decreased in the sup45-2 strain as shown in
western blots of the eRF1 co-IP with eRF3. Por1 served as negative control. (C) Quantification of three different experiments shown in panels (A) and (B).
(D) The interaction of eRF1 and eRF3 is decreased in a DBP5 mutant. Western blot analysis of eRF3 co-IPs with eRF1 in wild-type and the rat8-2 stain
is shown. (E) Quantification of three different experiments shown in (D); *P < 0.05; **P < 0.01; ***P < 0.001.
during translation termination and that both proteins bind
simultaneously to the termination complex, possibly dur-
ing stop codon recognition. This finding contradicts older
models, in which Rli1 binds only for ribosome recycling.
An in vivo interaction of Dbp5 and eRF1 was shown ear-
lier (10). However, as Rli1 most likely binds to the ribosome
before Dbp5 and eRF1 have entered (Figure 1), we won-
dered whether Rli1 might support their recruitment to the
ribosome. We therefore investigated if an overexpression of
RLI1 would suppresses the sup45-2 mutant, which has de-
fects in ribosome binding (Figure 1C and D), (30). Indeed,
growth analyses show at least a partial rescue of the sup45-
2 growth defects in the presence of high copy RLI1 (Fig-
ure 2F). The reason for this suppression might be that an
increased amount of Rli1 proteins leads to their faster ri-
bosome binding, which supports the defective sup45 pro-
tein in associating with the ribosome. This seems indeed to
be the case as shown by co-IPs (Figure 2G). While the as-
sociation of the mutated eRF1 protein with the ribosome
is reduced to a quarter, increased Rli1 concentrations sup-
port the binding of sup45-2 to more than 60% (Figure 2H).
These findings suggest that the initial presence of Rli1 at the
ribosome could support the subsequent eRF1 recruitment
to the stop codon.
eRF1 and eRF3 do not enter the termination complex to-
gether
In contrast to Rli1, Dbp5 requires intact eRF1 for its bind-
ing to the ribosome (Figure 1). From previous studies, it
was suggested that Dbp5 might help to position eRF1 at
the stop codon and dissociate before eRF3 enters the termi-
nation complex (10). Thus, it seems conceivable that eRF1
and eRF3 are not recruited as a complex, but rather individ-
ually, which challenges current models. To analyse whether
Dbp5 and eRF1 form a complex already in the cytoplasm,
we took again advantage of the sup45-2 mutant, in which
the mutated eRF1 protein sup45-2 has a ribosome-binding
defect and is thus detached and freely present in the cyto-
plasm at the non-permissive temperature (Figure 1C and
D) (30) and analysed its binding to Dbp5. Indeed, co-IPs
revealed an increased binding of the cytoplasmic sup45-
2 to Dbp5 (Figure 3A and C), while at the same time its
interaction to eRF3 is decreased (Figure 3B and C). Re-
markably, despite the fact that the sup45-2 protein is less
stable as compared to wild-type eRF1, as reflected in the
lysate lanes, its binding to Dbp5 is significantly increased.
These results could suggest that a pre-formed complex of
Dbp5 and eRF1 in the cytoplasm approaches the termi-
nating ribosome, while eRF3 enters separately upon Dbp5-
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Figure 4. Nup159 recycles Dbp5-ATP also for translation termination. (A) Scheme of the reporter plasmids used in the dual reporter -galactosidase
luciferase assay. The lacZ gene, expressing -galactosidase and the luc gene, expressing luciferase is either separated by the stop codon UAG or in frame. In
the upper case, luciferase will only be expressed in case the stop codon is readthrough. The in-frame reporter serves as control to monitor basal expression
levels and relate it to the stop codon containing construct. (B)Mutants ofNUP159 show increased readthrough of the stop codon. The average readthrough
activity of at least three independent experiments is shown after shift of all indicated strains to 37◦C for 30 min. (C) High copyDBP5 rescues the increased
stop codon readthrough of rat7ΔN. All strains were shifted to 37◦C for 30min. (D) The interaction of Dbp5 and eRF1 is disturbed in the recycling defective
mutant rat7ΔN. Western blot analysis of a co-IP with Dbp5 and eRF1 is shown. Aco1 served as a negative control. (E) Quantification of three different
experiments shown in panel (D). (F) The interaction of eRF1 and eRF3 and the ribosome is diminished in rat7ΔN cells. Western blot analysis of a co-IP
with eRF1-GFP and eRF3 or the ribosome bound protein Asc1 is shown. (G) Quantification of three different experiments shown in panel (F). (H) Dbp5
and eRF1 directly interact in the presence of a non-hydrolysable ATP-analogue. An in vitro binding study with recombinant proteins in which GST-tagged
Dbp5 or eRF3 were used in pull-down experiments in the presence of His-eRF1 and if indicated 1 mMAMP–PNP is shown in western blot analysis. GST
alone served as a non-binding control; *P < 0.05; **P < 0.01; ***P < 0.001.
a complex formation between the three termination factors
is unlikely or their potential contact is very short.
To further investigate whether Dbp5might indeed deliver
eRF1 to the ribosome and eRF1 and eRF3 do not enter the
ribosome together, we analysed if mutations inDBP5would
lead to a reduced binding of eRF1 to eRF3 and to the ribo-
some. For this purpose, we used the rat8-2 strain that pro-
duces instable Dbp5 protein due to a leucine to proline ex-
change at position 267 (33) (Figure 6H). Indeed, in vivo in-
teraction studies of eRF1 and eRF3 in rat8-2mutants reveal
a ∼70% reduction of eRF1 binding to the ribosome and to
eRF3 upon a 1 h temperature shift to 37◦C (Figure 3D and
E). The reduced eRF1 and eRF3 interaction was also de-
tected earlier and seems to happen immediately, already af-
ter a 20 min temperature shift of the rat8-2 strain. However,
the ribosomal binding of eRF1was less obviously decreased
after this short shifting time (10). But the longer 1 h shift
produces a clear ribosome binding defect of eRF1 (Figure
3D and E). Together, our findings suggest that Dbp5 might
deliver eRF1 to the ribosome without eRF3.
Nup159 recycles Dbp5–ADP for export and translation ter-
mination
The ATPase activity of Dbp5 is essential not only for
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(10,16,17). During termination, we suggest that the helicase
might deliver eRF1 and it seems possible that it could use
its ATPase-dependent activity to position eRF1 properly
on the stop codon. In particular, because we have shown
earlier that its ATPase activity is necessary not only for its
function in mRNA export, but also for its role in transla-
tion termination (10). In both cases, upon ATP-hydrolysis,
the enzyme needs to be recycled. During mRNA export,
the nucleoporin Nup159/Rat7 is the ADP-release factor of
Dbp5 (17). Thus, it is conceivable that recycling from ter-
mination also occurs at the NPC via Nup159, rather than
at the ribosome. In particular, because Dbp5 must return
to the cytoplasm to capture a new molecule of eRF1 as
they first interact in the soluble fraction of the cytosol (Fig-
ure 1). Indeed, readthrough experiments with a dual -
galactosidase luciferase reporter system show an increased
readthrough activity in different nup159mutants, very sim-
ilar to the dbp5 mutant rat8-2 (Figure 4A and B), (10).
As both nup159 mutants, rat7-1 and rat7ΔN, the latter of
which specifically lacks the interaction domain for Dbp5
(34), exhibit increased readthough activities as compared
to wild-type (Figure 4B), Nup159 seems to be the recycling
factor for Dbp5 not only for mRNA export, but also for
translation termination. In support of this model, we found
that overexpression of DBP5 leads to a rescue of the high
readthrough activity in rat7ΔN cells (Figure 4C) indicating
that less recycling by Nup159 is needed when more Dbp5–
ATP is present.
These results suggest that Nup159 recycles Dbp5–ADP
also upon its action in translation termination, which is
quite attractive, because in this way Dbp5 might couple two
important cellular processes––nuclear mRNA export and
translation. When the translation rate is low, Dbp5 is free
to increasingly act in mRNA export to raise the mRNA
amount in the cytoplasm and vice versa, high translation
rates could reducemRNAexport. To verify a dependence of
the eRF1–Dbp5 interaction on Nup159, because their con-
tact should only be established when Dbp5 is ATP-bound,
we performed co-IPs with these proteins in rat7ΔN. Indeed,
while the interaction of Dbp5 and eRF1 was clearly de-
tectable in wild-type, it was significantly reduced in rat7ΔN
(Figure 4D and E), supporting a model in which Dbp5 is
recycled at the NPC with ATP. These findings further sug-
gest that Dbp5–ATP can bind eRF1, while Dbp5–ADP
might release the termination factor. As Dbp5 could not
be re-charged in rat7ΔN and thus cannot deliver eRF1 to
the ribosome anymore, the interaction of eRF1 with eRF3
should also be decreased in this mutant, which is indeed the
case as shown by co-IPs (Figure 4F and G).
The switch in eRF1 binding and release through ATP-
hydrolysis of Dbp5 was further investigated in in vitro ex-
periments with purified recombinantly expressed proteins.
We show that Dbp5 only binds to eRF1 in the presence of
the non-hydrolysable ATP-analogue AMP–PNP, whereas
eRF3 interacts also ATP-independently with eRF1 (Figure
4H). Together, these in vivo and in vitro studies support a
model in which eRF1 associates with Dbp5–ATP in the cy-
toplasm and dissociates from Dbp5–ADP at the ribosome,
where Dbp5 possibly uses its ATP-dependent helicase ac-
tivity to place eRF1 properly on the stop codon. Moreover
it becomes evident that eRF1 and Dbp5 form a complex in
the cytoplasm, from which eRF3 is absent.
Binding of Dbp5 and eRF3 to eRF1 is mutually exclusive
As Dbp5 and eRF1 enter termination complexes together,
and Dbp5 does not interact with eRF3 (10), it seems possi-
ble that the binding of Dbp5 and eRF3 with eRF1 is mutu-
ally exclusive. It was shown that the eRF3-interaction do-
main of eRF1 comprises the last 25 amino acid residues of
its C-terminus (5). In vitro binding studies with recombi-
nant proteins were carried out to investigate whether this
domain is also the Dbp5-interaction domain. Indeed, while
full-length eRF1 interacts with both, eRF3 and Dbp5, no
interaction was detectable with eRF125C (Figure 5A), in-
dicating that both termination factors share the same bind-
ing site on eRF1. Interestingly, although also the middle
domain of eRF1 was reported to contribute to the eRF1–
eRF3 interaction (35), we found that the deletion of the C-
terminal domain is sufficient to abrogate the interaction of
eRF1 with eRF3 and Dbp5 in vitro. Moreover, a preformed
interaction of Dbp5 and eRF1 was not disrupted by the
addition of increasing amounts of eRF3 in a competition
assay (Figure 5B). Intriguingly, these findings suggest in-
deed a sequential and mutually exclusive binding of Dbp5
and eRF3 to eRF1 with a first complex formation between
Dbp5 and eRF1. Thus, a model is possible, in which during
the progress of termination, Dbp5–ATP prohibits the ac-
cess of eRF3 to eRF1 until eRF1 was placed properly in the
ribosomal A-site. Such a mechanism would prevent a pre-
mature access of eRF3 and a consequent premature GTP-
hydrolysis. Because as soon as eRF3 contacts its guanine
exchange factor eRF1 at the ribosome, eRF3 binds GTP,
which is subsequently hydrolysed, resulting in the immedi-
ate dissociation of eRF3 from the ribosome (36,37). The
suggested sequential entry of the termination factors would
have the advantage that the contact of eRF3 with eRF1 is
controlled, which will prevent prematureGTP-hydrolysis of
eRF3 and its subsequent premature dissociation before the
stop codon is successfully recognized.
eRF3 binds to the ribosome prior to eRF1
Protection of eRF1 from premature eRF3 access would
only be necessary if eRF3would already be present at the ri-
bosome when eRF1 enters. Therefore, we analysed its ribo-
somal association in the tef2-9mutant that arrests in trans-
lation elongation as shown in Figure 1E and F. Strikingly,
eRF3, but almost no eRF1 is detectable in the polysomal
fractions of this elongation mutant, suggesting that eRF3
can independently bind ribosomes before they arrive at a
stop codon and is therefore already present when eRF1 en-
ters (Figure 6A and B). These findings are supported by
co-immunoprecipitation analyses of eRF3 with ribosomal
proteins in the mutant sup45-2. In the situation in which
this mutant eRF1 protein accumulates with Dbp5 in the cy-
toplasm (Figure 1), the binding of eRF3 to the ribosomal
protein uS3 is not reduced, but rather increases as its eRF1
mediated GTP-hydrolysis and release is prevented (Figure
6C and D).
Because Rli1 is also present at that early time point, we
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Figure 5. Dbp5 and eRF3 interaction with eRF1 is mutually exclusive. (A) The interaction site of eRF1withDbp5 and eRF3 overlap.Western blot analyses
of pull-downs experiments with GST–Dbp5, GST–eRF3 or GST and His-eRF1 or His-eRF125 lacking the last C-terminal amino acid residues are shown.
All binding buffers contained 1 mM AMP–PNP. (B) A preformed complex of eRF1 and Dbp5 cannot be disrupted by eRF3. Western blot analysis of
a competition assay of the indicated recombinantly expressed proteins is shown. Increasing amounts of eRF3 were added to the preformed complex of
GST–Dbp5 and His-eRF1. Rli1 served as a positive control for eRF3 binding. All binding buffers for Figure 5 contained 1 mM AMP–PNP.
In vitro binding studies revealed that either nucleotide free
eRF3, or GDP-bound but not GTP-bound eRF3 directly
interacts with Rli1 (Figure 6E), (23), suggesting that Rli1
might bind to eRF3–GDP at the ribosome, where they wait
for the arrival of eRF1. Furthermore, Rli1 interacts with
eRF3 without the addition of ATP (Figure 6E), support-
ing a model in which nucleotide-free Rli1 binds to the ribo-
some and eRF3 and the recruitment of ATP to Rli1 occurs
later. As this nucleotide-free state of Rli1 was shown to re-
sult in a rather weak association with the ribosome (23), it
is conceivable that Rli1 might change its position on the ri-
bosome during the stepwise assembly of all termination fac-
tors. Upon eRF1 entry, eRF3 most likely binds to GTP, as
its affinity to the triphosphate increases upon eRF1 contact
(36,37), which would trigger its dissociation from Rli1, be-
cause it interacts only with eRF3–GDP (Figure 6E). These
rearrangements in the termination complex through eRF3–
GTP-hydrolysis stimulate the eRF1-mediated polypeptide-
and tRNA-release by moving eRF1 into its favourable po-
sition to terminate translation (37). The poly(A) binding
protein Pab1 might further support this early association
of eRF3 to the ribosome and Rli1 as eRF3 and Pab1 were
shown to interact (38,39).
Dbp5 enables a stable contact of eRF1 and eRF3 at the ribo-
some
In a model in which Dbp5 delivers eRF1 and prevents pre-
mature excess of eRF3, one would expect that in a situa-
tion in which the Dbp5 binding to eRF1 is inhibited, the re-
lease factor might be able to access the ribosome alone and
immediately contact eRF3. This situation should result in
the immediate dissociation of eRF1 and eRF3 from each
other and from the ribosome, because their contact would
not be prevented until eRF1 was properly positioned by
Dbp5. This is indeed the case. In amutant of theDbp5 recy-
cling factor Nup159, rat7ΔN, Dbp5 remains ADP-bound,
which prevents its complex formation with eRF1 (Figure
4D), or in mutant DBP5, such as rat8-2, in which the pro-
tein is detached from the NPC at 37◦C and not re-charged
with ATP (40), eRF1 is not Dbp5 bound. In both cases, the
freely available eRF1 leads to the reduced presence of eRF1
and eRF3 at the ribosome as reflected in uS3 co-IPs (Fig-
ure 6F–I). Possibly eRF1 and eRF3 are less present at the
ribosome, because both release factors instantly dissociate
upon their uncontrolled contact, because their contact ini-
tiates the GTP-binding of eRF3, its subsequent hydrolysis,
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Figure 6. eRF3–GDP binds Rli1 prior to the entry of Dbp5 and eRF1. (A) eRF3 is present on ribosomes stalled in translation elongation. Western blot
analysis of the collected fractions of the tef2-9 gradient shown in Figure 1E with antibodies against eRF3, eRF1 and Asc1 are displayed. (B) Quantification
of four different western blot analyses shown in panel (A). (C) Ribosome binding of eRF3 in sup45-2 is increased. Western blot analysis of co-IPs of eRF3
and the positive control Asc1 with uS3 (top) and uL29 (bottom) are shown. (D) Quantification of four different IPs shown in (C). (E) Rli1 binds nucleotide
free eRF3 directly and releases eRF3-GTP. Western blot analysis of in vitro pull-down experiments with Rli1 is shown. (F–I) The ribosomal association
of eRF1, eRF3 and Dbp5 is decreased in nup159 (F and G) or dbp5 (H and I) mutants. Western blot analyses of the uS3-co-precipitated proteins in the
indicated strains are shown. (G and I) Quantification of four (G) and three (I) different IPs shown in panels (F) and (H), respectively. (J) Defects in eRF1
delivery partially suppresses the growth defects of trp5Δ. Serial dilutions of the indicated strains are shown upon growth on full medium agar plates at the
indicated temperatures; *P < 0.05; **P < 0.01; ***P < 0.001.
premature contact would support the observed increased
readthrough activity (Figure 4B and C).
It is quite intriguing thatDbp5 controls the entry of eRF1
into termination reactions. However, this novel function
might have an impact not only at termination codons on
readthrough activity, but also on termination events at near
cognate codons, such as the UGG tryptophan codon that
is similar to the stop codon UGA. In such situation it is
observed that mRNA translation is not continued and in-
stead translation termination occurs. To investigate whether
Dbp5 would genetically interact with the tryptophan syn-
thetasemutant trp5Δ, we generated the rat8-2 trp5Δ double
mutant andmonitored the growth at different temperatures.
We found that the double mutant partially suppresses both
single mutants at 16◦C and rat8-2 strain also at higher tem-
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tations in DBP5 indeed affect termination events at near
cognate codons and the deleterious effect of the trp5 dele-
tion stems from inefficient decoding of UGG codons, and
increased eRF1-catalysed mistermination events on such
codons. This effect appears suppressed in rat8-2 mutants
where the delivery of eRF1 to such codons would be re-
duced (Figure 6J).
eIF3 enters translation termination after the Dbp5-mediated
delivery of eRF1
In addition to eRF1, eRF3, Rli1 and Dbp5, the transla-
tion initiation factor, eIF3with its subunit Hcr1 were shown
to participate in translation termination (15). Mutations
in eIF3 reduce the rate of stop codon readthrough, while
hcr1Δ shows an increased readthrough activity and this
phenotype was suppressed by high copy Rli1. A model was
proposed in which Hcr1 is not a bona fide translation ini-
tiation factor, but rather acts in termination by promot-
ing GDP–eRF3 ejection from the ribosomes (15). In such
a model Dbp5 would not bind to Hcr1, because it would
dissociate before Hcr1 would contact eRF3. To investigate
this, we carried out co-IPs with Hcr1 and Dbp5 and could
confirm theHcr1 eRF3 interaction, while no interaction be-
tweenHcr1 andDbp5was visible (Figure 7A). Interestingly,
also the interaction of Hcr1 with the ribosome is less strong
as that of eRF1, supporting the model that Hcr1 ejects
eRF3 from the ribosome. eIF3 was suggested to promote
ribosome recycling after termination. As such, one would
expect the complex to bind after translation termination.
Indeed, one of the eIF3 subunits Prt1 clearly interacts with
Rli1, eRF3, eRF1 and the ribosome, represented by Asc1
in wild-type cells, but these interactions were abrogated in
sup45-2 cells, in which the termination reaction does not oc-
cur (Figure 7B). A Dbp5 Prt1 interaction was not detected,
which might suggest that a potential interaction is either
rather short or Prt1 associates only after Dbp5 has deliv-
ered eRF1. We further show in co-IPs that the interaction
of eIF3 with Rli1 and the ribosome is independent on the
ATP-binding of Rli1, because both eIF3 subunits, Prt1 and
Nip1 interact without or with the addition of AMP–PNP
(Figure 7C).
These data support the following stepwise entry model
for translation termination in yeast (Figure 8). Nucleotide-
free Rli1 binds to the ribosome as soon as the A-site is un-
occupied. eRF3–GDP associates with Rli1 and waits for
the entrance of eRF1. Rli1 furthermore supports the en-
try of eRF1 into the ribosome, which is delivered and po-
sitioned at the stop codon by the helicase Dbp5. The con-
tact of eRF3 and eRF1 is controlled by the dissociation of
Dbp5, which occurs upon hydrolysis of its ATP through
Gle1- and IP6-stimulation. ADP–Dbp5 recycling is medi-
ated at the NPC through Nup159, which couples transla-
tion to mRNA-export. Dissociation of Dbp5 allows con-
tact of eRF1 and eRF3, which stimulates eRF3 to associate
with GTP and induces a stronger binding to Rli1, which
might indicate that Rli1 changes its position. The subse-
quent GTP-hydrolysis of eRF3 results in the final position-
ing of eRF1, dissociation of eRF3–GDP by Hcr1, which
is delivered by eIF3 to the ribosome and to peptidyl-tRNA
hydrolysis and polypeptide chain release from the ribosome.
Subsequent recycling of the ribosomal subunits is mediated
by Rli1 (4,23,26).
DISCUSSION
Translation termination depends on the two key factors
eRF1 and eRF3, but also on Dbp5 and Rli1 (10,13). How-
ever, their function and the order in which the termination
complex assembles, was unclear. Current models suggest
that eRF1 and eRF3 enter the ribosome together as a com-
plex (1,2,4), but we show here that this is very unlikely and
propose a new translation termination model in which the
termination complex assembles stepwise (Figure 8).
Polysomal gradients and co-IPs indicate that nucleotide-
free Rli1 and eRF3–GDP binds to the ribosome prior to
eRF1 and Dbp5 entry (Figures 1 and 6). Our data support
a function of Rli1 in promoting the recruitment of the other
termination factors. In particular, it promotes the binding
of the Dbp5–eRF1 complex leading to the formation of
a ternary complex with Rli1 (Figures 2F–H and 6E). For
such a function, Rli1 would not require its ATPase activ-
ity, which is in agreement with earlier studies in which it
was shown that ATP-hydrolysis by Rli1 does not take place
during the termination process (4,13). It was furthermore
suggested earlier that Rli1 associates with the termination
complex upon dissociation of eRF3–GDP, taking over its
position to lock eRF1 in its favourable position to facilitate
peptidyl-tRNA hydrolysis (4,26). In contrast to this model,
we present evidence that Rli1 and eRF3–GDP are the ini-
tial components of the termination complex that bind to
the ribosome. However, our data are in agreement with a
model in which in the course of the stepwise assembly, Rli1
could take over the position of eRF3, because initially eRF3
binds to Rli1 in its GDP bound form and dissociates upon
GTP binding and hydrolysis (Figure 6E), which could allow
the remodelling of the complex and enable Rli1 to occupy
the eRF3 position upon its release. Because Rli1 is most
likely nucleotide-free in this early stage of translation termi-
nation (Figure 6E), it is conceivable that the rearrangements
upon eRF3 dissociation might be supported by its binding
to ATP, which is later on required for the splitting of the ri-
bosomal subunits (23,24). However, it is also possible that
the entry of eIF3 and/or the dissociation of eRF3 through
Hcr1 (Figure 7A–C) induce these rearrangements.
In contrast to earlier models, our results furthermore
indicate that Dbp5–ATP captures eRF1 in the cytoplasm
(Figures 3A,C and 4D) and delivers it to the stop codon-
bound ribosome on which eRF3–GDP and Rli1 are al-
ready present (Figures 1F,G and 6A,B). The interaction be-
tween Rli1 and Dbp5 might thereby support the Dbp5–
eRF1 recruitment (Figure 2). Upon placing eRF1 prop-
erly on the stop codon, Dbp5–ADP dissociates and is re-
cycled at the NPC via Nup159 (Figure 4). In this way, the
two key processes of mRNA export and translation are
coupled via Dbp5. How the duty of Dbp5 in both pro-
cesses is divided and how Dbp5 captures eRF1 is currently
unclear and needs further investigation. Interestingly, the
overall cellular protein abundance estimates suggest an in-
tracellular Dbp5:eRF1:eRF3 ratio of ∼1:2:4 (https://www.
yeastgenome.org/). Dbp5 as a limiting factor further quali-
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Figure 7. The eIF3 complex binds to the ribosome after the Dbp5-mediated delivery of eRF1. (A) The eRF3 release factor Hcr1 does not bind to Dbp5
and only weakly to the ribosome. Co-IPs with GFP-tagged Hcr1 and as a control eRF1–GFPwith Dbp5, eRF3 and the ribosomal protein Asc1 are shown.
The asterisk indicates Hcr1–GFP. (B) Defects in the eRF1 delivery result in the absence of the eIF3 subunit Prt1 at the ribosome. Co-IPs of GFP-tagged
Prt1 with HA-tagged Rli1, eRF1, Dbp5, eRF3 and the ribosomal protein Asc1 are shown in wild-type and sup45-2 strains. The asterisk indicates that the
sup45-2 lysate lanes were exposed four times as long as the wild-type lanes. (C) The binding of the eIF3 subunits Prt1 and Nip1 are independent of the
nucleotide association of Rli1. The GFP-tagged eIF3 subunits were precipitated and the co-precipitated GST-tagged Rli1 and Asc1 are shown.
eRF3, because only theDbp5-delivered eRF1 can engage in
proper termination events. Excess of eRF1 overDbp5might
be required, because it participates also in ribosome recy-
cling (4,23,26) and thus remains bound for a longer time.
The high amounts of eRF3 might be required, because it
waits on every ribosome at late stages of elongation (Figure
6A and B) for eRF1 to enter. In support of this view, it is
interesting to note that a 20% decrease of the basal cellular
protein levels of Dbp5 or eRF1 already negatively impact
protein biosynthesis, while a 60% decrease of eRF3 has no
effect (14). Thus, theDbp5-mediated delivery of eRF1 is the
rate-limiting step, supporting a view that Dbp5 controls the
termination event.
Interestingly, our in vivo results clearly show that Dbp5 is
not bound to the ribosome during elongation (Figures 1F,
G, 2D and E), although its human homolog DDX19 has
been shown to stabilize translation elongation in vitro (14).
This might either be a difference between the human and
the yeast helicase, but it is also conceivable that in the in vivo
situation a contact of Dbp5 with the elongating ribosome is
prevented and its recruitment is only possible when bound
to eRF1.
Importantly, the simultaneous entry of Dbp5 and eRF1
in a complex has the advantage that Dbp5 protects eRF1
from premature access to eRF3, because Dbp5 occupies the
binding domain of eRF3, located at the last 25 amino acid
residues of the C-terminal domain (Figure 5). This is par-
ticularly important, because eRF3 is already present at the
ribosome, when Dbp5–eRF1 enters (Figure 6A and B). In
fact, a separated entry of eRF1 and eRF3 is actually sup-
ported by earlier studies, showing that a reduced eRF3 ex-
pression does not lead to a decreased ribosomal association
of eRF1 (3).
In situations of defective Dbp5 or Dbp5–ATP recycling,
as in the rat8-2 and nup159ΔN mutants, respectively, the
protected eRF1 delivery to the ribosome cannot occur and
eRF1 can contact eRF3 prior to its proper positioning and
stop codon recognition. This contact would induce eRF3
to release GDP and bind GTP, because the affinity of eRF3
to GTP strongly increases upon eRF1 contact (36,37). This
in turn can trigger the premature GTP-hydrolysis and sub-
sequent dissociation of eRF3–GDP and eRF1 from each
other and the ribosome (Figure 6F–I), as evident in these
mutants (Figures 3D, E, 4F and G). In support of such
a model, it is interesting to note that a reduced binding
of eRF3 to polysomes was already detected in rat8-2 cells
upon a very short, 20 min temperature shift to the non-
permissive temperature and in mutants of the co-factor of
Dbp5, GLE1 (10,12). As eRF1 would not have been prop-
erly positioned when Dbp5 cannot deliver it, stop codon
recognition, polypeptide chain- and tRNA-release would
be unsuccessful and translation might be continued with
near-cognate tRNAs, resulting in the observed readthrough
activity in nup159 and dbp5 mutants (Figure 4B and C).
Longer temperature shifts of both mutants and thus con-
stant defects in stop codon recognition and mRNA trans-
port cannot be tolerated and are lethal to cells (33,34).
Dbp5 not only impacts stop codon readthrough, but also
controls the delivery of eRF1 to near-cognate codons, such
as the UGG tryptophan codon, suggested by its suppres-
sion of the trp5Δ strain (Figure 6J). This supports a view,
inwhichDbp5 controls the delivery of eRF1. This discovery
further suggests that cells may use this system to trigger stop
codon readthrough in particular situations. Stress for ex-
ample changes the expression program of cells, as it blocks
bulk mRNA export, while it allows the uncontrolled export
of stress specific mRNAs (41,42). Such massive changes in
the cellular expression program might also involve Dbp5.
Intriguingly, it was reported that Dbp5 mislocalizes to the
nucleus upon ethanol stress (43), which would circumvent
the helicase to support efficient termination and rather pro-
mote the readthrough of stop codons. Also during glucose
starvation, in which the ATP-production is reduced, Dbp5
is most likely not efficiently re-charged with ATP, which in
turn should reduce the Dbp5-mediated eRF1 delivery and
result in an increased readthrough of stop codons.
Generally, stop codon readthrough has the potential to
create proteins with new or additional functions. Extended
C-termini could for instance add nuclear localization sig-
nals to normally cytoplasmic proteins and in this way re-
direct them to the nucleus. It is also possible that the
longer protein is unstable and quickly degraded. Moreover,
when no additional stop codon is present in an mRNA
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Figure 8. Stepwise entry model for translation termination. (Top) Step 1: Nucleotide-free Rli1 associates with the ribosomes as soon as the A-site is free.
It binds to eRF3–GDP. Step 2: Rli1 supports the entry of Dbp5–ATP bound eRF1. Gle1/IP6 stimulated ATP-hydrolysis of Dbp5–ATP leads to the
proper positioning of eRF1 on the stop codon. Dbp5–ADP dissociates and is recycled at the nuclear pore complex by Nup159. Step 3: Dissociation of
Dbp5–ADP allows the controlled interaction of eRF1 with eRF3. This in turn triggers the GTP recruitment of eRF3. Subsequent GTP hydrolysis leads to
conformational changes in eRF1 allowing adjustments in its positioning in the ribosomal peptidyl-transferase center. eRF3–GDP dissociates in a complex
with Hcr1, which was delivered by eIF3. Step 4: eRF3–GDP dissociation allows change of position and strong binding of Rli1–ATP that locks eRF1 in the
position necessary to mediate peptidyl-tRNA hydrolysis. Step 5: Upon peptide release, ATP-hydrolysis of Rli1–ATP recycles the ribosomal subunits, which
is supported by eRF1. (Bottom) Situation in which Dbp5 cannot deliver eRF1 to the ribosome that consequently results in the stop codon readthrough.
Step1: Rli1 associates and binds eRF3–GDP. Step 2: eRF1 is not protected by Dbp5 and contacts eRF3 before being properly positioned, leading to
premature GTP-binding, hydrolysis and the subsequent release of eRF1 and eRF3–GDP from the ribosome before the polypeptide chain and the tRNA
are released. Because eRF1 had contact to eRF3 before it was placed in the optimal position, it dissociates at the same time as eRF3. Step3: A near-cognate
tRNA gets access to the A-site, the stop codon is suppressed and translation elongation continues until the next stop codon is reached.
mRNA into the poly(A) tail. In such cases, the consequence
is the degradation of the protein and the mRNA by the no-
stop decay (NSD) system (44). In higher eukaryotes e.g.
in Drosophila or mammals, stop codon readthrough oc-
curs also during developmental processes and is called func-
tional translational readthrough (FTR) (45,46). In these
cases, the stop codons are suppressed and treated as sense
codons due to the competition between eRF1 and near-
cognate tRNAs at the A-site. It is tempting to speculate that
Dbp5/DDX19 might be involved in regulating such pro-
cesses.
Most interestingly, one-third of all inherited disorders
are caused by protein truncating pre-termination mutations
that lead to non-functional proteins or cause dominant neg-
ative effects, leading to cancer and neurodegenerative dis-
eases (47,48). Nonsense suppression therapies comprise ap-
proaches aiming at suppressing translation termination at
in-frame premature stop codons to restore the deficient pro-
tein function. Using Dbp5/DDX19 as a drug target to de-
crease its function and increase readthrough at premature
stop codons for suppression therapy might be a novel start-
ing point for therapies.
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Abstract: The DEAD-box protein Dbp5 (human DDX19) remodels RNA-protein complexes. Dbp5
functions in ribonucleoprotein export and translation termination. Termination occurs, when the
ribosome has reached a stop codon through the Dbp5 mediated delivery of the eukaryotic termination
factor eRF1. eRF1 contacts eRF3 upon dissociation of Dbp5, resulting in polypeptide chain release
and subsequent ribosomal subunit splitting. Mutations in DBP5 lead to stop codon readthrough,
because the eRF1 and eRF3 interaction is not controlled and occurs prematurely. This identifies
Dbp5/DDX19 as a possible potent drug target for nonsense suppression therapy. Neurodegenerative
diseases and cancer are caused in many cases by the loss of a gene product, because its mRNA
contained a premature termination codon (PTC) and is thus eliminated through the nonsense
mediated decay (NMD) pathway, which is described in the second half of this review. We discuss
translation termination and NMD in the light of Dbp5/DDX19 and subsequently speculate on reducing
Dbp5/DDX19 activity to allow readthrough of the PTC and production of a full-length protein to
detract the RNA from NMD as a possible treatment for diseases.
Keywords: translation; translation termination; mRNA quality control; NMD; Dbp5; Rat8; DDX19;
mRNA degradation
Translational control is an organized and adaptable mechanism, which is vital for all organisms in life.
The expression level and the quality of the protein expressed from a protein-coding gene depend both
on the stability and on the quality of the expressed mRNA. Eukaryotic cells have evolved nuclear and
cytoplasmic mRNA surveillance systems. Nuclear quality control captures transcripts that experience
problems in 5′-capping, 3′ polyadenylation and/or intron splicing, prevents their nuclear export and
initiates their degradation [1–3]. In contrast to that, the cytoplasmic quality control system ensures
integrity of the mRNA open reading frame by monitoring ribosomal decoding. If this is not the case
and the ribosome stalls without encountering a stop codon, those transcripts are eliminated by the
no-go decay (NGD) and no-stop decay (NSD). When a premature termination codon (PTC) is detected,
mRNA degradation occurs via the nonsense mediated decay (NMD) [4,5].
In this review we will summarize the process of translation termination with a focus on
Dbp5/DDX19. We will then introduce the principles of NMD and explain the role of Dbp5/DDX19
between these two events. Finally, we will discuss why we think that Dbp5/DDX19 might be an
interesting drug target to manipulate these processes and use this for potential treatments of diseases.
1. Translation Termination
On normal mRNAs, translation initiation is followed by elongation and ends with termination.
Subsequently the ribosomes are split, which is termed ribosome recycling. These processes are linked
Int. J. Mol. Sci. 2020, 21, 1085; doi:10.3390/ijms21031085 www.mdpi.com/journal/ijms
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through proteins that act comprehensively to maintain the homeostasis of the 40S and 60S ribosomal
subunits, important for repeated rounds of translation. Initiation and elongation involve multiple
players and several excellent reviews exist that describe the earlier phases of translation in detail [6–8].
Translation termination comprises three key events: (1) Recognition of the stop codon, (2) hydrolysis
of the terminal peptidyl-tRNA bond and polypeptide chain release, and (3) ribosome recycling and
disassembly of the termination complex. As soon as one of the three stop codons is reached on the
RNA, the eukaryotic release factor eRF1 (encoded by SUP45 in yeast) binds to the ribosomal A-site.
eRF1 interacts with the GTPase eRF3 (encoded by SUP35 in yeast), leading to polypeptide chain
release and ribosome recycling [9]. eRF1 consists of three domains, which structurally mimic the
shape of tRNAs with which it competes for binding to the ribosome. The N terminal domain, which
comprises the YxCxxxF and TASNIKS motifs, is most important for recognition and binding to the
stop codon [10–12]. The central domain on the other hand, especially the methylated GGQ motif,
is necessary for the hydrolysis of the peptidyl-tRNA bond [13]. The C-terminal domain of eRF1 finally
contacts eRF3, leading to its GTP-binding and subsequent hydrolysis and results in a conformational
change important for proper termination [14,15]. Importantly, GTP hydrolysis of eRF3 leads to the
dissociation of eRF1 and eRF3, allowing eRF1 to interact with Rli1 (ABCE1 in human) [6]. Rli1 not only
functions in translation termination but also has an important function in ribosome splitting by forcing
the ribosomal subunits apart through a tweezers-like movement upon NTP-hydrolysis. However,
in termination the ordered binding of Rli1 to eRF1 after eRF3 release leads to conformational changes
of eRF1, resulting in the aminoacyl bond hydrolysis [16–19].
During ribosome recycling, the ribosomes are split, resulting in free 60S subunit and a 40S subunit
bound to mRNA and the deacylated tRNA, and subsequently, the post-termination complexes are
disassembled. Recycling requires Rli1 to free the subunits and the eukaryotic initiation factors (eIF)
1, 1A and 3 to prevent reformation of the ribosome through occupying the post-recycled ribosomal
subunits [20].
Most of the knowledge about termination and recycling was gained through in vitro assays
and kinetic analyses in which nothing seemed to be missing. However, the situation in vivo must
be different and regulation of these processes more complex because additional termination factors
were discovered. Defects in termination, detected in termination readthrough assays, identified
mutations in eIF5A and Pub1 that affect translation termination. Pub1 seems to fine tune termination in
different nucleotide surroundings and eIF5A supports eRF1 activity in polypeptide chain release [21,22].
Research, mostly with Sachharomyces cerevisiae, identified additional important termination factors.
Readthrough defects were furthermore detected in mutants of the initiation factors eIF3 and Hcr1 [23,24]
and the DEAD-box RNA helicase Dbp5 [25]. The initiation factors eIF3 and Hcr1 function in the release
of the termination complex, which is why Hcr1 is not only considered as bona fide initiation factor
anymore. It was shown, that Hcr1, which is delivered by eIF3, releases eRF3-GDP from the ribosome
after termination [16,23,24]. The function of Dbp5 in translation termination was surprising. Not only
because it has an additional well-known function in mRNA export but also because identification of its
function abrogated the prior view that eRF1 and eRF3 would enter the ribosome together.
2. The Function of Dbp5 in Translation Termination
The DEAD-box protein Dbp5 has a well-established function in mRNA export from the nucleus
to the cytoplasm [25–29]. Dbp5 (encoded by RAT8 in yeast and DDX19 in humans) is conserved and
essential in all eukaryotes. It acts as an RNA helicase with an ATP dependent RNA- and protein
complex remodeling activity [27,30]. Dbp5 belongs to the helicase superfamily 2 (SF2) and contains
13 characteristic sequence motifs and the eponymous sequence Asp-Glu-Ala-Asp (DEAD) in motif 2
(Figure 1) [31]. Dbp5 is localized in the nucleus, in the cytoplasm and concentrated around the nuclear
rim [27,32]. A nuclear export signal and a nuclear import signal were identified in the N-terminus of
the protein, enabling shuttling between the compartments [33]. The helicase core of Dbp5 is composed
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of two highly conserved RecA-like domains linked by a hinge region [34]. The unique N-terminal
extension of Dbp5 is important for its autoregulation and determines the specificity of the enzyme [35].
Figure 1. Scheme of the domain structure of Dbp5. Indicated are the domains important for RNA- and
ATP binding (red) and the domains important for the interaction partners and co-factors (grey).
In mRNA export, Dbp5 displaces the mRNA export receptor heterodimer Mex67-Mtr2 from
the appearing transcript on the cytoplasmic side of the nuclear pore complex (NPC) [36]. Located
at the cytoplasmic filaments of the NPC, Dbp5 interacts with the N-terminal domain of its ADP
release factor NUP159/Rat7 for recycling, enabling multiple rounds of Mex67-dissociation [27,37,38].
Under physiological conditions, Nup159 is not the only co-factor required for Dbp5 activity but also
Gle1-IP6 [38,39]. Gle1-IP6 preferentially binds to ATP-Dbp5 and causes a conformational change to
initiate ATPase activity [40,41]. ATP bound Dbp5 shows the highest affinity for single stranded RNA,
and the presence of a non-hydrolysable ATP analog leads to tightly bound RNA in vitro [38,42]. Thus,
by binding to Gle1, the ATPase- and remodeling-activity of Dbp5 is triggered and the subsequent
conformational change allows Nup159 binding and recycling of the helicase [29,40,43,44]. Besides
mRNA export, Dbp5 was identified to participate in the nuclear export of pre-ribosomal subunits and
tRNA; however, its role in these processes is less well understood [33,45].
The function of Dbp5 in translation termination was first identified in 2007 [25]. Dbp5 was
detected in polysomes and mutants of DBP5 were shown to be hypersensitive to translational
inhibitors. In addition, physical interaction of Dbp5 and eRF1 was shown [25]. Subsequently, also
Gle1 was identified to co-localize with translating ribosomes and identified as an interaction partner of
eRF1 [40,46]. Most importantly, mutations in DBP5 and GLE1 caused severe stop codon readthrough
defects [25,40]. Likewise, it was recently shown that the human protein DDX19 stabilizes translation
termination complexes and participates in termination [47].
Subsequent in vivo and in vitro studies suggest that Dbp5 regulates a stepwise assembly of
the termination complex (Figure 2) and [16]. Although not all details are clear and established, the
following model suggests the most likely mechanism for translation termination. Unlike what was
anticipated in older models, eRF1 and eRF3 presumably do not enter termination together as a complex,
but rather Rli1 and eRF3-GDP associate with the ribosome first as soon as the A-site is unoccupied.
Subsequently, nucleotide free Rli1 promotes the binding of the Dbp5-eRF1 complex, which formed
before in the cytoplasm. After delivery of eRF1 through the helicase Dbp5 and its proper positioning
in the A-site of the ribosome, which requires ATP hydrolysis, Dbp5-ADP dissociates. For its recycling
Dbp5 moves to the NPC, where it releases the ADP and re-binds to ATP through the actions of
Nup159 and Gle1-IP6. Dbp5-ATP then captures a new eRF1 molecule, preparing for the next round of
translation termination [16]. The double duty of Dbp5 in mRNA export and in termination, not only
couples these important processes but also shows how efficient nature uses one factor for several
functions. Remarkably, Gle1 seems to stay longer at the ribosome than Dbp5 and presumably has an
additional function in ribosome recycling or translation initiation. This is independent of Dbp5 and
IP6, as Gle1 interacts with the eIF3, which was not seen for Dbp5 [16,43,46].
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Figure 2. Model for translation termination. The yeast DEAD-box RNA helicase Dbp5 delivers eRF1 to
the ribosome located on a stop codon. Its function is to prevent an early contact of eRF1 with eRF3.
As soon as eRF1 was placed properly, the ATP-hydrolysis of Dbp5 dissociates the helicase. Free eRF1
subsequently contacts eRF3 that waited in its GDP-bound form attached to Rli1. This contact triggers
GTP-binding of eRF3 and subsequent hydrolysis causing polypeptide chain and tRNA release. At the
same time, eIF3 delivers Hcr1, which eliminates eRF3 from the complex. Removal of eRF3 enables
contact of eRF1 with Rli1-ATP and through ATP-hydrolysis the ribosomal subunits are split.
The scenario at the ribosome after Dbp5 has delivered eRF1 and has left the termination complex
continues with the interaction of eRF1 and eRF3 (Figure 2). Their interaction is prevented as long as
Dbp5 is bound, because both proteins bind to the C-terminus of eRF1, and their binding is mutually
exclusive. In fact, competition experiments revealed that eRF3 is not able to dissociate a preformed
Dbp5-eRF1 complex [16]. In this way, the interaction of eRF1 and eRF3 is prevented until eRF1 was
properly positioned. This is most important to prevent a premature contact, because as soon as these
proteins interact with each other, eRF3 has a higher affinity to GTP, which instantly triggers GTP
hydrolysis and dissociation of eRF1 and eRF3. eRF3-GDP is removed from the termination complex
by Hcr1 [16,23,24]. Such a regulatory principle, the shielded delivery of eRF1 by Dbp5, makes sense,
when considering the situation in mutants of DBP5, in which eRF1 does not bind and is therefore not
delivered to the ribosome by the helicase.
3. Mutations in DBP5 Lead to Termination Readthrough
When Dbp5 is not functional, as shown in several mutants, eRF1 approaches the ribosome on its
own and contacts eRF3 before it is properly positioned for termination, resulting in the immediate
dissociation of both release factors and translational readthrough [16]. Inefficient termination increases
the chance of the incorporation of a near-cognate tRNA and results in ongoing translation and longer
proteins (Figure 3) and [16].
In most cases, general readthrough might be problematic for cells, however, tuning readthrough
also holds the possibility for regulation. Such a potential regulation is still unclear and not much is
known for a possible role of Dbp5. However, for example during stress, Dbp5 localizes to the nuclei
of cells [48] and is thus depleted from the cytoplasm. Its absence presumably causes translational
readthrough at stop codons, allowing the synthesis of longer polypeptides. This could create proteins
with new functions, such as proteins that in their longer form now contain a nuclear localization signal
or a degradation signal, which can change their place of function or eliminate this protein function
altogether. In multicellular organisms, Dbp5/DDX19 might even be developmentally regulated, e.g.,
by phosphorylation or other modifications, for such purposes under normal conditions. These aspects
certainly need more research for clarification.
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Figure 3. Lack of Dbp5 leads to translational readthrough. Mutations in Dbp5 prevent a shielded
entry of eRF1 to the ribosome, resulting in an early contact of eRF1 and eRF3 and their subsequent
dissociation. This increases the probability for the incorporation of a near-cognate tRNA and the
continuation in translation.
4. Regulatory Principles in Nonsense Mediated Decay (NMD)
For more than 25 years, one major goal has been to understand the mechanisms underlying NMD.
Although at first only considered as a cytoplasmic mRNA quality control system, current research
has clearly identified its power in regulating the RNA-transcriptome beyond RNA surveillance, e.g.,
in biological contexts such as development [49,50]. Therefore, it is of particular interest to identify the
parameters that in the cells discriminate mRNAs that should be translated from those that should
be degraded. Clearly, NMD is linked to inefficient translation termination [51]. However, when and
why this can occur is not fully understood. Not only the RNA sequence itself is relevant but also the
proteins within the ribonucleoparticle (RNP).
Generally, in mRNA surveillance, a premature termination codon (PTC) is distinguished from a
normal one as the trigger for NMD. NMD can only be initiated during translation termination as it
requires the decoding of a stop codon by eRF1 and eRF3 [52]. At a PTC, the ATPase and helicase Upf1
interacts with eRF1 and eRF3 to initiate the NMD pathway (Figure 4) and [53,54]. Upf1 is activated by
its less abundant co-factors Upf2 and Upf3 [55,56]. These trigger a conformational change in Upf1 to
increase its ATPase and Helicase activity, which is initially inhibited by eRF1 and eRF3 [53,57]. In higher
eukaryotes SMG1 (and its co-factors SMG8 and SMG9) binds to UPF1 to form the SURF (SMG1 UPF1
Release Factors) complex [58,59]. Then, the helicase DHX34 promotes the association with UPF2 and
UPF3 to form the DECID (decay inducing) complex [60]. Further, SMG1 phosphorylates UPF1 [61],
which is considered to be the step that commits an mRNA to NMD [62]. In S. cerevisiae phosphorylation
of Upf1 was also described, but there the relevance is not clear [63,64]. After formation of the Upf1-2,3
complex (or DECID complex in higher eukaryotes), Upf1 triggers rapid mRNA degradation.
Of course, the NMD pathway should only be initiated when translation termination occurs
prematurely. Several models have been proposed to describe the differentiation of a normal stop
codon and a PTC. The two main models are the exon junction complex (EJC) induced NMD and the
long 3′UTR model [65]. The former is based on the position of the EJC, a complex that is placed
during splicing near the exon–exon junction [66]. Stop codons typically occur in the last exon and
have no downstream EJC in the 3′UTR. If, however, translation is terminated at a stop codon that is
followed by an EJC, the complex strongly promotes NMD [67–69]. It serves as a binding platform for
UPF2 and UPF3 and, if downstream of a termination event, promotes their interaction with the SURF
complex [58,70,71] The long 3′UTR model, which is more relevant in yeast but also described in higher
eukaryotes, focuses on the distance between a stop codon and the poly(A) tail. A normal stop codon
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is typically in proximity to the poly(A) tail and the poly(A) binding protein Pab1 (PABP in human).
Pab1 interacts with eRF3, promotes regular termination and prevents NMD [51,72,73]. At a PTC the
distance to Pab1 is increased, which allows the formation of the Upf1-2,3 complex and the initiation
of NMD. Further, Upf1 ubiquitously binds any mRNA and is displaced by the translating ribosome.
As a consequence, Upf1 stays bound to the 3′UTR. It was suggested that longer 3′UTRs have more
bound Upf1 molecules, which might promote the Upf1 binding to the terminating ribosome [74,75].
In addition to these two models, it was found that the sequence downstream (and in a few cases
upstream) of the stop codon further promotes or inhibits NMD [76–79].
Figure 4. Termination at a premature termination codon (PTC) and the subsequent initiation of the
nonsense mediated decay (NMD) of the mRNA. Under normal conditions yeast Dbp5 promotes the
stop codon recognition by eRF1 and eRF3 also at a PTC. However, when recognized as premature by the
NMD machinery, Upf1 binds to the release factors and assembles the Upf1-2,3 complex. Consequently,
further translation is inhibited, and downstream factors are recruited to promote rapid mRNA decay.
The decapping factors Dcp1 and Dcp2 and Xrn1 act from 5′ to 3′ and the Ski complex and the exosome
degrade the PTC-containing mRNA from 3′ into 5′ direction.
Although there is growing insight into the mechanisms by which NMD is initiated and degrades
transcripts, there are still many open questions. It is for instance unknown how PTC-detection is
signaled to the ends of the transcript, where degradation is initiated. In this context, the mRNP
conformation during NMD is presumably important but not yet understood. For the EJC induced
NMD in humans, it was described that Upf1 interacts with the cap binding complex (CBC) in a
process where the mRNA might fold back so that the Upf1 complex at the PTC can reach the 5′
end [80,81]. In yeast NMD, however, where the 3′ UTR length is the main determinant, the CBC
is dispensable [82]. Moreover, NMD was shown to occur also on transcripts in which CBC has
dissociated and instead the cap binding protein and translation initiation factor eIF4E has bound [76,83].
Presumably several proteins are involved in the required mRNP remodeling for NMD, but this is to
date almost completely unknown.
In the EJC independent initiation of NMD, it is unclear how Upf2 and Upf3 join Upf1. In yeast,
it is assumed that they must be specifically recruited to NMD targets, due to their low cellular
abundance. However, their association with translated mRNPs is Upf1 independent [84], suggesting an
involvement of other currently unknown NMD factors. The sequences that affect NMD, and proteins
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that bind to these sequences are poorly understood, but these appear to affect both the EJC induced
NMD and long 3′ UTR induced NMD in yeast as well as in metazoans [76–79].
NMD of different targets presumably requires a different subset of proteins; even the co-factor
Upf2 is not required for all NMD [65,67]. Which proteins are functioning in which instances of NMD
and how this is regulated are still very hazy matters. Future research will have to identify new NMD
factors and sort out their functions on different NMD targets. In particular research in simple organisms
such as baker’s yeast can help to untangle the underlying basic principles of NMD.
5. Termination Readthrough and Nonsense Mediated Decay (NMD)
Another aspect is important in this regard. Many inherited human diseases and cancer types
are caused by the loss of a specific protein due to the elimination of its transcripts that contained a
premature termination codon (PTC) [85–87]. In fact, one-third of inherited human diseases are due to
PTCs, and such premature stops in translation account for up to 70% of all genetic disorders [88–90].
Such PTC containing transcripts can result from, e.g., splicing defects or mutations in the DNA. Usually,
such PTC containing mRNAs are recognized and eliminated by nonsense mediated decay, so that
the protein is never made. However, some PTC-containing transcripts escape NMD and produce
truncated, dominant, negatively operating gene products that can also cause diseases [85,91].
It was observed that overexpressing Upf1 alleviates the negative effects in a TDP-43 induced
rat model of the neurodegenerative disease ALS [92]. Thus, promoting NMD in such cases might
be a valuable therapeutic approach. However, in some cases, the remaining functional allele is
haploinsufficient, and NMD cannot regain the functional protein of a PTC containing transcript [93].
In these cases, readthrough of the PTC may recover the loss of function. When a PTC is read through,
a near cognate tRNA is inserted at the stop codon, and translation continues until it is terminated by
the correct termination codon [94]. Hence, the produced protein has, if at all, only one amino acid
exchange and can, at least partially, recover the loss of function. Indeed, for several targets it was
reported that nonsense suppressors increase the amount of functional protein [95]. Such an approach
is also potentially interesting for cancer research as some types of cancer carry nonsense mutations
in tumor suppressors [96–98], which may regain function through readthrough. Generally, nonsense
suppression as a therapeutic approach is encouraged by the fact that PTCs are more susceptible to read
through than normal stop codons, presumably due to reduced termination efficiency at a PTC [51,95].
Research with suppression agents revealed that global translation is unaffected at concentrations that
cause read through at PTCs [95,99,100]. This does not preclude, however, the possibility of side effects
of nonsense suppression therapy as NMD is also involved in regulatory mechanisms that include wild
typical PTC-containing mRNAs [101].
Attempts were started to downregulate NMD, allowing the production of some of the full-length
protein as treatment for diseases. Such drugs could act as nonsense suppressors (e.g., Ataluren or RTC13).
These compounds can be natural or synthetic aminoglycosides and nonaminoglycosides [100,102–106].
Interestingly, several compounds have already been identified to inhibit the helicase and ATPase
activities of the Plasmodium falciparum Dbp5/DDX19 homolog PfD66 [107]. Although promising,
a great concern with these compounds is that they lack drug target specificity. Moreover, the many gaps
and weaknesses in current NMD models urge for further research of the mechanisms and participating
factors in NMD.
Further, different NMD targets do not respond similarly to one nonsense suppressor. Ataluren
(also called PTC124), a therapeutic for Duchenne muscular dystrophy, was not approved for Cystic
Fibrosis, as clinical trials did not show sufficient improvement [108,109]. This highlights the necessity
to investigate further and for different approaches in nonsense suppression. Here Dbp5/DDX19 might
serve as an interesting new drug target to fine tune translation read through, possibly in conjunction
with other drugs in lower doses (Figure 5).
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Figure 5. Affecting the availability of functional Dbp5 might generate full length proteins from PTC
containing mRNAs. With a reduced function of Dbp5, the stop codon recognition of eRF1 and eRF3
is impaired. If the PTC is not recognized as a stop codon, a near cognate peptidyl-tRNA enters the
ribosome, and translation elongation continues. A normal stop codon is less susceptible to translational
readthrough than a PTC, presumably due to additional factors that promote translation termination,
such as Pab1. Hence, there is a high probability that translation can terminate at the correct stop codon
rather than at the PTC. This will most likely generate a full-length protein with only one amino acid
exchange instead of a truncated polypeptide.
Strategies to repress NMD for correct protein production are one hope for therapy. Understanding
the full mechanistic details of translation termination and NMD in the cellular context will be important
and necessary to develop more sophisticated therapies for PTC-caused diseases.
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